https://www.spreaker.com/podcast/pharmatalkradio--6440740enScienceCopyright Conference Forumhttps://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/e5998a3328cac37b741454b3a81caf15.jpghttps://www.spreaker.com/podcast/pharmatalkradio--6440740Tue, 14 Jul 2026 18:29:00 +0000Conference ForumConference Forumservice@tcfllc.orgPharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry...falseepisodichttps://www.spreaker.com/episode/what-to-expect-at-partnerships-with-sites-2026--72972952https://api.spreaker.com/episode/72972952Tue, 14 Jul 2026 18:28:46 +0000Conference Forum327falsefullhttps://www.spreaker.com/episode/unlocking-unstructured-data-with-ai-for-optimized-protocol-development--72296117More specifically, Mike discusses:  

• How Advarra is leveraging past IRB data sources to identify common causes of site burden, study delays and amendments 
• What questions sponsors should be asking of AI vendors, to pick the correct partner 
• How sponsors have responded to the insights surfaced by this technology  
• Why sponsors must adapt to a flexibility mindset in order to truly make changes with downstream impact 

]]>https://api.spreaker.com/episode/72296117Tue, 02 Jun 2026 16:49:02 +0000Conference ForumIn this podcast, Mike Eckrote, SVP, Strategic Solutions at Advarra, talks about how artificial intelligence is being used to pull insights out of structured and unstructured data sources to help sponsors avoid protocol amendments and delays.   More...More specifically, Mike discusses:  

• How Advarra is leveraging past IRB data sources to identify common causes of site burden, study delays and amendments 
• What questions sponsors should be asking of AI vendors, to pick the correct partner 
• How sponsors have responded to the insights surfaced by this technology  
• Why sponsors must adapt to a flexibility mindset in order to truly make changes with downstream impact 

]]>1444falsefullhttps://www.spreaker.com/episode/bridging-access-gaps-sponsor-led-enablement-of-research-naive-sites-to-expand-patient-reach--71926598

• How naïve sites can help address access and enrollment bottlenecks
• How to support inexperienced sites with the right sponsor-led infrastructure
• What it takes to shift internal expectations and foster lasting site partnerships

Speakers:
Carrie Lewis Executive Director, Clinical Program Optimization, Endo
Suzy Montayne Site Relationship Manager, Endo
Terry Oehler, DPM Founder & CEO, Colorado Clinical Research]]>https://api.spreaker.com/episode/71926598Fri, 08 May 2026 16:28:10 +0000Conference ForumTapping into research-naïve sites offers a strategic opportunity to expand patient access. That’s exactly what Endo did when faced with challenges activating sites for their orthopedic study. This case study shares how Endo enabled a new site through...

• How naïve sites can help address access and enrollment bottlenecks
• How to support inexperienced sites with the right sponsor-led infrastructure
• What it takes to shift internal expectations and foster lasting site partnerships

Speakers:
Carrie Lewis Executive Director, Clinical Program Optimization, Endo
Suzy Montayne Site Relationship Manager, Endo
Terry Oehler, DPM Founder & CEO, Colorado Clinical Research]]>1404falsefullhttps://www.spreaker.com/episode/building-trust-driven-partnerships-astrazeneca-s-concierge-approach-to-accelerating-site-activation-and-enrollment--71926279

• How continuous site feedback loops and flexibility with SOPs improved startup timelines
• Metrics from a recent study showing impact: 30% faster budget negotiations, 27% reduced activation times, 68% of recruitment from 42% of sites
• Tools and tactics used to build consistency, transparency, and trust across studies
• Lessons learned and how the program has scaled globally

Speakers:
Shannon Edwards Site Engagement Lead, AstraZeneca
Tina Nghiem Site Engagement Lead, AstraZeneca
]]>https://api.spreaker.com/episode/71926279Fri, 08 May 2026 16:20:55 +0000Conference ForumAstraZeneca’s US Site Engagement Leads will share how they are reimagining sponsor-site relationships through a trust-first, high-engagement operating model that emphasizes flexibility, responsiveness, and co-creation. This session will showcase how...

• How continuous site feedback loops and flexibility with SOPs improved startup timelines
• Metrics from a recent study showing impact: 30% faster budget negotiations, 27% reduced activation times, 68% of recruitment from 42% of sites
• Tools and tactics used to build consistency, transparency, and trust across studies
• Lessons learned and how the program has scaled globally

Speakers:
Shannon Edwards Site Engagement Lead, AstraZeneca
Tina Nghiem Site Engagement Lead, AstraZeneca
]]>1317falsefullhttps://www.spreaker.com/episode/eli-lilly-on-site-enablement-co-designing-solutions-with-sites--71926159
Fireside Guest: Shafaat Ali Khan Clinical Research Lead (CRL) Director – Investigator Engagement, Eli Lilly & Co
Moderator: Jyoti Angal, PhD Director, Clinical Research, Avera McKennan Hospital & University Health Center]]>https://api.spreaker.com/episode/71926159Fri, 08 May 2026 16:14:16 +0000Conference ForumA case study highlighting how Eli Lilly partnered with clinical sites to co-design practical, site-centric solutions that enhanced trial execution and operational efficiency. Fireside Guest: Shafaat Ali Khan Clinical Research Lead (CRL) Director –...
Fireside Guest: Shafaat Ali Khan Clinical Research Lead (CRL) Director – Investigator Engagement, Eli Lilly & Co
Moderator: Jyoti Angal, PhD Director, Clinical Research, Avera McKennan Hospital & University Health Center]]>2590falsefullhttps://www.spreaker.com/episode/what-a-strategic-partnership-looks-like-in-practice-inside-the-takeda-basil-collaboration-that-delivered-tenfold-enrollment--71925843

• Identifying and partnering with highpotential sites
• Incorporating site feedback and early collaboration to improve trial execution
• Building trust and fostering long-term site relationships
• Key actions that led to exceptional enrollment and trial efficiency

Speakers:
Brandon Doyle, MBA Associate Director, Study Site Engagement, Takeda 
Mark Rapp, MD Principal Investigator, Basil Clinical Research
]]>https://api.spreaker.com/episode/71925843Fri, 08 May 2026 16:04:24 +0000Conference ForumThis case study highlights how Basil Clinical Research and Takeda’s first-time partnership became the top global recruiter, exceeding enrollment goals by tenfold through proactive assessments, early collaboration, and inclusive design. Learn how...

• Identifying and partnering with highpotential sites
• Incorporating site feedback and early collaboration to improve trial execution
• Building trust and fostering long-term site relationships
• Key actions that led to exceptional enrollment and trial efficiency

Speakers:
Brandon Doyle, MBA Associate Director, Study Site Engagement, Takeda 
Mark Rapp, MD Principal Investigator, Basil Clinical Research
]]>1234falsefullhttps://www.spreaker.com/episode/using-digital-technologies-to-enhance-patient-experience-and-better-manage-supply-chain--71878585

• Integrating connectivity into drug delivery devices as a way to improve patient engagement and adherence
• How pharma can use drug delivery device data with predictive analytics to forecast demand and optimize production
• Enabling patient-centric design and innovation by analyzing device usage data

To learn more about the PODD Conference, please visit PODDConference.com.]]>https://api.spreaker.com/episode/71878585Tue, 05 May 2026 17:17:06 +0000Conference ForumIn this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts address:  - Integrating connectivity into drug delivery devices as a way to improve patient engagement and...

• Integrating connectivity into drug delivery devices as a way to improve patient engagement and adherence
• How pharma can use drug delivery device data with predictive analytics to forecast demand and optimize production
• Enabling patient-centric design and innovation by analyzing device usage data

To learn more about the PODD Conference, please visit PODDConference.com.]]>1782falsefullhttps://www.spreaker.com/episode/ensuring-sustainability-throughout-drug-and-device-development--71878583

How pharma and suppliers can improve sustainability

Creating designs with lower carbon footprints relative to fabrication and materials

Circular recycling models

To learn more about the PODD Conference, please visit PODDConference.com.
]]>https://api.spreaker.com/episode/71878583Tue, 05 May 2026 17:15:12 +0000Conference ForumIn this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts address how the biopharma and drug delivery industries actively move to embed sustainability into core...

How pharma and suppliers can improve sustainability

Creating designs with lower carbon footprints relative to fabrication and materials

Circular recycling models

To learn more about the PODD Conference, please visit PODDConference.com.
]]>1720falsefullhttps://www.spreaker.com/episode/utilizing-ai-to-facilitate-combination-product-development--71878564
To learn more about the PODD Conference, please visit PODDConference.com.
]]>https://api.spreaker.com/episode/71878564Tue, 05 May 2026 17:13:12 +0000Conference ForumIn this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives discuss specific examples of AI/ML usage by pharma companies through the combination product development process from iteration to...
To learn more about the PODD Conference, please visit PODDConference.com.
]]>1796falsefullhttps://www.spreaker.com/episode/achieving-effective-manufacturing-scaleup-for-clinical-and-commercial-success--71878319
In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma and CDMO executives discuss effective partnering between pharma and manufacturing as well as growing pains and lessons learned in scaling.

To learn more about the PODD Conference, please visit PODDConference.com.
]]>https://api.spreaker.com/episode/71878319Tue, 05 May 2026 17:09:57 +0000Conference ForumManufacturing scaleup is a key hurdle in enabling the efficacy of new device technologies. Often this requires a mix of internal and external manufacturing and implementing a commercial control strategy across partners. In this panel discussion from...
In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma and CDMO executives discuss effective partnering between pharma and manufacturing as well as growing pains and lessons learned in scaling.

To learn more about the PODD Conference, please visit PODDConference.com.
]]>1784falsefullhttps://www.spreaker.com/episode/advances-and-opportunities-in-dual-chamber-injectables--71876825

• Overcoming primary container and autoinjector challenges for liquid-liquid delivery
• Improving upon dual chamber reconstitution devices
• Finding the right approach to navigate supply chain

To learn more about the PODD Conference, please visit PODDConference.com.]]>https://api.spreaker.com/episode/71876825Tue, 05 May 2026 14:45:09 +0000Conference ForumIn this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss progess in the development of liquid/liquid and liquid/lyo dual chamber systems. Specifically, they...

• Overcoming primary container and autoinjector challenges for liquid-liquid delivery
• Improving upon dual chamber reconstitution devices
• Finding the right approach to navigate supply chain

To learn more about the PODD Conference, please visit PODDConference.com.]]>1644falsefullhttps://www.spreaker.com/episode/how-evinova-is-integrating-ai-into-clinical-development-to-bring-big-impact-to-big-pharma--70250752About this Podcast:
 As pharma sponsors continually assesses how to integrate AI into their ways of working, Evinova’s Chief Technology Officer, Sean Connolly, talks about where, how, and when AI is actually making an impact on clinical development based on insights and experiences of working with pharma.

Sean share his thoughts on going for low hanging fruit to encourage adoption, what he's seen in terms of pharma companies that are successfully implementing AI across their enterprise, and how he would recommend organizations that are just starting out on their AI journey assess their individual needs and priorities when it comes to AI.

More specifically, Sean discusses:  

• Separating short-term, mid-term and long-term costs and benefits of implementing AI 

• What business leaders at JP Morgan Health 2026 were saying about how they view the value of AI 

• AI deployed for bottom-line revenue versus internal team efficiency 

• What the first steps would be for sponsors to successfully integrate AI across their enterprise 

]]>https://api.spreaker.com/episode/70250752Tue, 24 Feb 2026 15:21:13 +0000Conference ForumAbout this Podcast:  As pharma sponsors continually assesses how to integrate AI into their ways of working, Evinova’s Chief Technology Officer, Sean Connolly, talks about where, how, and when AI is actually making an impact on clinical development...About this Podcast:
 As pharma sponsors continually assesses how to integrate AI into their ways of working, Evinova’s Chief Technology Officer, Sean Connolly, talks about where, how, and when AI is actually making an impact on clinical development based on insights and experiences of working with pharma.

Sean share his thoughts on going for low hanging fruit to encourage adoption, what he's seen in terms of pharma companies that are successfully implementing AI across their enterprise, and how he would recommend organizations that are just starting out on their AI journey assess their individual needs and priorities when it comes to AI.

More specifically, Sean discusses:  

• Separating short-term, mid-term and long-term costs and benefits of implementing AI 

• What business leaders at JP Morgan Health 2026 were saying about how they view the value of AI 

• AI deployed for bottom-line revenue versus internal team efficiency 

• What the first steps would be for sponsors to successfully integrate AI across their enterprise 

]]>1651falsefullhttps://www.spreaker.com/episode/how-bayer-reorganized-their-clinical-operations-structure-for-efficiency-and-cost-savings--69670902Recorded at DPHARM 2025, Bayer's Dr Bernhard Glombitza reports on the development, implementation and early impact of their clinical operations reorgnization. He describes how shifting from a traditional hierarchical model to a network of highly empowered teams reduced management layers, broadening the scope of work and changed cross-country operations monitoring. 

Dr Glombitza details the results of the change thus far, including significant increases in efficiency and reduction in cost, maintaining quality levels and study targets, and improving employee job satisfaction. ]]>https://api.spreaker.com/episode/69670902Thu, 29 Jan 2026 19:32:41 +0000Conference ForumAbout this podcast: Recorded at DPHARM 2025, Bayer's Dr Bernhard Glombitza reports on the development, implementation and early impact of their clinical operations reorgnization. He describes how shifting from a traditional hierarchical model to a...Recorded at DPHARM 2025, Bayer's Dr Bernhard Glombitza reports on the development, implementation and early impact of their clinical operations reorgnization. He describes how shifting from a traditional hierarchical model to a network of highly empowered teams reduced management layers, broadening the scope of work and changed cross-country operations monitoring. 

Dr Glombitza details the results of the change thus far, including significant increases in efficiency and reduction in cost, maintaining quality levels and study targets, and improving employee job satisfaction. ]]>750bayer,clinicaloperations,clinicalresearch,clinicaltrialoperations,disruptive,dpharm,innovation,medicinedevelopmentfalsefullhttps://www.spreaker.com/episode/how-amicus-embedded-patient-advocacy-into-its-corporate-dna--69667685About this podcast:
In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact.

More specifically, Ms Gershkowitz focuses on:

• Defining role standards and recruiting the right talent 
• Co-creatin research with patient communities and developing patient-centered outcomes
• Generating metrics that demonstrate the impact on R&D

]]>https://api.spreaker.com/episode/69667685Thu, 29 Jan 2026 16:18:09 +0000Conference ForumAbout this podcast: In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure...About this podcast:
In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact.

More specifically, Ms Gershkowitz focuses on:

• Defining role standards and recruiting the right talent 
• Co-creatin research with patient communities and developing patient-centered outcomes
• Generating metrics that demonstrate the impact on R&D

]]>1517amicustx,clinicalresearch,clinicaltrials,medicinedevelopment,papus,patient,patientadvocacy,patientcentricity,patientsaspartners,researchanddevelopmentfalsefullhttps://www.spreaker.com/episode/designing-clinical-trials-balancing-simplicity-with-complexity--69622422
More specifically:

• Prioritizing data collection strategy to answer key scientific questions while avoiding overcomplication
• Designing trials around real patients rather than ideal patients
• Better understanding the objectives of the study and asking the questions that achieve those objectives
• Better partnering with patients and PIs

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.

]]>https://api.spreaker.com/episode/69622422Tue, 27 Jan 2026 15:56:48 +0000Conference ForumWhen designing clinical trials, CMOs aim to answer meaningful questions for a plethora of stakeholders. Inherently, this results in study protocols with more measures, biomarkers and data collection that both provides a platform for strategic...
More specifically:

• Prioritizing data collection strategy to answer key scientific questions while avoiding overcomplication
• Designing trials around real patients rather than ideal patients
• Better understanding the objectives of the study and asking the questions that achieve those objectives
• Better partnering with patients and PIs

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.

]]>1830falsefullhttps://www.spreaker.com/episode/platform-approaches-to-streamline-combination-product-development--69622419

• Advantages and disadvantages to platform approaches for device development
• Opportunities to overcome technical limitations
• Approaches to bring a platform into multiple product design history files
• Regulatory hurdles
• Assessing business case and getting organizational buy-in

To learn more about the PODD Conference, please visit Drug-Delivery.org.]]>https://api.spreaker.com/episode/69622419Tue, 27 Jan 2026 15:27:56 +0000Conference ForumInvesting in developing a durable platform and strategy early leads to fewer delays throughout development. Locking requirements in early and educating teams to approach combination product development holistically lowers the time to development...

• Advantages and disadvantages to platform approaches for device development
• Opportunities to overcome technical limitations
• Approaches to bring a platform into multiple product design history files
• Regulatory hurdles
• Assessing business case and getting organizational buy-in

To learn more about the PODD Conference, please visit Drug-Delivery.org.]]>1813falsefullhttps://www.spreaker.com/episode/what-is-the-state-of-clinical-trial-patient-matching-right-now--69135642About this podcast:
Recorded at the 2025 DPHARM conference, this state of the union panel convenes site, technology and pharma to discuss: 

• Different models and the pros and cons of the deployment models
• What makes a great patient matching solution
• Predicting what the future growth of this segment looks like
• The role of AI in this space

]]>https://api.spreaker.com/episode/69135642Fri, 19 Dec 2025 17:58:19 +0000Conference ForumAbout this podcast: Recorded at the 2025 DPHARM conference, this state of the union panel convenes site, technology and pharma to discuss:  - Different models and the pros and cons of the deployment models - What makes a great patient matching...About this podcast:
Recorded at the 2025 DPHARM conference, this state of the union panel convenes site, technology and pharma to discuss: 

• Different models and the pros and cons of the deployment models
• What makes a great patient matching solution
• Predicting what the future growth of this segment looks like
• The role of AI in this space

]]>2416ai,clinicalresearch,clinicaltrial,clinicaltrialoperations,disruptiveinnovation,dpharm,medicinedevelopment,patientmatchingfalsefullhttps://www.spreaker.com/episode/balancing-innovation-and-practicality-in-immuno-oncology-dose-selection--69135639About this podcast: 
Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for multi-dose selection, alternative dose-selection strategies with imaging, biomarkers and tumor burden analysis, the higher costs and longer timelines, and financial impacts for early-phase oncology companies. 

For more information, go to IO360summit.com.]]>https://api.spreaker.com/episode/69135639Fri, 19 Dec 2025 17:51:21 +0000Conference ForumAbout this podcast:  Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for...About this podcast: 
Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for multi-dose selection, alternative dose-selection strategies with imaging, biomarkers and tumor burden analysis, the higher costs and longer timelines, and financial impacts for early-phase oncology companies. 

For more information, go to IO360summit.com.]]>2712doseselection,fda,immunooncology,io360summit,oncology,projectoptimusfalsefullhttps://www.spreaker.com/episode/leveraging-local-hcps-to-decentralize-clinical-research-in-north-carolina--69135638About this podcast: 
Recorded at the 2025 CRAACO meeting, UNC Lineberger’s Comprehensive Cancer Center shares  an initiative to allow local HCPs to still provide clinical care to patients but decentralized research elements to the university system, following the FDA’s change in guidance on Form FDA 1572, which stopped requiring local healthcare professionals (HCPs) involved in DCTs to be listed if they’re only performing standard-of-care. 


Dr J Kaitlin Morrison talks about the process from an initial pilot of two sites to more than 23 today, providing cancer patients across the state the opportunity to access clinical trials. Specifically:

• How they are managing relationships with sites
• How they’re monitoring research elements
• Goals, next steps and thoughts for industry sponsors

]]>https://api.spreaker.com/episode/69135638Fri, 19 Dec 2025 17:43:14 +0000Conference ForumAbout this podcast:  Recorded at the 2025 CRAACO meeting, UNC Lineberger’s Comprehensive Cancer Center shares  an initiative to allow local HCPs to still provide clinical care to patients but decentralized research elements to the university system,...About this podcast: 
Recorded at the 2025 CRAACO meeting, UNC Lineberger’s Comprehensive Cancer Center shares  an initiative to allow local HCPs to still provide clinical care to patients but decentralized research elements to the university system, following the FDA’s change in guidance on Form FDA 1572, which stopped requiring local healthcare professionals (HCPs) involved in DCTs to be listed if they’re only performing standard-of-care. 


Dr J Kaitlin Morrison talks about the process from an initial pilot of two sites to more than 23 today, providing cancer patients across the state the opportunity to access clinical trials. Specifically:

• How they are managing relationships with sites
• How they’re monitoring research elements
• Goals, next steps and thoughts for industry sponsors

]]>1238clinicalresearchascare,clinicaltrials,craaco,hcp,northcarolina,uncfalsefullhttps://www.spreaker.com/episode/using-patient-engagement-and-digital-innovation-to-elevate-patient-insights-and-outcomes--69135636About this podcast:
This podcast, recorded at the 2025 Patients as Partners Europe meeting, addresses how Novo Nordisk is consolidating patient insights to ensure greater knowledge-sharing, data integrity and traceability, addressing the unmet needs of patients, aligning product outcomes with patient expectations, and more. 

For more information, go to theconferenceforum.org. ]]>https://api.spreaker.com/episode/69135636Fri, 19 Dec 2025 17:36:38 +0000Conference ForumAbout this podcast: This podcast, recorded at the 2025 Patients as Partners Europe meeting, addresses how Novo Nordisk is consolidating patient insights to ensure greater knowledge-sharing, data integrity and traceability, addressing the unmet needs...About this podcast:
This podcast, recorded at the 2025 Patients as Partners Europe meeting, addresses how Novo Nordisk is consolidating patient insights to ensure greater knowledge-sharing, data integrity and traceability, addressing the unmet needs of patients, aligning product outcomes with patient expectations, and more. 

For more information, go to theconferenceforum.org. ]]>1199clinicalresearch,medicinedevelopment,novonordisk,patient,patientengagement,patientsaspartnerseufalsefullhttps://www.spreaker.com/episode/what-to-expect-at-the-2026-patients-as-partners-in-clinical-research-conference--69120974patientsaspartnersconference.com.]]>https://api.spreaker.com/episode/69120974Thu, 18 Dec 2025 17:15:19 +0000Conference ForumIn this podcast, Kate Woda, Conference Director of the Patients as Partners in Clinical Research conference discusses what attendees can expect at the 13th annual event, including key topic areas, session highlights, presenting companies and more. For...patientsaspartnersconference.com.]]>322biopharma,biotech,clinicalresearch,clinicaltrials,conference,hybridtrials,medicinedevelopment,patientadvocacy,patientadvocates,patientdata,patientengagement,patientexperience,patientinput,patientinsights,patientinvolvement,patientsaspartners,patientvoice,pharma,researchanddevelopment,sitemanagementfalsefullhttps://www.spreaker.com/episode/the-role-of-the-cmo-in-bd-and-m-a-partnering-with-pharma--69004904

• Different kinds of BD deals to be aware of
• How the CMO fits into various phases of transactions
• Appreciating how different c-suite colleagues and direct reports experience these transactions
• The different pharma teams CMOs will interact with
• What happens after the acquisition

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>https://api.spreaker.com/episode/69004904Fri, 12 Dec 2025 10:15:21 +0000Conference ForumIn this podcast, featuring a panel discussion from the 2025 Chief Medical Officer Summit 360°, CMOs with recent M&A and partnership experience share those experiences as well as how CMOs of other small to midsize emerging biotech companies can...

• Different kinds of BD deals to be aware of
• How the CMO fits into various phases of transactions
• Appreciating how different c-suite colleagues and direct reports experience these transactions
• The different pharma teams CMOs will interact with
• What happens after the acquisition

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>1670falsefullhttps://www.spreaker.com/episode/advances-in-payload-delivery-and-drug-conjugation--69004173 conjugation and bioconjugation approaches to make ASOs and small molecules more tolerable while improving targeting. Technologies discussed include ADCs, PDCs, SMDCs, VDCs, RDCs and AOCs. Specifically they address:

• Biological and chemical challenges for these therapies
• Building out scalable manufacturing and a regulatory strategy
• Hurdles to overcome to get products to market

To learn more about the PODD Conference, please visit Drug-Delivery.org.]]>https://api.spreaker.com/episode/69004173Fri, 12 Dec 2025 09:25:39 +0000Conference ForumIn this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss conjugation and bioconjugation approaches to make ASOs and small molecules more tolerable while... conjugation and bioconjugation approaches to make ASOs and small molecules more tolerable while improving targeting. Technologies discussed include ADCs, PDCs, SMDCs, VDCs, RDCs and AOCs. Specifically they address:

• Biological and chemical challenges for these therapies
• Building out scalable manufacturing and a regulatory strategy
• Hurdles to overcome to get products to market

To learn more about the PODD Conference, please visit Drug-Delivery.org.]]>1799falsefullhttps://www.spreaker.com/episode/building-up-a-cmo-team-as-your-company-evolves--68820082

• Balancing the mix of hires and outsourcing
• Hiring for skillsets to enable efficiency without overhiring
• Reactive vs proactive hiring
• Building in a stage appropriate way but also hiring in time for later stages

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>https://api.spreaker.com/episode/68820082Mon, 01 Dec 2025 16:49:25 +0000Conference ForumThis podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° about how to strategically approach hiring FTEs, insourcing, outsourcing and contracting to be appropriately prepared for the different stages of a biotech...

• Balancing the mix of hires and outsourcing
• Hiring for skillsets to enable efficiency without overhiring
• Reactive vs proactive hiring
• Building in a stage appropriate way but also hiring in time for later stages

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>1940falsefullhttps://www.spreaker.com/episode/beyond-lnps-delivering-genetic-medicines-with-novel-vehicles--68819889
In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on:

• Where LNPs potentially fall short
• Where different tools can enable therapeutic delivery
• Challenges to achieving meaningful clinical impact for these different vehicles
• Building out a portfolio of delivery vehicles

To learn more about the PODD Conference, please visit Drug-Delivery.org.
]]>https://api.spreaker.com/episode/68819889Mon, 01 Dec 2025 16:28:56 +0000Conference ForumWhile lipid nanoparticles are the most clinically advanced drug delivery system for nucleic acid therapeutics, they are only one tool in a toolbox of potential delivery vehicles. In this panel discussion from the 2025 PODD: Partnership Opportunities...
In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on:

• Where LNPs potentially fall short
• Where different tools can enable therapeutic delivery
• Challenges to achieving meaningful clinical impact for these different vehicles
• Building out a portfolio of delivery vehicles

To learn more about the PODD Conference, please visit Drug-Delivery.org.
]]>1792falsefullhttps://www.spreaker.com/episode/pfizer-on-advancing-data-analysis-capabilities-through-a-new-edc-cdms-platform--68727873About this podcast: 
This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose, and analysis data set. This session focuses on:

• Engaging all stakeholders in designing the platform
• The evolution of the platform focus: the transition from the majority of data coming from EDC to 3/4 of the data from third party sources
• Impact of the advanced data analysis capabilities for risk management
• Review of impact on initial studies now using the platform 

For more information, go to DPHARMconference.com. 
]]>https://api.spreaker.com/episode/68727873Mon, 24 Nov 2025 20:42:27 +0000Conference ForumAbout this podcast:  This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose, and analysis data set. This session focuses on: - Engaging all stakeholders...About this podcast: 
This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose, and analysis data set. This session focuses on:

• Engaging all stakeholders in designing the platform
• The evolution of the platform focus: the transition from the majority of data coming from EDC to 3/4 of the data from third party sources
• Impact of the advanced data analysis capabilities for risk management
• Review of impact on initial studies now using the platform 

For more information, go to DPHARMconference.com. 
]]>926cdms,clinicaldata,clinicaldatamanagementsystem,clinicaloperations,clinicaltrialoperations,dpharm,edc,electronicdatacapture,pfizerfalsefullhttps://www.spreaker.com/episode/insights-from-tufts-csdd-into-evolving-trial-partnerships-models--68727872About this podcast: 
Preliminary survey results conducted by the Tufts CSDD focus on the strategic and structural growth of new trial sites and partnerships in bringing trials directly to the local communities. The preliminary survey findings also shed light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape.

The significant shift towards bringing clinical trials directly to local communities through various innovative models is noteworthy. Many new clinical trial execution models have been introduced during the past decade including site staff embedded within clinical care settings, remote sites, retail pharmacies, urgent care facilities, and mobile units going directly into local communities. 

This session comes from the 2025 Partnerships with Sites Summit. ]]>https://api.spreaker.com/episode/68727872Mon, 24 Nov 2025 20:20:28 +0000Conference ForumAbout this podcast:  Preliminary survey results conducted by the Tufts CSDD focus on the strategic and structural growth of new trial sites and partnerships in bringing trials directly to the local communities. The preliminary survey findings also...About this podcast: 
Preliminary survey results conducted by the Tufts CSDD focus on the strategic and structural growth of new trial sites and partnerships in bringing trials directly to the local communities. The preliminary survey findings also shed light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape.

The significant shift towards bringing clinical trials directly to local communities through various innovative models is noteworthy. Many new clinical trial execution models have been introduced during the past decade including site staff embedded within clinical care settings, remote sites, retail pharmacies, urgent care facilities, and mobile units going directly into local communities. 

This session comes from the 2025 Partnerships with Sites Summit. ]]>965clinicalresearch,clinicalresearchsites,clinicaltrials,clinicaltrialsites,csdd,healthcare,medicinedevelopment,partnershipswithsites,tuftsfalsefullhttps://www.spreaker.com/episode/adcs-chemotherapy-and-checkpoint-blockade-in-urothelial-carcinoma--68727810About this podcast:
This session, from the 2025 IO360 Summit, focuses on different strategies to augment immune response in urothelial carcinoma, presented by Dr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center. 

Dr Rosenberg focuses on: 

• The background and previous data of immune checkpoint blockade as monotherapy and in combination with chemotherapy, in urothelial cancer
• The potential role of Immunogenic Cell Death and whether it has a clinical impact on patient care and creating an anti-tumor immune response
• Enfortumab vedotin, an ADC targeting Nectin-4

For more information, go to IO360summit.com.
]]>https://api.spreaker.com/episode/68727810Mon, 24 Nov 2025 19:57:01 +0000Conference ForumAbout this podcast: This session, from the 2025 IO360 Summit, focuses on different strategies to augment immune response in urothelial carcinoma, presented by Dr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center.  Dr Rosenberg focuses on: ...About this podcast:
This session, from the 2025 IO360 Summit, focuses on different strategies to augment immune response in urothelial carcinoma, presented by Dr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center. 

Dr Rosenberg focuses on: 

• The background and previous data of immune checkpoint blockade as monotherapy and in combination with chemotherapy, in urothelial cancer
• The potential role of Immunogenic Cell Death and whether it has a clinical impact on patient care and creating an anti-tumor immune response
• Enfortumab vedotin, an ADC targeting Nectin-4

For more information, go to IO360summit.com.
]]>1158adc,antibodydrugconjugate,chemotherapy,clinicalresearch,clinicaltrials,immunogeniccelldeath,immunotherapy,io360,io360summit,memorialsloankettering,mskcc,oncologyfalsefullhttps://www.spreaker.com/episode/understanding-the-immunological-effects-of-radiopharmaceuticals--68660555About this podcast:
This presentation from the 2025 IO360º Summit focuses on the immunological effects of radiopharmaceuticals, presented by Chaitanya Divgi, Sr Strategic Expert, Therapeutic Innovation, at Novartis. 

Specifically, this podcast dives deeper into: 

• An introduction to radioligand therapy
• A focus on PSMA-targeted radionuclide therapy
• Prelimary work on the relationship between systemic radiation therapy and immune effects at the tumor level 

For more information, visit IO360summit.com 
]]>https://api.spreaker.com/episode/68660555Mon, 24 Nov 2025 19:38:28 +0000Conference ForumAbout this podcast: This presentation from the 2025 IO360º Summit focuses on the immunological effects of radiopharmaceuticals, presented by Chaitanya Divgi, Sr Strategic Expert, Therapeutic Innovation, at Novartis.  Specifically, this podcast dives...About this podcast:
This presentation from the 2025 IO360º Summit focuses on the immunological effects of radiopharmaceuticals, presented by Chaitanya Divgi, Sr Strategic Expert, Therapeutic Innovation, at Novartis. 

Specifically, this podcast dives deeper into: 

• An introduction to radioligand therapy
• A focus on PSMA-targeted radionuclide therapy
• Prelimary work on the relationship between systemic radiation therapy and immune effects at the tumor level 

For more information, visit IO360summit.com 
]]>1091cancer,clinicalresearch,clinicaltrials,immunooncology,immunotherapy,io360,oncology,radioligand,radiopharmaceuticalsfalsefullhttps://www.spreaker.com/episode/how-j-j-is-integrating-patient-centricity-across-the-enterprise--68645078About this episode:
In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses: 

• J&J’s approach to patient centricity across the enterprise
• Her thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex science
• Moving risk benefit assessments earlier into clinical development and the necessary change management
• Incorporating multiple streams of data for the purpose of creating medicines that truly address patient needs in the real world

For more information, go to PatientsasPartnersConference.com. ]]>https://api.spreaker.com/episode/68645078Wed, 19 Nov 2025 20:36:16 +0000Conference ForumAbout this episode: In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses:  - J&J’s approach to patient centricity across the enterprise - Her thoughts on balancing balancing...About this episode:
In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses: 

• J&J’s approach to patient centricity across the enterprise
• Her thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex science
• Moving risk benefit assessments earlier into clinical development and the necessary change management
• Incorporating multiple streams of data for the purpose of creating medicines that truly address patient needs in the real world

For more information, go to PatientsasPartnersConference.com. ]]>1560biotech,chiefmedicalofficer,clinicalresearch,commercialization,j&j,johnson&johnson,medicalaffairs,medicinedevelopment,ocmo,officeofchiefmedicalofficer,pap,patientcentricity,patientfocus,patientfocusedmedicinedevelopm,patientsaspartners,pennyheaton,pharmafalsefullhttps://www.spreaker.com/episode/biogen-s-nicole-murphy-on-drug-delivery-innovation-and-the-acquisition-of-alcyone-therapeutics--68639096

• Cross-functional collaboration to deliver value
• How Biogen is using AI to enhance innovation
• Supply chain simplification
• Biogen's partnership philosophy as it relates to drug delivery
• Their recent $2 billion manufacturing investment in the Research Triangle Park
• And Biogen's acquisition of Alcyone Therapeutics 

It's an enlightening look into what real leadership in drug delivery, manufacturing and supply chain management looks like. 

For more information, go to Drug-Delivery.org.]]>https://api.spreaker.com/episode/68639096Wed, 19 Nov 2025 13:08:48 +0000Conference ForumIn this podcast, Nicole Murphy, EVP and Head of Pharmaceutical Operations & Technology at Biogen, discusses: - Cross-functional collaboration to deliver value - How Biogen is using AI to enhance innovation - Supply chain simplification - Biogen's...

• Cross-functional collaboration to deliver value
• How Biogen is using AI to enhance innovation
• Supply chain simplification
• Biogen's partnership philosophy as it relates to drug delivery
• Their recent $2 billion manufacturing investment in the Research Triangle Park
• And Biogen's acquisition of Alcyone Therapeutics 

It's an enlightening look into what real leadership in drug delivery, manufacturing and supply chain management looks like. 

For more information, go to Drug-Delivery.org.]]>1873falsefullhttps://www.spreaker.com/episode/what-to-expect-at-the-2026-io360-summit--68536549
For more information about the upcoming event, full agenda and speakers, visit IO360Summit.com.  ]]>https://api.spreaker.com/episode/68536549Wed, 12 Nov 2025 13:54:18 +0000Conference ForumIn this podcast, Kate Woda, Conference Director of the Immuno-Oncology 360° Summit, discusses what attendees can expect at the 12th annual event, including key topic areas, session highlights, presenting companies and more. For more information about...
For more information about the upcoming event, full agenda and speakers, visit IO360Summit.com.  ]]>262adcs,adjuvant,autoimmunedisease&io,biomarkers,bispecifics,businessadvancments,celltherapy,clinicaldevelopments,imagingadvancements,immunooncology,immunotherapy,investingaspects,iobiotech,iocombinations,memorialsloan,mountsinai,neoadjuvant,networking,parkerinstitute,translationalsciencefalsefullhttps://www.spreaker.com/episode/cmos-working-flexibly-with-consultants-and-fractional-expertise--68340348

• Different profiles of fractional consultants
• What to look for in a consultant and how to ensure alignment with the team
• Scoping the role of fractional talent and iterating as company needs evolve
• How to best work with firms representing fractional talent
• Advice for CMOs thinking about consulting

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>https://api.spreaker.com/episode/68340348Mon, 03 Nov 2025 20:10:40 +0000Conference ForumThis podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with CMOs and advisory solutions firms about how CMOs can work with consultants and fractional talent to stay on budget while getting the expertise needed....

• Different profiles of fractional consultants
• What to look for in a consultant and how to ensure alignment with the team
• Scoping the role of fractional talent and iterating as company needs evolve
• How to best work with firms representing fractional talent
• Advice for CMOs thinking about consulting

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>1855falsefullhttps://www.spreaker.com/episode/principles-and-strategies-for-designing-best-in-class-immuno-oncology-adcs--68265763About this podcast:
This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. 

For more information, go to IO360summit.com.]]>https://api.spreaker.com/episode/68265763Fri, 24 Oct 2025 17:36:30 +0000Conference ForumAbout this podcast: This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies...About this podcast:
This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. 

For more information, go to IO360summit.com.]]>1055adcs,antibody,antibodydrugconjugate,cancer,drugdevelopment,immunooncology,immunooncology360,immunotherapy,io360,medicinedevelopment,oncologyfalsefullhttps://www.spreaker.com/episode/how-patient-organizations-are-bridging-patient-inclusivity-gaps-at-the-site-level--68265751About this podcast:
This podcast comes from the 2025 Patients as Partners in Clinical Research conference. 

This panel discussion demonstrates how patient advocates are bridging the divide at the site level to improve patient representation in clinical trials. More specifically, this podcast focuses on: 

• Strategies for overcoming limited resources and lack of infrastructure, which can hinder inclusive clinical trial participation
• Successful models for empowering local leaders and leveraging community-based networks to increase participation
• Evaluating the impact of outreach and engagement efforts on enrollment representation and overall care equity
• And more

For more information, go to PatientsAsPartnersConference.com.
]]>https://api.spreaker.com/episode/68265751Fri, 24 Oct 2025 16:31:39 +0000Conference ForumAbout this podcast: This podcast comes from the 2025 Patients as Partners in Clinical Research conference.  This panel discussion demonstrates how patient advocates are bridging the divide at the site level to improve patient representation in...About this podcast:
This podcast comes from the 2025 Patients as Partners in Clinical Research conference. 

This panel discussion demonstrates how patient advocates are bridging the divide at the site level to improve patient representation in clinical trials. More specifically, this podcast focuses on: 

• Strategies for overcoming limited resources and lack of infrastructure, which can hinder inclusive clinical trial participation
• Successful models for empowering local leaders and leveraging community-based networks to increase participation
• Evaluating the impact of outreach and engagement efforts on enrollment representation and overall care equity
• And more

For more information, go to PatientsAsPartnersConference.com.
]]>2518clinicalresearch,clinicalresearchsite,clinicaltrials,drugdevelopment,medicinedevelopment,patientadvocacy,patientadvocacygroup,patientcentricity,patientsaspartners,patientsaspartnersconferencefalsefullhttps://www.spreaker.com/episode/how-roche-reduced-unnecessary-protocol-amendments-to-impact-timeline-and-cost--68230839About this podcast: 
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program. 

More specifically, Ms Thompson discusses how Roche is: 

• Leveraging historical amendment data to enable study teams to understand why protocols are being amended
• Utilizing a visual data science platform to generate insights from data to make better data-driven decisions
• Applying retrospective learning into current protocols to curb the need for amendments
• Building in business value 

For more information, go to DPHARMconference.com.]]>https://api.spreaker.com/episode/68230839Tue, 21 Oct 2025 19:07:29 +0000Conference ForumAbout this podcast:  Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments...About this podcast: 
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program. 

More specifically, Ms Thompson discusses how Roche is: 

• Leveraging historical amendment data to enable study teams to understand why protocols are being amended
• Utilizing a visual data science platform to generate insights from data to make better data-driven decisions
• Applying retrospective learning into current protocols to curb the need for amendments
• Building in business value 

For more information, go to DPHARMconference.com.]]>788biotech,clinical,clinicalresearch,clinicaltrialoperations,clinicaltrials,disruptiveinnovations,dpharm,medicinedevelopment,modernizingclinicaltrials,pharma,protocolamendments,roche,trialsfalsefullhttps://www.spreaker.com/episode/how-to-embed-clinical-research-in-rural-and-frontier-health-systems--68230170About this podcast:
This session was recorded at the September 2025 CRAACO: Clinical Research as a Care Option conference.

Rural sites represent untapped potential for reaching a broader array of patients and providing them access to life-changing clinical trials, but existing clinical trial infrastructure does not set rural sites up for success. 

Funded through the Genentech Innovation Fund, Montana State University and Billings Clinic created a rural clinical research readiness toolkit for unaffiliated rural and frontier healthcare systems to empower them to meet clinical research demands without compromising local care delivery.

More specifically, this presentation covers the tools created to toolkit empowers sites to do clinical research, including:

• Interpretable workflow templates
• A workload calculator for staff capacity planning
• Patient safety indicators to support enrollment and retention
• EHR-based visualization methods to assist clinical decision-making when trial participants are also patients
• And more

For more information, go to theconferenceforum.org.
]]>https://api.spreaker.com/episode/68230170Tue, 21 Oct 2025 18:03:25 +0000Conference ForumAbout this podcast: This session was recorded at the September 2025 CRAACO: Clinical Research as a Care Option conference. Rural sites represent untapped potential for reaching a broader array of patients and providing them access to life-changing...About this podcast:
This session was recorded at the September 2025 CRAACO: Clinical Research as a Care Option conference.

Rural sites represent untapped potential for reaching a broader array of patients and providing them access to life-changing clinical trials, but existing clinical trial infrastructure does not set rural sites up for success. 

Funded through the Genentech Innovation Fund, Montana State University and Billings Clinic created a rural clinical research readiness toolkit for unaffiliated rural and frontier healthcare systems to empower them to meet clinical research demands without compromising local care delivery.

More specifically, this presentation covers the tools created to toolkit empowers sites to do clinical research, including:

• Interpretable workflow templates
• A workload calculator for staff capacity planning
• Patient safety indicators to support enrollment and retention
• EHR-based visualization methods to assist clinical decision-making when trial participants are also patients
• And more

For more information, go to theconferenceforum.org.
]]>1151billingsclinic,clinicalresearch,clinicalresearchasacareoption,clinicaltrials,clinicaltrialsascare,communitybasedresearch,craaco,integratingclinicaltrials,montanastateuniversityfalsefullhttps://www.spreaker.com/episode/optimizing-the-value-proposition-in-small-companies-with-limited-budgets--67952187

• The importance of storytelling and leading thoughtfully
• Effective prioritization and execution towards the company narrative
• Balancing the team to be lean while avoiding the potential pitfalls of running lean
• Balancing the data collected to be interesting to investigators and important for the program to proceed
• Clinical data generation is better than preclinical dreams
• Strategically choosing a first indication and building sufficient scientific bridging to support subsequent indications

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>https://api.spreaker.com/episode/67952187Tue, 30 Sep 2025 14:32:55 +0000Conference ForumThis podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how CMOs can support value creation in biotechs and how that is influenced buy the current biotech financial climate. Specifically: - The...

• The importance of storytelling and leading thoughtfully
• Effective prioritization and execution towards the company narrative
• Balancing the team to be lean while avoiding the potential pitfalls of running lean
• Balancing the data collected to be interesting to investigators and important for the program to proceed
• Clinical data generation is better than preclinical dreams
• Strategically choosing a first indication and building sufficient scientific bridging to support subsequent indications

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>1813falsefullhttps://www.spreaker.com/episode/from-the-dpharm-2024-archives-biogen-pilot-on-using-vocal-biomarkers-to-identify-potential-participants-for-clinical-trials--67912594
For more information, go to DPHARMconference.com]]>https://api.spreaker.com/episode/67912594Fri, 26 Sep 2025 18:57:07 +0000Conference ForumIn this podcast from the DPHARM 2024 archives, Biogen discussed how they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to provide access to patients  with a clinically validated...
For more information, go to DPHARMconference.com]]>1269advancing,biogen,biomarkers,clinicalresearch,clinicaltrials,digitalbiomarkers,digitalhealth,digitalhealthtechnology,digitalinnovation,dpharmfalsefullhttps://www.spreaker.com/episode/merck-on-enhancing-trial-participation-relevance-and-impact-through-patient-and-community-engagement--67912506

• Identifying and addressing patient and community needs
• Strategies for earning trust and fostering sustained engagement
• Key collaborations and partnerships driving meaningful change
• Approaches to developing patient-centered endpoints and outcomes
• Methods for effectively communicating and disseminating trial results

For more information, go to PatientsAsPartnersConference.com
]]>https://api.spreaker.com/episode/67912506Fri, 26 Sep 2025 18:52:45 +0000Conference ForumAt the March 2025 Patients as Partners conference, Merck presents how they advancing patient and community engagement through targeted initiatives designed to improve trial participation, relevance, and long-term impact. Key topics include: -...

• Identifying and addressing patient and community needs
• Strategies for earning trust and fostering sustained engagement
• Key collaborations and partnerships driving meaningful change
• Approaches to developing patient-centered endpoints and outcomes
• Methods for effectively communicating and disseminating trial results

For more information, go to PatientsAsPartnersConference.com
]]>1124clinicalresearch,clinicaltrials,drugdevelopment,medicinedevelopment,merck,patientadvocacy,patientengagement,patientparticipation,patientsaspartnersfalsefullhttps://www.spreaker.com/episode/ensuring-continuity-in-patient-insights-to-strengthen-medicine-development--67482335
This session was recorded at the March 2025 Patients as Partners conference. In this session, Pfizer addressed how they were working to ensure continuity in the patient insights they were collecting, throughout the product life cycle. This included: 

• Approaches for aligning internal processes to facilitate the seamless flow of patient insights from early-phase to late-phase teams

• Suggested tools, including an AI Insights tool designed to centralize and leverage previous patient feedback, supporting a more integrated approach to patient engagement

• Strategies to build on existing insights, enhance collaboration across teams, and drive more effective patient-centered outcomes in R&D processes

For more information, go to PatientsAsPartnersConference.com.





]]>https://api.spreaker.com/episode/67482335Fri, 22 Aug 2025 19:02:25 +0000Conference ForumSummary:  This session was recorded at the March 2025 Patients as Partners conference. In this session, Pfizer addressed how they were working to ensure continuity in the patient insights they were collecting, throughout the product life cycle. This...
This session was recorded at the March 2025 Patients as Partners conference. In this session, Pfizer addressed how they were working to ensure continuity in the patient insights they were collecting, throughout the product life cycle. This included: 

• Approaches for aligning internal processes to facilitate the seamless flow of patient insights from early-phase to late-phase teams

• Suggested tools, including an AI Insights tool designed to centralize and leverage previous patient feedback, supporting a more integrated approach to patient engagement

• Strategies to build on existing insights, enhance collaboration across teams, and drive more effective patient-centered outcomes in R&D processes

For more information, go to PatientsAsPartnersConference.com.





]]>1102clinicalresearch,clinicaltrials,drugdevelopment,medicinedevelopment,patientcentricity,patientinsights,patientsaspartners,pfizerfalsefullhttps://www.spreaker.com/episode/accelerating-patient-enrollment-in-clinical-trials-by-deploying-a-product-model-approach--67481948
From the DPHARM Archives, this podcast was recorded at the September 2024 DPHARM conference. In this podcast, BMS present how they specifically targeted the challenge of recruiting patients for clinical trials, aiming to make the process faster and easier. By bringing trials directly to patients, their ultimate objective was to significantly expedite patient enrollment. In this case example, they brought the audience through their new product model approach, for the organization's overarching goal of reducing the drug timeline from discovery to launch by three years.]]>https://api.spreaker.com/episode/67481948Fri, 22 Aug 2025 18:23:56 +0000Conference ForumSummary:  From the DPHARM Archives, this podcast was recorded at the September 2024 DPHARM conference. In this podcast, BMS present how they specifically targeted the challenge of recruiting patients for clinical trials, aiming to make the process...
From the DPHARM Archives, this podcast was recorded at the September 2024 DPHARM conference. In this podcast, BMS present how they specifically targeted the challenge of recruiting patients for clinical trials, aiming to make the process faster and easier. By bringing trials directly to patients, their ultimate objective was to significantly expedite patient enrollment. In this case example, they brought the audience through their new product model approach, for the organization's overarching goal of reducing the drug timeline from discovery to launch by three years.]]>976bms,bristolmyerssquibb,clinicaltrials,disruptingclinicaltrials,dpharm,medicinedevelopment,patientenrollment,patientrecruitmentfalsefullhttps://www.spreaker.com/episode/stanford-s-dr-crystal-mackall-on-the-evolution-of-and-future-directions-in-cell-therapy--67370767About this podcast:
Recorded at the 2025 Immuno-Oncology 360º Summit, Stanford University's Dr Crystal Mackall shares work from her lab developing GD2-targeting CAR T cell therapy for the treatment of deadly pediatric brain tumor, as well as broader lessons on the evolution of cell therapy, and her forward-looking perspective on shaping the next generation of cancer treatments.

For more information, go to IO360summit.com. 
]]>https://api.spreaker.com/episode/67370767Thu, 14 Aug 2025 19:37:07 +0000Conference ForumAbout this podcast: Recorded at the 2025 Immuno-Oncology 360º Summit, Stanford University's Dr Crystal Mackall shares work from her lab developing GD2-targeting CAR T cell therapy for the treatment of deadly pediatric brain tumor, as well as broader...About this podcast:
Recorded at the 2025 Immuno-Oncology 360º Summit, Stanford University's Dr Crystal Mackall shares work from her lab developing GD2-targeting CAR T cell therapy for the treatment of deadly pediatric brain tumor, as well as broader lessons on the evolution of cell therapy, and her forward-looking perspective on shaping the next generation of cancer treatments.

For more information, go to IO360summit.com. 
]]>1739braintumor,cancer,cartcelltherapy,celltherapy,crystalmackall,immunooncology,immunotherapy,io360,io360summit,pedatriccancer,stanfordfalsefullhttps://www.spreaker.com/episode/de-risking-clinical-operations-by-taking-a-scaffolding-approach-to-outsourcing--67344969Summary:
Rescuing a clinical trial and choosing to switch vendor's mid-trial are some of the most expensive decisions biotech CMOs can make. These rescues require a significant amount of time, money and energy and may not even address the root issue behind a trial's poor performance. In this podcast, Raul Lima, SVP, Strategic Clinical Operations, inSeption Group, discusses a scaffolding approach that prioritizes areas that require immediate support without sacrificing the entirety of the trial. Specifically:

• How biotechs can better identify root causes of issues and correct them
• Mistakes CMOs make when implementing rescues
• When and how a scaffolding approach can be more resource, time and financially efficient

For more information about inSeption Group, visit inSeptionGroup.com. 

For more information about the annual Chief Medical Officer Summit 360° and its affiliated editorials, podcasts and webcasts, please visit CMO360.org.
]]>https://api.spreaker.com/episode/67344969Tue, 12 Aug 2025 15:55:00 +0000Conference ForumSummary: Rescuing a clinical trial and choosing to switch vendor's mid-trial are some of the most expensive decisions biotech CMOs can make. These rescues require a significant amount of time, money and energy and may not even address the root issue...Summary:
Rescuing a clinical trial and choosing to switch vendor's mid-trial are some of the most expensive decisions biotech CMOs can make. These rescues require a significant amount of time, money and energy and may not even address the root issue behind a trial's poor performance. In this podcast, Raul Lima, SVP, Strategic Clinical Operations, inSeption Group, discusses a scaffolding approach that prioritizes areas that require immediate support without sacrificing the entirety of the trial. Specifically:

• How biotechs can better identify root causes of issues and correct them
• Mistakes CMOs make when implementing rescues
• When and how a scaffolding approach can be more resource, time and financially efficient

For more information about inSeption Group, visit inSeptionGroup.com. 

For more information about the annual Chief Medical Officer Summit 360° and its affiliated editorials, podcasts and webcasts, please visit CMO360.org.
]]>1686falsefullhttps://www.spreaker.com/episode/balancing-between-concentration-and-volume-when-developing-patient-centric-biologics--67344127Summary:
When developing patient-centric products for biologics, different doses, expressed by different combinations of volume/concentration may require different delivery devices. As a result, it takes a great deal of time and effort in planning and coordinating the formulation and device activities. In this podcast, Pharma and Drug Delivery executives from Nanoform, Pfizer, GSK, Takeda and Kymanox discuss how they facilitate partnerships between drug product development, device engineering and clinical study teams to determine how to balance concentration and volume and develop optimal devices for delivery and commercialization. Specifically:

• Impact on increasing concentration of drugs on deliverability
• Technical feasibility of manufacturing larger volume devices
• Patient tolerability and human factors that impact patient adherence

This panel discussion was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.]]>https://api.spreaker.com/episode/67344127Tue, 12 Aug 2025 14:03:18 +0000Conference ForumSummary: When developing patient-centric products for biologics, different doses, expressed by different combinations of volume/concentration may require different delivery devices. As a result, it takes a great deal of time and effort in planning and...Summary:
When developing patient-centric products for biologics, different doses, expressed by different combinations of volume/concentration may require different delivery devices. As a result, it takes a great deal of time and effort in planning and coordinating the formulation and device activities. In this podcast, Pharma and Drug Delivery executives from Nanoform, Pfizer, GSK, Takeda and Kymanox discuss how they facilitate partnerships between drug product development, device engineering and clinical study teams to determine how to balance concentration and volume and develop optimal devices for delivery and commercialization. Specifically:

• Impact on increasing concentration of drugs on deliverability
• Technical feasibility of manufacturing larger volume devices
• Patient tolerability and human factors that impact patient adherence

This panel discussion was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.]]>1682falsefullhttps://www.spreaker.com/episode/directors-talk-dpharm-2025-ai-sessions-part-iii--67114814]]>https://api.spreaker.com/episode/67114814Fri, 25 Jul 2025 17:56:47 +0000Conference ForumIn this podcast series, DPHARM Director Tracey Kimball with Valerie Bowling, Executive Director of the Conference Forum, break down what to expect at DPHARM 2025. Part III of this podcast series covers sessions addressing AI in Clinical Trials.]]>372falsefullhttps://www.spreaker.com/episode/innovations-in-manufacturing-to-make-car-t-more-accessible-and-affordable--67058175Summary:
Accessibility to CAR-T is limited by traditional manufacturing, with its associated challenges and high cost. Moffitt Cancer Center's Chief BioEngineering Officer, Dr Greg Sawyer, highlights Moffitt's significant progress in enhancing T cell potency and boosting efficacy through engineering strategies. Dr Sawyer discusses assays enabling precise asessment of T cell potency, developments in manufacturing, and more, and the resulting impact on scalability and efficiency. 

This presentation comes from the March 2025 Immuno-Oncology 360º Summit. For more information, go to IO360summit.com. ]]>https://api.spreaker.com/episode/67058175Fri, 25 Jul 2025 14:21:46 +0000Conference ForumSummary: Accessibility to CAR-T is limited by traditional manufacturing, with its associated challenges and high cost. Moffitt Cancer Center's Chief BioEngineering Officer, Dr Greg Sawyer, highlights Moffitt's significant progress in enhancing T cell...Summary:
Accessibility to CAR-T is limited by traditional manufacturing, with its associated challenges and high cost. Moffitt Cancer Center's Chief BioEngineering Officer, Dr Greg Sawyer, highlights Moffitt's significant progress in enhancing T cell potency and boosting efficacy through engineering strategies. Dr Sawyer discusses assays enabling precise asessment of T cell potency, developments in manufacturing, and more, and the resulting impact on scalability and efficiency. 

This presentation comes from the March 2025 Immuno-Oncology 360º Summit. For more information, go to IO360summit.com. ]]>1190cancer,cartcell,chimericantigenreceptor,clinicaltrials,immunooncology,immunooncology360,io360,manufacturing,medicinedevelopment,moffittcancercenter,oncology,tcellsfalsefullhttps://www.spreaker.com/episode/achieving-oral-delivery-of-peptides-through-formulation-and-molecule-design-approaches--67109486Summary:
In this podcast, Pharma and Drug Delivery executives from Novartis, AstraZeneca, Merck and Quotient Sciences discuss traditional and novel approaches to improve the oral delivery of peptides including:

• The biopharmaceutics of oral peptide and the use of permeation enhancers
• Alternate sites for the delivery of oral peptides throughout the GI tract
• Improving oral exposure through ingestible devices 
• Delivering ASOs and other large synthetics
• Next-generation approaches for delivery

This presentation was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.]]>https://api.spreaker.com/episode/67109486Fri, 25 Jul 2025 09:39:16 +0000Conference ForumSummary: In this podcast, Pharma and Drug Delivery executives from Novartis, AstraZeneca, Merck and Quotient Sciences discuss traditional and novel approaches to improve the oral delivery of peptides including: - The biopharmaceutics of oral peptide...Summary:
In this podcast, Pharma and Drug Delivery executives from Novartis, AstraZeneca, Merck and Quotient Sciences discuss traditional and novel approaches to improve the oral delivery of peptides including:

• The biopharmaceutics of oral peptide and the use of permeation enhancers
• Alternate sites for the delivery of oral peptides throughout the GI tract
• Improving oral exposure through ingestible devices 
• Delivering ASOs and other large synthetics
• Next-generation approaches for delivery

This presentation was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.]]>1743falsefullhttps://www.spreaker.com/episode/catalyzing-change-the-business-imperative-of-patient-centric-drug-development--67058171Summary: 
In this podcast, Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, presented the business rationale for patient-centric medicine development, how it's disrupting the pharmaceutical industry and why companies have to act swiftly to remain competitive. 

Dr Yanni discusses how to align medicine development with healthcare delivery and the necessary cultural transformation that is critical to sustaining it, practical steps to incorporate patient input early into the R&D process, operationalizing patient-centric processes, methods to measure impact, and more.

This presentation was recorded at the March 2025 Patients as Partners in Clinical Research conference. For more information, go to PatientsAsPartnersConference.com.]]>https://api.spreaker.com/episode/67058171Mon, 21 Jul 2025 19:05:10 +0000Conference ForumSummary:  In this podcast, Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, presented the business rationale for patient-centric medicine development, how it's disrupting the pharmaceutical industry and why companies have to act swiftly...Summary: 
In this podcast, Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, presented the business rationale for patient-centric medicine development, how it's disrupting the pharmaceutical industry and why companies have to act swiftly to remain competitive. 

Dr Yanni discusses how to align medicine development with healthcare delivery and the necessary cultural transformation that is critical to sustaining it, practical steps to incorporate patient input early into the R&D process, operationalizing patient-centric processes, methods to measure impact, and more.

This presentation was recorded at the March 2025 Patients as Partners in Clinical Research conference. For more information, go to PatientsAsPartnersConference.com.]]>1564astellas,clinicalresearch,clinicaltrials,drugdevelopment,medicinedevelopment,patient,patientcentric,patientcentricity,patientsaspartners,trialparticipantfalsefullhttps://www.spreaker.com/episode/how-emerging-biopharma-cmos-can-better-partner-with-patient-organizations--67059043

• Patient voice driving drug development forward
• Supporting health equity and patient access after approval
• Building genuine relationships and engaging early to get to the right patients at the right time and for better advocacy about your research
• Building a community of awareness and working with patients for support throughout the regulatory process
• Integrating the patient perspective in early
• Real world examples and their impacts

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>https://api.spreaker.com/episode/67059043Mon, 21 Jul 2025 18:59:52 +0000Conference ForumThis podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs across indications about how CMOs can better develop drugs patients want and derisk development by partnering with patient organizations....

• Patient voice driving drug development forward
• Supporting health equity and patient access after approval
• Building genuine relationships and engaging early to get to the right patients at the right time and for better advocacy about your research
• Building a community of awareness and working with patients for support throughout the regulatory process
• Integrating the patient perspective in early
• Real world examples and their impacts

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>1904falsefullhttps://www.spreaker.com/episode/joint-site-and-sponsor-perspectives-on-innovative-solutions-addressing-sites-challenges--67058174Summary:
In this session, pharma sponsors and sites gather to present innovative solutions to solve site challenges in workforce and capability gaps, increasing technology burden, patient enrollment and managing clinical trial protocol complexity. They discuss efforts to address those challenges, early impacts and outcomes. 

In this panel: 

• Dennis Salotti, MS, MBA, Executive Director & Head of Clinical Outsourcing & Innovation, Jazz Pharmaceuticals
• Kristin Herman, Executive Director, Clinical Trials Office, Sidney Kimmel Cancer Center, Jefferson Health
• Eileen Hughes, RN, BS, Senior Manager, Site Partnerships, CSL Behring
• Lisa Kiehne, SVP, Operations, The START Center for Cancer Research 
• Christopher McNair, PhD, Associate Director, Data Science and Cancer Informatics, Sidney Kimmel Cancer Center, Jefferson Health
• Tracey Robertson, Head of Patient and Site Engagement Capability Management, Boehringer Ingelheim 

This panel was recorded at the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research. For more information about the 2025 DPHARM, visit DPHARMconference.com. ]]>https://api.spreaker.com/episode/67058174Mon, 21 Jul 2025 18:31:24 +0000Conference ForumSummary: In this session, pharma sponsors and sites gather to present innovative solutions to solve site challenges in workforce and capability gaps, increasing technology burden, patient enrollment and managing clinical trial protocol complexity....Summary:
In this session, pharma sponsors and sites gather to present innovative solutions to solve site challenges in workforce and capability gaps, increasing technology burden, patient enrollment and managing clinical trial protocol complexity. They discuss efforts to address those challenges, early impacts and outcomes. 

In this panel: 

• Dennis Salotti, MS, MBA, Executive Director & Head of Clinical Outsourcing & Innovation, Jazz Pharmaceuticals
• Kristin Herman, Executive Director, Clinical Trials Office, Sidney Kimmel Cancer Center, Jefferson Health
• Eileen Hughes, RN, BS, Senior Manager, Site Partnerships, CSL Behring
• Lisa Kiehne, SVP, Operations, The START Center for Cancer Research 
• Christopher McNair, PhD, Associate Director, Data Science and Cancer Informatics, Sidney Kimmel Cancer Center, Jefferson Health
• Tracey Robertson, Head of Patient and Site Engagement Capability Management, Boehringer Ingelheim 

This panel was recorded at the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research. For more information about the 2025 DPHARM, visit DPHARMconference.com. ]]>2912boehringeringelheim,cancerresearch,clinicalcare,clinicalresearch,clinicalresearchsite,clinicalsite,clinicaltrial,clinicaltrialsite,disruptiveinnovations,dpharm,drugdevelopment,jazzpharmaceuticals,jeffersonhealth,medicinedevelopment,novonordiskfalsefullhttps://www.spreaker.com/episode/what-to-expect-at-the-craaco-clinical-research-as-a-care-option-2025-event--66897339

• How to develop a clinical research program within a community cancer center, with Dr Brian Slomovitz, Mount Sinai Medical Center Miami Beach
• Turning clinical environments into learning health systems, with Dr Laura Esserman, UCSF Carol Franc Buck Breast Cancer Center
• How to better partner with multiple location health system structures for clinical trials 
• Addressing medical staff shortages and challenges to support clinical research
• The impact of clinical trial participation on cost and performance in cancer centers
• EHR and AI advancements for clinical research 
• And more 

Want to know more about CRAACO? Visit CRAACOevent.com.
]]>https://api.spreaker.com/episode/66897339Tue, 08 Jul 2025 13:38:48 +0000Conference ForumConference Forum Director Valerie Bowling and CRAACO Producer Danny McCarthy break down what to expect at the 2025 CRAACO program. This podcast covers the keynotes, panels and key themes for this year's event, including:  - How to develop a clinical...

• How to develop a clinical research program within a community cancer center, with Dr Brian Slomovitz, Mount Sinai Medical Center Miami Beach
• Turning clinical environments into learning health systems, with Dr Laura Esserman, UCSF Carol Franc Buck Breast Cancer Center
• How to better partner with multiple location health system structures for clinical trials 
• Addressing medical staff shortages and challenges to support clinical research
• The impact of clinical trial participation on cost and performance in cancer centers
• EHR and AI advancements for clinical research 
• And more 

Want to know more about CRAACO? Visit CRAACOevent.com.
]]>644clinicalcare,clinicalresearch,clinicalresearchasacareoption,clinicaltrials,clinicaltrialsascare,connectingcareandresearch,craaco,drugdevelopment,healthsystem,hospital,medicinedevelopment,pharmafalsefullhttps://www.spreaker.com/episode/directors-talk-podd-2025-keynotes-key-themes--66806552

• Regeneron Co-Founder and CSO, Dr George Yancopoulos
• Novo Nordisk Chief Scientific Advisor, Dr Lotte Bjerre Knudsen
• MIT's Robert Langer
• Patient Keynote, Jimi Olaghere
• Northeastern University's Dr Mansoor Amiji
• Drug Delivery Technology Presentation Tracks
• Networking Opportunities
• and more

Want to know more about PODD? Check it out at PODDConference.com.]]>https://api.spreaker.com/episode/66806552Mon, 30 Jun 2025 15:20:48 +0000Conference ForumPODD: Partnership Opportunities in Drug Delivery Directors Valerie Bowling and Andrew Goldstein break down what to expect at PODD 2025. This podcast covers keynotes and key themes for this year's event, including: - Regeneron Co-Founder and CSO, Dr...

• Regeneron Co-Founder and CSO, Dr George Yancopoulos
• Novo Nordisk Chief Scientific Advisor, Dr Lotte Bjerre Knudsen
• MIT's Robert Langer
• Patient Keynote, Jimi Olaghere
• Northeastern University's Dr Mansoor Amiji
• Drug Delivery Technology Presentation Tracks
• Networking Opportunities
• and more

Want to know more about PODD? Check it out at PODDConference.com.]]>689falsefullhttps://www.spreaker.com/episode/enhanced-strategic-fda-collaboration-working-with-cder-and-cber--66755532

• Engaging with the FDA on a peer-to-peer level
• Effectively negotiating about innovative approaches that may be outside of guidelines
• How to react and respond to feedback and questions from the FDA

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>https://api.spreaker.com/episode/66755532Thu, 26 Jun 2025 11:54:51 +0000Conference ForumThis podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs across indications about how CMOs can best support their regulatory teams and engage with the FDA and other regulators. Specifically, the...

• Engaging with the FDA on a peer-to-peer level
• Effectively negotiating about innovative approaches that may be outside of guidelines
• How to react and respond to feedback and questions from the FDA

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>1782falsefullhttps://www.spreaker.com/episode/biomaterial-implants-to-reduce-patient-burden-and-improve-adherence--66755339

• Defining biocompatible materials and biomaterials
• Differences between small and larger molecules
• Benefits and challenges of implants

To learn more about the PODD conference, please visit Drug-Delivery.org.
]]>https://api.spreaker.com/episode/66755339Thu, 26 Jun 2025 11:13:19 +0000Conference ForumThis podcast features a panel discussion from the 2024 PODD Conference with biopharma leaders about biomaterial approaches to develop implants that can deliver molecules and optimize for dose frequency. Specifically: - Defining biocompatible...

• Defining biocompatible materials and biomaterials
• Differences between small and larger molecules
• Benefits and challenges of implants

To learn more about the PODD conference, please visit Drug-Delivery.org.
]]>1741falsefullhttps://www.spreaker.com/episode/are-site-networks-the-solution-to-the-industry-productivity-and-recruitment-challenge--66748104Summary:
The consolidation of independent clinical trial sites into larger, integrated networks represents a strategic evolution in clinical research. This panel from the 2024 DPHARM conference discusses whether or not this level of consolidation can bring new researchers and new sites into clinical research, and lead to reduced risk to sponsors, increased predictability, streamlined site operations and greater access for patients. 

More specifically, this panel focuses on: 

• What is the true value of site networks?
• What does the landscape look like today – by TA/country / region?
• If scaled, what will the benefit look like for patients and can it impact the speed of treatment to patients?
• Case examples of the impact of current clinical research networks

In this panel:

• Mark Travers, PhD, MBA, VP, Head of GCTO Regions, Monitoring Excellence, Global Operations and eTMF, Merck
• Paul Evans, President and CEO, Velocity Clinical Research
• Mark Scullion, MBA, CEO, Atlas Clinical Research
• Nick Slack, MBE, Chairman and CEO, The START Center for Cancer Research

For more information, go to DPHARMconference.com. 

]]>https://api.spreaker.com/episode/66748104Wed, 25 Jun 2025 18:40:36 +0000Conference ForumSummary: The consolidation of independent clinical trial sites into larger, integrated networks represents a strategic evolution in clinical research. This panel from the 2024 DPHARM conference discusses whether or not this level of consolidation can...Summary:
The consolidation of independent clinical trial sites into larger, integrated networks represents a strategic evolution in clinical research. This panel from the 2024 DPHARM conference discusses whether or not this level of consolidation can bring new researchers and new sites into clinical research, and lead to reduced risk to sponsors, increased predictability, streamlined site operations and greater access for patients. 

More specifically, this panel focuses on: 

• What is the true value of site networks?
• What does the landscape look like today – by TA/country / region?
• If scaled, what will the benefit look like for patients and can it impact the speed of treatment to patients?
• Case examples of the impact of current clinical research networks

In this panel:

• Mark Travers, PhD, MBA, VP, Head of GCTO Regions, Monitoring Excellence, Global Operations and eTMF, Merck
• Paul Evans, President and CEO, Velocity Clinical Research
• Mark Scullion, MBA, CEO, Atlas Clinical Research
• Nick Slack, MBE, Chairman and CEO, The START Center for Cancer Research

For more information, go to DPHARMconference.com. 

]]>2103atlasclinicalresearch,clinicalresearch,clinicaltrials,clinicaltrialsite,disruptiveinnovations,dpharm,merck,modernizingclinicalresearch,sitenetwork,startcenterforcancerresearch,velocityclinicalresearchfalsefullhttps://www.spreaker.com/episode/2025-biotech-markets-immuno-oncology-outlook--66747944Summary:
Mizuho Securities Analyst, Dr Graig Suvannavejh, joined the 2025 Immuno-Oncology 360º Summit to share an outlook on the IO biotech market, high-level thoughts on the IO space, and public IO company case studies to illustrate the market's perception of what's happening in IO. 

More specifically:

• The current tailwinds working for and headwinds working against investment in biotech
• The increasing specialization of investors and lack of generalist investors 
• The impacts of challenging and/or disappointing readouts after the first wave of checkpoint inhibitors
• Where investors are more positive on biotech, and reasons for optimism in coming pipelines

For more information, visit IO360summit.com 

]]>https://api.spreaker.com/episode/66747944Wed, 25 Jun 2025 18:13:01 +0000Conference ForumSummary: Mizuho Securities Analyst, Dr Graig Suvannavejh, joined the 2025 Immuno-Oncology 360º Summit to share an outlook on the IO biotech market, high-level thoughts on the IO space, and public IO company case studies to illustrate the market's...Summary:
Mizuho Securities Analyst, Dr Graig Suvannavejh, joined the 2025 Immuno-Oncology 360º Summit to share an outlook on the IO biotech market, high-level thoughts on the IO space, and public IO company case studies to illustrate the market's perception of what's happening in IO. 

More specifically:

• The current tailwinds working for and headwinds working against investment in biotech
• The increasing specialization of investors and lack of generalist investors 
• The impacts of challenging and/or disappointing readouts after the first wave of checkpoint inhibitors
• Where investors are more positive on biotech, and reasons for optimism in coming pipelines

For more information, visit IO360summit.com 

]]>1203biotech,biotechetf,biotechinvestment,biotechmarket,cancer,immunooncology,investors,io360,market,medicinedevelopment,spx,xbifalsefullhttps://www.spreaker.com/episode/directors-talk-dpharm-2025-pharma-from-the-trenches-part-ii--66594668https://api.spreaker.com/episode/66594668Tue, 17 Jun 2025 19:47:18 +0000Conference ForumIn this podcast series, DPHARM Director Tracey Kimball with Valerie Bowling, Executive Director of the Conference Forum, break down what to expect at DPHARM 2025. Part II of this podcast series covers the 16 Pharma from the Trenches track case studies.296bio,clinical,conference,event,lifescience,pharma,r&dfalsefullhttps://www.spreaker.com/episode/directors-talk-dpharm-2025-keynotes-key-topics-part-i--66509199

• Former Merck CEO, Ken Frazier
• Former Head of FDA, Scott Gottlieb
• CRISPR Gene Therapy Patient Keynote, Victoria Gray
• Tuft's Ken Getz
• How DPHARM is tackling AI
• What to do about Protocol Complexity
• and more

Want to know more about DPHARM? Check it out at DPHARMconference.com.]]>https://api.spreaker.com/episode/66509199Wed, 11 Jun 2025 16:28:39 +0000Conference ForumIn this podcast series, DPHARM Directors Tracey Kimball and Valerie Bowling break down what to expect at DPHARM 2025. Part I of this podcast series covers keynotes and key topics for this year's event, including: - Former Merck CEO, Ken Frazier -...

• Former Merck CEO, Ken Frazier
• Former Head of FDA, Scott Gottlieb
• CRISPR Gene Therapy Patient Keynote, Victoria Gray
• Tuft's Ken Getz
• How DPHARM is tackling AI
• What to do about Protocol Complexity
• and more

Want to know more about DPHARM? Check it out at DPHARMconference.com.]]>639ai,clinical,conference,dpharm,event,fda,pharma,protocol,r&d,trialsfalsefullhttps://www.spreaker.com/episode/streamlining-effective-patient-engagement-through-pharma-patient-advocacy-collaboration--66399540About this podcast: 
Partnerships between industry and patient advocacy groups supply medicine development with critical patient expertise, insights and experience  on the journey towards greater patient centricity. This podcast focuses specifically on the role of patient advocacy groups in medicine development in providing a direct, and often untapped, resource for patient insights, community connections and protocol feedback. 

Dr Matthew Reaney, Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Trish Davidson, Senior Consultant at the Tufts Center for the Study of Drug Development and Director, PALADIN Consortium about the role of patient advocacy groups in medicine development and how PALADIN is connecting industry stakeholders to reduce duplicative efforts in patient engagement resources and advance more efficient patient engagement across the industry.

In the podcast, Matt touches upon IQVIA's recent collection of perspectives from researchers, approvers and patients. The book, Patient-centricity in the Biopharmaceutical Industry: Are We Nearly There Yet? was collated and edited by Matt and gathers diverse insights on patient-centric intervention development. In formats ranging from poetry to short fiction and personal narratives to more traditional reviews of the research, 30+ contributors across the industry discuss how to be truly “patient centric.” It can be accessed for free at https://bit.ly/PatientCentricityBook. 

For more information on PharmaTalk Radio podcasts, you can visit theconferenceforum.org.]]>https://api.spreaker.com/episode/66399540Thu, 05 Jun 2025 17:52:03 +0000Conference ForumAbout this podcast:  Partnerships between industry and patient advocacy groups supply medicine development with critical patient expertise, insights and experience  on the journey towards greater patient centricity. This podcast focuses specifically...About this podcast: 
Partnerships between industry and patient advocacy groups supply medicine development with critical patient expertise, insights and experience  on the journey towards greater patient centricity. This podcast focuses specifically on the role of patient advocacy groups in medicine development in providing a direct, and often untapped, resource for patient insights, community connections and protocol feedback. 

Dr Matthew Reaney, Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Trish Davidson, Senior Consultant at the Tufts Center for the Study of Drug Development and Director, PALADIN Consortium about the role of patient advocacy groups in medicine development and how PALADIN is connecting industry stakeholders to reduce duplicative efforts in patient engagement resources and advance more efficient patient engagement across the industry.

In the podcast, Matt touches upon IQVIA's recent collection of perspectives from researchers, approvers and patients. The book, Patient-centricity in the Biopharmaceutical Industry: Are We Nearly There Yet? was collated and edited by Matt and gathers diverse insights on patient-centric intervention development. In formats ranging from poetry to short fiction and personal narratives to more traditional reviews of the research, 30+ contributors across the industry discuss how to be truly “patient centric.” It can be accessed for free at https://bit.ly/PatientCentricityBook. 

For more information on PharmaTalk Radio podcasts, you can visit theconferenceforum.org.]]>1477clinicalresearch,clinicaltrials,drugdevelopment,iqvia,medicinedevelopment,paladin,patientadvocacy,patientadvocacygroup,patientcentric,patientcentricity,patientengagement,patientsaspartnersfalsefullhttps://www.spreaker.com/episode/lessons-learned-in-the-development-and-introduction-of-closed-loop-systems--66184143

• Success in diabetes and lessons for other indications like oncology and CNS
• New frontiers in improving closed-loop therapies
• Increasing access across therapy areas

To learn more about the PODD conference, please visit Drug-Delivery.org.]]>https://api.spreaker.com/episode/66184143Wed, 21 May 2025 14:18:20 +0000Conference ForumThis podcast features a panel discussion from the 2024 PODD Conference with pharma, medtech and academic leaders about technological development and patient and clinical adoption of closed-loop systems. Specifically: - Success in diabetes and lessons...

• Success in diabetes and lessons for other indications like oncology and CNS
• New frontiers in improving closed-loop therapies
• Increasing access across therapy areas

To learn more about the PODD conference, please visit Drug-Delivery.org.]]>1912closed-loopsystems,diabetes,drugdelivery,medtech,pharma,poddfalsefullhttps://www.spreaker.com/episode/best-practices-and-potential-pitfalls-enriching-clinical-trials-with-pros--66183912

• How PROs provide evidence on the effect of interventions on patient symptoms and quality of life, but by the nature of being subjective, they are prone to bias 
• The growth of electronic health technologies provides unprecedented opportunities to systematically collect PROs
• Disadvantages of electronic methods include technical difficulties, cost, longer start-up time, and “digital divide” between patients

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>https://api.spreaker.com/episode/66183912Wed, 21 May 2025 13:39:39 +0000Conference ForumPatient-reported outcomes (PROs) are increasingly recognized by regulators, clinicians, and patients as valuable tools to collect patient-centered data. This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with...

• How PROs provide evidence on the effect of interventions on patient symptoms and quality of life, but by the nature of being subjective, they are prone to bias 
• The growth of electronic health technologies provides unprecedented opportunities to systematically collect PROs
• Disadvantages of electronic methods include technical difficulties, cost, longer start-up time, and “digital divide” between patients

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>1958ai,biotech,clinicaltrials,cmo,patientreportedoutcomes,patients,pharma,wearablesfalsefullhttps://www.spreaker.com/episode/operationalizing-the-patient-voice-for-long-term-protocol-planning-and-execution--66150597Summary:
This podcast from the 2024 DPHARM conference showcases the value of patient engagement as a core strategic investment by focusing on the connection between patient engagement and tangible patient benefits / long-term business sustainability. 

The case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how this connection can be done in larger corporations and to emphasize patient engagement as a long-term growth driver and not just a short-term cost. 
More specifically: 

• Protocol design and executional practice, and the impact of current practices on protocol performance
• Framework, process and use cases for optimization of protocol performance through operationalization of patient preferences 
• Direct impact on corporate goals like recruitment, retention and growth 

For more information, go to DPHARMconference.com]]>https://api.spreaker.com/episode/66150597Mon, 19 May 2025 14:28:16 +0000Conference ForumSummary: This podcast from the 2024 DPHARM conference showcases the value of patient engagement as a core strategic investment by focusing on the connection between patient engagement and tangible patient benefits / long-term business sustainability. ...Summary:
This podcast from the 2024 DPHARM conference showcases the value of patient engagement as a core strategic investment by focusing on the connection between patient engagement and tangible patient benefits / long-term business sustainability. 

The case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how this connection can be done in larger corporations and to emphasize patient engagement as a long-term growth driver and not just a short-term cost. 
More specifically: 

• Protocol design and executional practice, and the impact of current practices on protocol performance
• Framework, process and use cases for optimization of protocol performance through operationalization of patient preferences 
• Direct impact on corporate goals like recruitment, retention and growth 

For more information, go to DPHARMconference.com]]>1801clinicalresearch,clinicaltrials,dpharm,patientengagement,patientsaspartners,protocolcomplexity,protocoldesign,rochefalsefullhttps://www.spreaker.com/episode/navigating-data-quality-and-scalability-challenges-when-using-real-world-data-from-ehrs--66089462Summary:
In this podcast from the 2024 CRAACO: Clinical Research as a Care Option conference, Dr Meredith Zozus, UT Health San Antonio, walks through several studies illustrating differences in data quality and scalability using EHRs in the conduct of structured protoocls versus retrospective studies using EHR. The results highlight the important methods and approaches for using EHR data in clinicla studies, which is a key component of integrating care and research. 

For more information, go to CRAACOevent.com.]]>https://api.spreaker.com/episode/66089462Wed, 14 May 2025 19:56:58 +0000Conference ForumSummary: In this podcast from the 2024 CRAACO: Clinical Research as a Care Option conference, Dr Meredith Zozus, UT Health San Antonio, walks through several studies illustrating differences in data quality and scalability using EHRs in the conduct of...Summary:
In this podcast from the 2024 CRAACO: Clinical Research as a Care Option conference, Dr Meredith Zozus, UT Health San Antonio, walks through several studies illustrating differences in data quality and scalability using EHRs in the conduct of structured protoocls versus retrospective studies using EHR. The results highlight the important methods and approaches for using EHR data in clinicla studies, which is a key component of integrating care and research. 

For more information, go to CRAACOevent.com.]]>1599clinicalcare,clinicalresearchasacareoption,clinicalresearchascare,clinicaltrials,craaco,data,dataanalysis,dataquality,ehr,electronichealthrecord,realworlddata,rwd,utsanantoniofalsefullhttps://www.spreaker.com/episode/addressing-the-realities-of-scaling-t-cell-therapies-for-patient-access-and-affordability--66088759Summary:
This podcast delves into the critical challenges of scalability in T-cell therapies (including CAR-T, TILs, and TCR-T). The panelists discuss the primary obstacles hindering the increased availability of T-cell therapies to patients, the most promising upcoming approaches to enhance access, the greatest opportunities to improve efficiencies and scalability, and the developments in the near future that could help meet growing demand. 

For more information, go to IO360summit.com. ]]>https://api.spreaker.com/episode/66088759Wed, 14 May 2025 18:36:34 +0000Conference ForumSummary: This podcast delves into the critical challenges of scalability in T-cell therapies (including CAR-T, TILs, and TCR-T). The panelists discuss the primary obstacles hindering the increased availability of T-cell therapies to patients, the most...Summary:
This podcast delves into the critical challenges of scalability in T-cell therapies (including CAR-T, TILs, and TCR-T). The panelists discuss the primary obstacles hindering the increased availability of T-cell therapies to patients, the most promising upcoming approaches to enhance access, the greatest opportunities to improve efficiencies and scalability, and the developments in the near future that could help meet growing demand. 

For more information, go to IO360summit.com. ]]>2411cancer,clinicalresearch,drugdevelopment,immunooncology,immunooncology360,immunotherapy,io360,medicinedevelopment,oncology,patientaccess,patientaccessibility,scalability,tcell,tcelltherapyfalsefullhttps://www.spreaker.com/episode/the-current-status-of-patient-centricity-in-medicine-development--66088137Summary:
This podcast focuses on the current state of patient centricity within the biopharmaceutical industry, how it's being implemented, operationalized and scaled within organizations, and showing the tangible value of engaging patients. 

Dr Matthew Reaney,  Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, to share their experiences, what they've seen in patient centricity gains, standing up patient centricity functions and proving the business case for doing so.

For more information, go to theconferenceforum.org.

]]>https://api.spreaker.com/episode/66088137Wed, 14 May 2025 17:42:45 +0000Conference ForumSummary: This podcast focuses on the current state of patient centricity within the biopharmaceutical industry, how it's being implemented, operationalized and scaled within organizations, and showing the tangible value of engaging patients.  Dr...Summary:
This podcast focuses on the current state of patient centricity within the biopharmaceutical industry, how it's being implemented, operationalized and scaled within organizations, and showing the tangible value of engaging patients. 

Dr Matthew Reaney,  Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, to share their experiences, what they've seen in patient centricity gains, standing up patient centricity functions and proving the business case for doing so.

For more information, go to theconferenceforum.org.

]]>1547astellas,biopharmaceutical,clinicalresearch,clinicaltrials,drugdevelopment,iqvia,lifesciences,medicinedevelopment,patientcentric,patientcentricity,patientfocus,patientsaspartnersfalsefullhttps://www.spreaker.com/episode/patients-as-partners-caregiver-keynote-the-life-changing-power-of-a-clinical-trial--65784657Summary:
In this podcast, recorded at the 2025 Patients as Partners in Clinical Research conference, patient advocate and caregiver Dr Justin Hopkin, University of Rochester, describes his family's journey before, during and after his son was diagnosed with a rare, life-threatening disease. 

Dr Hopkin talks about the process of getting a diagnosis, the critical role of a clinical trial for his son, the impact on his other children, and his advice for medicine developers and clinical trial designers. 

For more information, go to PatientsAsPartnersConference.com]]>https://api.spreaker.com/episode/65784657Mon, 28 Apr 2025 20:18:33 +0000Conference ForumSummary: In this podcast, recorded at the 2025 Patients as Partners in Clinical Research conference, patient advocate and caregiver Dr Justin Hopkin, University of Rochester, describes his family's journey before, during and after his son was...Summary:
In this podcast, recorded at the 2025 Patients as Partners in Clinical Research conference, patient advocate and caregiver Dr Justin Hopkin, University of Rochester, describes his family's journey before, during and after his son was diagnosed with a rare, life-threatening disease. 

Dr Hopkin talks about the process of getting a diagnosis, the critical role of a clinical trial for his son, the impact on his other children, and his advice for medicine developers and clinical trial designers. 

For more information, go to PatientsAsPartnersConference.com]]>1442advocacy,caregiver,clinicalcare,clinicalresearch,clinicaltrials,papus,patientadvocacy,patientengagement,patientsaspartners,rarediseasefalsefullhttps://www.spreaker.com/episode/bispecific-antibodies-for-pd-1-and-vegf-impact-and-market-dynamics-for-io-landscape--65682356Summary:
This podcast, recorded at the 2025 Immuno-Oncology 360º (IO360º) Summit, explores the clinical and market implications of emerging data on bispecific antibodies targeting PD-1 and VEGF and their potential to disrupt existing immunotherapy paradigms.

More specifically: 

• Assessing the potential of this therapeutic approach to challenge established treatments like pembrolizumab by targeting both PD-1 and VEGF
• Insights into how these developments could influence industry trends and investor sentiment
• Forward-looking forecasts on market share and commercial positioning for PD-1/PD-L1 and VEGF-targeting therapies

In this podcast:

• Roy Baynes, MD, PhD, EVP & CMO at Eikon Therapeutics

• Asthika Goonewardene, MBA, Managing Director, Senior Biotech Analyst at Truist Securities

For more information, go to IO360summit.com





]]>https://api.spreaker.com/episode/65682356Wed, 23 Apr 2025 16:45:56 +0000Conference ForumSummary: This podcast, recorded at the 2025 Immuno-Oncology 360º (IO360º) Summit, explores the clinical and market implications of emerging data on bispecific antibodies targeting PD-1 and VEGF and their potential to disrupt existing immunotherapy...Summary:
This podcast, recorded at the 2025 Immuno-Oncology 360º (IO360º) Summit, explores the clinical and market implications of emerging data on bispecific antibodies targeting PD-1 and VEGF and their potential to disrupt existing immunotherapy paradigms.

More specifically: 

• Assessing the potential of this therapeutic approach to challenge established treatments like pembrolizumab by targeting both PD-1 and VEGF
• Insights into how these developments could influence industry trends and investor sentiment
• Forward-looking forecasts on market share and commercial positioning for PD-1/PD-L1 and VEGF-targeting therapies

In this podcast:

• Roy Baynes, MD, PhD, EVP & CMO at Eikon Therapeutics

• Asthika Goonewardene, MBA, Managing Director, Senior Biotech Analyst at Truist Securities

For more information, go to IO360summit.com





]]>1175bispecificantibodies,eikontherapeutics,immunooncology,immunooncology360,immunotherapy,io,io360,oncology,pd1,truistsecurities,vegffalsefullhttps://www.spreaker.com/episode/sustained-release-innovations-to-reduce-patient-burden--65666251

• Contrasting approaches for both biologics and small molecules
• Next generation technologies to provide less frequent administration
• Scalable and sustainable ways to provide longer lasting treatments by going beyond conventional sustained release technologies

To learn more about the PODD conference, please visit Drug-Delivery.org.

]]>https://api.spreaker.com/episode/65666251Tue, 22 Apr 2025 16:02:03 +0000Conference ForumThis podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about approaches and challenges in developing sustained release and long acting injectable formulations of therapeutics. Specifically: -...

• Contrasting approaches for both biologics and small molecules
• Next generation technologies to provide less frequent administration
• Scalable and sustainable ways to provide longer lasting treatments by going beyond conventional sustained release technologies

To learn more about the PODD conference, please visit Drug-Delivery.org.

]]>1840biotech,drugdelivery,patient,pharmafalsefullhttps://www.spreaker.com/episode/how-pharma-is-adopting-generative-ai-across-clinical-development--65597110Summary: 
In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management required to implement GenAI adoption, use cases and lessons learned, ensuring GenAI use is fit-for-purpose, and more. 

For more information, go to DPHARMconference.com.]]>https://api.spreaker.com/episode/65597110Wed, 16 Apr 2025 18:33:48 +0000Conference ForumSummary:  In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management...Summary: 
In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management required to implement GenAI adoption, use cases and lessons learned, ensuring GenAI use is fit-for-purpose, and more. 

For more information, go to DPHARMconference.com.]]>1543clinicaldevelopment,clinicalresearch,clinicaltrialoperations,dpharm,genai,generativeai,johnson&johnson,merck,moderna,regeneron,sanofifalsefullhttps://www.spreaker.com/episode/tufts-center-for-study-of-drug-development-on-evolving-clinical-trial-partnerships--65258792Summary: 
New clinical trial execution models have been introduced over the last decade, providing local communities with more direct access to clinical research through remote sites, retail pharmacies, mobile units, site staff embedded in clinical care settings, and more. 

In this session, recorded at the 2024 CRAACO: Clinical Research as a Care Option conference, Joan Chambers of the Tufts Center for the Study of Drug Development shared preliminary survey results conducted by the Tufts CSDD to help industry understand the strategic and structural growth
of new trial sites and partnerships in bringing trials directly to local communities.

This podcast sheds light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape.

For more information, go to theconferenceforum.org. 
]]>https://api.spreaker.com/episode/65258792Mon, 31 Mar 2025 17:11:04 +0000Conference ForumSummary:  New clinical trial execution models have been introduced over the last decade, providing local communities with more direct access to clinical research through remote sites, retail pharmacies, mobile units, site staff embedded in clinical...Summary: 
New clinical trial execution models have been introduced over the last decade, providing local communities with more direct access to clinical research through remote sites, retail pharmacies, mobile units, site staff embedded in clinical care settings, and more. 

In this session, recorded at the 2024 CRAACO: Clinical Research as a Care Option conference, Joan Chambers of the Tufts Center for the Study of Drug Development shared preliminary survey results conducted by the Tufts CSDD to help industry understand the strategic and structural growth
of new trial sites and partnerships in bringing trials directly to local communities.

This podcast sheds light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape.

For more information, go to theconferenceforum.org. 
]]>1154falsefullhttps://www.spreaker.com/episode/new-approaches-to-achieve-targeted-brain-delivery-without-increasing-toxicity--64838331

• Nose-to-brain delivery
• Introcerebroventricular injections
• Blood-brain-barrier disruption via excipients
• Implantable approaches
• Combinations

To learn more about the PODD conference, please visit Drug-Delivery.org.
]]>https://api.spreaker.com/episode/64838331Wed, 12 Mar 2025 14:18:06 +0000Conference ForumThis podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about formulation and physical approaches to achieve targeted brain delivery. The panelists discuss challenges and updates, patient acceptability...

• Nose-to-brain delivery
• Introcerebroventricular injections
• Blood-brain-barrier disruption via excipients
• Implantable approaches
• Combinations

To learn more about the PODD conference, please visit Drug-Delivery.org.
]]>1778bbb,biotech,brain,drugdelivery,icv,implants,intranasal,pharmafalsefullhttps://www.spreaker.com/episode/partnering-with-patients-in-clinical-development-using-the-biopsychosocial-model--64715037Summary: 
This podcast covers how a co-creation and collaboration was formed between Abbott, the National Blood Clot Alliance and Luminous to gather qualitative insights exploring motivations in a key patient population for participating in clinical research. 

The podcast additionally covers how the partnership has influenced patient engagement in a large healthcare organization, the resulting shift in patient perceptions around clinical research, and how the biopsychosocial approach to engagement elicits deeper and more impactful insights. 

For more information on patient engagement in clinical research, go to patientsaspartners.org]]>https://api.spreaker.com/episode/64715037Wed, 05 Mar 2025 18:27:17 +0000Conference ForumSummary:  This podcast covers how a co-creation and collaboration was formed between Abbott, the National Blood Clot Alliance and Luminous to gather qualitative insights exploring motivations in a key patient population for participating in clinical...Summary: 
This podcast covers how a co-creation and collaboration was formed between Abbott, the National Blood Clot Alliance and Luminous to gather qualitative insights exploring motivations in a key patient population for participating in clinical research. 

The podcast additionally covers how the partnership has influenced patient engagement in a large healthcare organization, the resulting shift in patient perceptions around clinical research, and how the biopsychosocial approach to engagement elicits deeper and more impactful insights. 

For more information on patient engagement in clinical research, go to patientsaspartners.org]]>1713abbott,biopsychosocial,devicedevelopment,drugdevelopment,luminouseffect,medicinedevelopment,nationalbloodclotalliance,patientcentricity,patientengagement,patientsaspartners,theconferenceforumfalsefullhttps://www.spreaker.com/episode/vaccine-delivery-innovations--64584429

• Barriers to implementation of technological advancements
• How the vaccine marketplace differs from other therapeutic marketplaces and the drivers of meaningful innovation in the space
• How to best develop and position innovative vaccine technologies for success
• Unmet needs and opportunities for vaccine technologies
• Exciting emerging technologies

To learn more about the PODD conference, please visit Drug-Delivery.org.]]>https://api.spreaker.com/episode/64584429Wed, 26 Feb 2025 14:06:01 +0000Conference ForumThis podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about the technical innovation in the vaccine space within R&D over the past several years as well as the challenges and opportunities around...

• Barriers to implementation of technological advancements
• How the vaccine marketplace differs from other therapeutic marketplaces and the drivers of meaningful innovation in the space
• How to best develop and position innovative vaccine technologies for success
• Unmet needs and opportunities for vaccine technologies
• Exciting emerging technologies

To learn more about the PODD conference, please visit Drug-Delivery.org.]]>1748biotech,covid,drugdelivery,flu,injectable,nasal,pharma,sustainedrelease,vaccinefalsefullhttps://www.spreaker.com/episode/how-paladin-consortium-aims-to-enhance-efficient-patient-advocacy-industry-collaborations--64568006Summary:
In this podcast, PALADIN Consortium Committee Co-Chairs, Deirdre BeVard of CSL and Dr Len Valentino of World Federation of Hemophilia USA, discuss how the pre-competitive group is creating resources aimed at enhancing and speeding up industry-patient advocacy collaborations. 

For more information on PharmaTalk Radio podcasts, you can go to theconferenceforum.org. For more information on patient engagement in clinical research, visit patientsaspartners.org. ]]>https://api.spreaker.com/episode/64568006Tue, 25 Feb 2025 18:36:03 +0000Conference ForumSummary: In this podcast, PALADIN Consortium Committee Co-Chairs, Deirdre BeVard of CSL and Dr Len Valentino of World Federation of Hemophilia USA, discuss how the pre-competitive group is creating resources aimed at enhancing and speeding up...Summary:
In this podcast, PALADIN Consortium Committee Co-Chairs, Deirdre BeVard of CSL and Dr Len Valentino of World Federation of Hemophilia USA, discuss how the pre-competitive group is creating resources aimed at enhancing and speeding up industry-patient advocacy collaborations. 

For more information on PharmaTalk Radio podcasts, you can go to theconferenceforum.org. For more information on patient engagement in clinical research, visit patientsaspartners.org. ]]>1372biotech,clinicalresearch,clinicaltrials,collaborations,drugdevelopment,paladin,paladinconsortium,patientadvocacy,patientengagement,pharma,pharmatalkradiofalsefullhttps://www.spreaker.com/episode/what-cmos-need-to-know-and-do-when-preparing-for-product-launch--64564620

• The timing and strategy of building out medical affairs
• Strategic imperatives to achieve launch readiness
• Collaborating with your Chief Commercial Officer leading up to and after drug approval
• Managing the transition from development to commercial organization

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>https://api.spreaker.com/episode/64564620Tue, 25 Feb 2025 15:35:22 +0000Conference ForumCMOs play a critical role in ensuring activities prior to approval lead to a successful launch. In this podcast, originally recorded as a session at the 2024 CMO Summit 360°, panelists discuss the role of the CMO in preparing for a new product launch,...

• The timing and strategy of building out medical affairs
• Strategic imperatives to achieve launch readiness
• Collaborating with your Chief Commercial Officer leading up to and after drug approval
• Managing the transition from development to commercial organization

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.]]>1867falsefullhttps://www.spreaker.com/episode/what-to-expect-at-the-2025-patients-as-partners-eu-conference--64341594
For more information about the upcoming event, full agenda and speakers, visit https://patientsaspartnerseu.com/]]>https://api.spreaker.com/episode/64341594Wed, 12 Feb 2025 15:46:24 +0000Conference ForumValerie Bowling, Executive Director of Patients as Partners Europe conference, discusses what attendees can expect at the 9th annual conference, including key topic areas, session highlights, presenting companies and more. For more information about...
For more information about the upcoming event, full agenda and speakers, visit https://patientsaspartnerseu.com/]]>516falsefullhttps://www.spreaker.com/episode/understanding-financial-barriers-to-getting-more-coverage-for-patients-in-clinical-trials--64341169Summary:
In this podcast, recorded at the 2024 Clinical Research as a Care Option (CRAACO) event, Donna O'Brien, Manatt Health, Trevan Locke, Duke-Margolis, and Denise Snyder, Duke University School of Medicine, discuss the financial barriers to getting coverage for clinical trials, coverage by sponsors vs standard of care and new developments for the audience to be aware of. 

They also cover: 

• What policy approaches can empower hospitals, trial sponsors, providers, and other stakeholders to manage change with their own organizations and engage with payers to foster broader coverage of trial-related activities
• How we can improve evidence generation processes within our own organizations for both healthcare systems and pharma
• How can we effectively communicate steps that Federal agencies can take to encourage stakeholder collaboration to align on incentives for improving coverage of clinical trials for patients

For more information, go to CRAACOevent.com. 
]]>https://api.spreaker.com/episode/64341169Wed, 12 Feb 2025 15:15:59 +0000Conference ForumSummary: In this podcast, recorded at the 2024 Clinical Research as a Care Option (CRAACO) event, Donna O'Brien, Manatt Health, Trevan Locke, Duke-Margolis, and Denise Snyder, Duke University School of Medicine, discuss the financial barriers to...Summary:
In this podcast, recorded at the 2024 Clinical Research as a Care Option (CRAACO) event, Donna O'Brien, Manatt Health, Trevan Locke, Duke-Margolis, and Denise Snyder, Duke University School of Medicine, discuss the financial barriers to getting coverage for clinical trials, coverage by sponsors vs standard of care and new developments for the audience to be aware of. 

They also cover: 

• What policy approaches can empower hospitals, trial sponsors, providers, and other stakeholders to manage change with their own organizations and engage with payers to foster broader coverage of trial-related activities
• How we can improve evidence generation processes within our own organizations for both healthcare systems and pharma
• How can we effectively communicate steps that Federal agencies can take to encourage stakeholder collaboration to align on incentives for improving coverage of clinical trials for patients

For more information, go to CRAACOevent.com. 
]]>1645clinicalresearch,clinicalresearchasacareoption,clinicalresearchascare,clinicaltrials,craaco,dukemargolis,dukeuniversityschoolofmedicine,financialcoverage,manatthealth,patientcarefalsefullhttps://www.spreaker.com/episode/how-montefiore-gets-early-stage-clinical-trials-to-under-resourced-communities--64000262Summary:

Dr David Levitz, Medical Director of the Early Phase Program at Montefiore Einstein Cancer Center, talks about how the center has been able to offer its community access to early stage clinical research. 

Dr Levitz brings the audience through the necessary infrastructure, dedicated team, interdepartmental collaboration, higher-up support, recruitment and partnership strategies required to make this a reality. 

This presentation took place at the 2024 Clinical Research as a Care Option conference. For more information, go to CRAACOevent.com ]]>https://api.spreaker.com/episode/64000262Wed, 29 Jan 2025 16:09:06 +0000Conference ForumSummary: Dr David Levitz, Medical Director of the Early Phase Program at Montefiore Einstein Cancer Center, talks about how the center has been able to offer its community access to early stage clinical research.  Dr Levitz brings the audience...Summary:

Dr David Levitz, Medical Director of the Early Phase Program at Montefiore Einstein Cancer Center, talks about how the center has been able to offer its community access to early stage clinical research. 

Dr Levitz brings the audience through the necessary infrastructure, dedicated team, interdepartmental collaboration, higher-up support, recruitment and partnership strategies required to make this a reality. 

This presentation took place at the 2024 Clinical Research as a Care Option conference. For more information, go to CRAACOevent.com ]]>1443clinicalresearch,clinicalresearchasacareoption,clinicalresearchascare,clinicaltrials,craaco,earlystageclinicaltrials,montefiore,montefioreeinsteincancercenter,trialsascarefalsefullhttps://www.spreaker.com/episode/investment-trends-in-immuno-oncology--63701993Summary:
In this podcast, recorded at the February 2024 IO360º summit, biopharma, finance and investment experts discuss the fundability features of IO biotechs, and the current pharma needs that will drive potential partnerships or M&A. 

Moderater:
Axel Hoos, MD, PhD, Former CEO, Scorpion Therapeutics

Panelists: 
Irina Margine, PhD, Principal, Biotech Private Equity, Wellington Management
Khalil Barrage, Managing Partner, Invus Group
Jeffrey Bockman, PhD, EVP, Oncology and Virology Practices, Lumanity
Emmett Schmidt, MD, PhD, VP, Clinical Oncology, External Collaborations, Merck
Gayatri Varma, PhD, Executive Director and Head of Transactions, Oncology R&D, AstraZeneca

For more information, go to IO360summit.com.]]>https://api.spreaker.com/episode/63701993Wed, 22 Jan 2025 17:45:06 +0000Conference ForumSummary: In this podcast, recorded at the February 2024 IO360º summit, biopharma, finance and investment experts discuss the fundability features of IO biotechs, and the current pharma needs that will drive potential partnerships or M&A. ...Summary:
In this podcast, recorded at the February 2024 IO360º summit, biopharma, finance and investment experts discuss the fundability features of IO biotechs, and the current pharma needs that will drive potential partnerships or M&A. 

Moderater:
Axel Hoos, MD, PhD, Former CEO, Scorpion Therapeutics

Panelists: 
Irina Margine, PhD, Principal, Biotech Private Equity, Wellington Management
Khalil Barrage, Managing Partner, Invus Group
Jeffrey Bockman, PhD, EVP, Oncology and Virology Practices, Lumanity
Emmett Schmidt, MD, PhD, VP, Clinical Oncology, External Collaborations, Merck
Gayatri Varma, PhD, Executive Director and Head of Transactions, Oncology R&D, AstraZeneca

For more information, go to IO360summit.com.]]>2328biotech,cancer,cancertreatment,clinicalresearch,clinicaltrials,drugdevelopment,immunooncology,immunooncology360ºsummit,immunotherapy,investment,investmenttrends,io360º,oncology,pharmafalsefullhttps://www.spreaker.com/episode/advances-in-pulmonary-delivery-of-biologics--63783850

• The benefits and costs of different formulation approaches to deliver inhaled therapeutics what needs to be developed to enable more biologics
• Different device approaches including nebulizers, soft mist inhalers, dry powder inhalers and more
• Factors driving new platform and therapeutic development including patient-centricity, legacy technology and time to market
• Next-generation inhaled therapeutics like mRNA vaccines

To learn more about the PODD conference, please visit Drug-Delivery.org.]]>https://api.spreaker.com/episode/63783850Wed, 22 Jan 2025 16:32:32 +0000Conference ForumThis podcast features a panel discussion with pharma and biotech leaders about the past and future direction of pulmonary delivery of biologics. Specifically, the panelists discuss: - The benefits and costs of different formulation approaches to...

• The benefits and costs of different formulation approaches to deliver inhaled therapeutics what needs to be developed to enable more biologics
• Different device approaches including nebulizers, soft mist inhalers, dry powder inhalers and more
• Factors driving new platform and therapeutic development including patient-centricity, legacy technology and time to market
• Next-generation inhaled therapeutics like mRNA vaccines

To learn more about the PODD conference, please visit Drug-Delivery.org.]]>1837biotech,device,drugdelivery,formulation,glp,inhalers,mrna,pharma,rnafalsefullhttps://www.spreaker.com/episode/strategies-for-cmos-to-scale-up-effectively-as-their-biotech-company-evolves--63691023

• Determining the priority of roles/functions
• Balancing between outsourcing, contracting consultants and hiring internally
• Key hires for companies at different stages
• Managing the evolving culture of the company

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
]]>https://api.spreaker.com/episode/63691023Tue, 14 Jan 2025 18:42:35 +0000Conference ForumAs companies evolve, hiring is essential, sometimes while concurrently downsizing other areas of the company. In this podcast, originally recorded as a session at the 2024 CMO Summit 360°, panelists discuss how to scale up with effective budgeting in...

• Determining the priority of roles/functions
• Balancing between outsourcing, contracting consultants and hiring internally
• Key hires for companies at different stages
• Managing the evolving culture of the company

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
]]>1991falsefullhttps://www.spreaker.com/episode/boehringer-ingelheim-on-collaborations-in-clinical-development-for-launch-readiness--63688762
In this podcast from the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research, Boehringer Ingelheim's Candice Fitzgerald, MMedSc, shares how the organization built collaborative partnerships across functions to drive faster and more informed clinical development and launch readiness. 

Specifically, she covers:

• Deploying a more holistic, strategic approach to deliver on clinical development 
• The value of forging cross-functional partnerships
• The role of strategic messaging and how to ensure consistency through continual change
• Collecting strategic insights and the importance of taking action on those insights

For more information, go to DPHARMconference.com.
]]>https://api.spreaker.com/episode/63688762Tue, 14 Jan 2025 16:50:51 +0000Conference ForumSummary: In this podcast from the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research, Boehringer Ingelheim's Candice Fitzgerald, MMedSc, shares how the organization built collaborative partnerships across functions to drive faster and...
In this podcast from the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research, Boehringer Ingelheim's Candice Fitzgerald, MMedSc, shares how the organization built collaborative partnerships across functions to drive faster and more informed clinical development and launch readiness. 

Specifically, she covers:

• Deploying a more holistic, strategic approach to deliver on clinical development 
• The value of forging cross-functional partnerships
• The role of strategic messaging and how to ensure consistency through continual change
• Collecting strategic insights and the importance of taking action on those insights

For more information, go to DPHARMconference.com.
]]>711boehringeringelheim,clinicaldevelopment,clinicaloperations,clinicaltrialoperations,clinicaltrials,disruptiveinnovations,dpharm,modernizingclinicalresearchfalsefullhttps://www.spreaker.com/episode/payer-perspectives-on-drug-delivery--63340364
The panelists discuss the growing number of self-insured employers that are considering restricting drugs based on cost alone, the future of weight loss drugs and GLP-1s and potential factors influencing market access for gene therapies for more common conditions.

To learn more about the PODD conference, please visit Drug-Delivery.org.]]>https://api.spreaker.com/episode/63340364Mon, 16 Dec 2024 16:19:58 +0000Conference ForumThis podcast features a panel discussion with payers, investors and consultants about how they approach decisions to cover new medications and the role novel delivery approaches play in that decision-making from the 2024 PODD: Partnership...
The panelists discuss the growing number of self-insured employers that are considering restricting drugs based on cost alone, the future of weight loss drugs and GLP-1s and potential factors influencing market access for gene therapies for more common conditions.

To learn more about the PODD conference, please visit Drug-Delivery.org.]]>1811biotech,drugdelivery,genetherapy,glp1,insurance,marketaccess,payer,pharmafalsefullhttps://www.spreaker.com/episode/patient-engagement-practical-approaches-for-emerging-biotech-cmos--63339066
The panelists discuss evaluating how early to engage patients, navigating potential challenges associated with patient engagement both in earlier and later stages of development and how CMOs should advocate for patient-centricity when working within limited budgets.

To learn more about the CMO Summit and its associated editorials, podcasts and webinars, please visit CMO360.org.]]>https://api.spreaker.com/episode/63339066Mon, 16 Dec 2024 14:54:57 +0000Conference ForumThis podcast features a panel discussion on how to engage patients throughout the development process with biotech CMOs and representatives from Legacy Health Strategies, Sano Genetics and Tasso, from the 2025 Chief Medical Officer Summit 360°. The...
The panelists discuss evaluating how early to engage patients, navigating potential challenges associated with patient engagement both in earlier and later stages of development and how CMOs should advocate for patient-centricity when working within limited budgets.

To learn more about the CMO Summit and its associated editorials, podcasts and webinars, please visit CMO360.org.]]>1898biotech,clinicalresearch,clinicaltrials,cmo,patient,pharmafalsefullhttps://www.spreaker.com/episode/immuno-oncology-debate-2024-on-solving-cancer-s-top-challenges--63244520http://www.blogtalkradio.com/pharmatalk/2024/12/09/immuno-oncology-debate-2024-on-solving-cancers-top-challengesMon, 09 Dec 2024 05:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org 2257bispecific engagers,cell therapy,immuno-oncology,immunotherapy,io360falsefullhttps://www.spreaker.com/episode/cmo-misunderstandings-about-clinical-operations-and-how-to-improve--63244523http://www.blogtalkradio.com/pharmatalk/2024/12/05/cmo-misunderstandings-about-clinical-operations-and-how-to-improveThu, 05 Dec 2024 06:30:00 +0000Conference ForumMany of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical operations experts into the decision-making process...1954biotech,clinical development,clinical operations,cmo,pharmafalsefullhttps://www.spreaker.com/episode/how-roche-is-maximizing-the-impact-of-patient-insights-in-early-development--63244522http://www.blogtalkradio.com/pharmatalk/2024/12/03/how-roche-is-maximizing-the-impact-of-patient-insights-in-early-developmentTue, 03 Dec 2024 05:00:00 +0000Conference ForumFor more information, go to theconferenceforum.org 1131drug development,early development,patient insights,research and development,rochefalsefullhttps://www.spreaker.com/episode/designing-and-developing-drug-delivery-for-lower-and-middle-income-countries--63244525http://www.blogtalkradio.com/pharmatalk/2024/11/21/designing-and-developing-drug-delivery-for-lower-and-middle-income-countriesThu, 21 Nov 2024 05:00:00 +0000Conference ForumThis podcast features a panel discussion on desgining and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and AbbVie From the 2024 PODD: Partnership...2499drug delivery,lmic,medtech,pharma,reverse innovationfalsefullhttps://www.spreaker.com/episode/making-clinical-research-a-feasible-care-option-using-modern-software-infrastructure--63244529http://www.blogtalkradio.com/pharmatalk/2024/11/19/clinical-research-as-care-using-modern-software-infrastructureTue, 19 Nov 2024 05:00:00 +0000Conference ForumFor more information, go to CRAACOevent.com or realtime-eclinical.com1544clinical research,clinical research as a care op,craaco,devana,realtime eclinicalfalsefullhttps://www.spreaker.com/episode/using-patient-insights-meaningfully-throughout-the-medicine-disease-lifecycle--63244550http://www.blogtalkradio.com/pharmatalk/2024/11/08/using-patient-insights-meaningfully-throughout-the-medicine-disease-lifecycleFri, 08 Nov 2024 05:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org. 1228clinical trials,innovation clinical research,innovation in clinical researc,patient centricity,patients as partners in clinicfalsefullhttps://www.spreaker.com/episode/innovative-approach-for-elevating-patient-centric-solutions-in-pediatric-trials--63244530http://www.blogtalkradio.com/pharmatalk/2024/11/08/innovative-approach-for-elevating-patient-centric-solutions-in-pediatric-trialsFri, 08 Nov 2024 05:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org903clinical trials,patient centric clinical resea,patient centricity,patients as partners,patients as partners in clinicfalsefullhttps://www.spreaker.com/episode/incorporating-quantitative-values-of-patient-perspectives-into-trial-design--63244765http://www.blogtalkradio.com/pharmatalk/2024/10/25/incorporating-quantitative-values-of-patient-perspectives-into-trial-designFri, 25 Oct 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org1248clinical trial,patient perspective,patients as partners in clinic,quantitative,quantitative valuefalsefullhttps://www.spreaker.com/episode/accessing-a-novel-source-of-patient-experience-data-to-improve-clinical-research--63244544http://www.blogtalkradio.com/pharmatalk/2024/10/24/accessing-a-novel-source-of-patient-experience-data-to-improve-clinical-researchThu, 24 Oct 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org1016inspire,patient centric care,patient centricity,patient centric research,patient communityfalsefullhttps://www.spreaker.com/episode/empathy-and-behavioral-science-in-epros-to-increase-data-collection-adherence--63244533http://www.blogtalkradio.com/pharmatalk/2024/10/23/empathy-and-behavioral-science-in-epros-to-increase-data-collection-adherenceWed, 23 Oct 2024 04:00:00 +0000Conference ForumFor more information, go to theconferenceforum.org1430clinical outcome assessment,datacubed,dpharm,epro,patient reported outcomefalsefullhttps://www.spreaker.com/episode/antiviral-drug-development-overcoming-challenges-to-the-current-model--63244545http://www.blogtalkradio.com/pharmatalk/2024/10/11/antiviral-drug-development-overcoming-challenges-to-the-current-modelFri, 11 Oct 2024 04:00:00 +0000Conference ForumAs viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the...1628antiviral,biotech,drug delivery,pharma,poddfalsefullhttps://www.spreaker.com/episode/unlocking-pre-enrollment-data-to-help-sponsors-recruit-and-enroll-more-patients--63244531http://www.blogtalkradio.com/pharmatalk/2024/10/09/unlocking-pre-enrollment-data-to-help-sponsors-recruit-and-enroll-more-patientsWed, 09 Oct 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org1225clinical research,clinical trials,dpharm,onestudyteam,pre-enrollmentfalsefullhttps://www.spreaker.com/episode/strategies-to-empower-clinical-sites-streamline-trials-and-enhance-patient-care--63244521http://www.blogtalkradio.com/pharmatalk/2024/10/09/strategies-to-empower-clinical-sites-streamline-trials-and-enhance-patient-careWed, 09 Oct 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org2157clinical trials,clinical trial sites,patient care,patient centricity,patients as partnersfalsefullhttps://www.spreaker.com/episode/the-history-of-tumor-vaccines-and-why-the-newest-rna-cancer-vaccines-might-work--63244535http://www.blogtalkradio.com/pharmatalk/2024/10/07/the-history-of-tumor-vaccines-and-why-the-newest-rna-cancer-vaccines-might-workMon, 07 Oct 2024 04:00:00 +0000Conference ForumFor more information, visit immuno-oncology360.org. 1331cancer vaccines,immuno-oncology,immuno-oncology 360,immunotherapy,io360falsefullhttps://www.spreaker.com/episode/what-biotech-ceos-need-to-know-about-developing-a-commercialization-roadmap--63244536http://www.blogtalkradio.com/pharmatalk/2024/10/04/what-biotech-ceos-need-to-know-about-developing-a-commercialization-roadmapFri, 04 Oct 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org.  1523clinical research,clinical trials,disruptive innovation,dpharm,research and developmentfalsefullhttps://www.spreaker.com/episode/simplicity-in-technology-delivery-for-clinical-trials--63244538http://www.blogtalkradio.com/pharmatalk/2024/09/20/simplicity-in-technology-delivery-for-clinical-trialsFri, 20 Sep 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org1270advancing clinical trials,clinical research,clinical trials,dpharm,technology in trialsfalsefullhttps://www.spreaker.com/episode/micromachines-biologic-approaches-and-new-tools-pushing-the-boundaries-in-oral--63244551http://www.blogtalkradio.com/pharmatalk/2024/09/19/micromachines-biologic-approaches-and-new-tools-pushing-the-boundaries-in-oralThu, 19 Sep 2024 04:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1696biologic,biotech,drug delivery,oral delivery,pharmafalsefullhttps://www.spreaker.com/episode/combining-ai-and-empirical-science-to-advance-cancer-immunotherapies--63244570http://www.blogtalkradio.com/pharmatalk/2024/09/13/combining-ai-and-empirical-science-to-advance-cancer-immunotherapiesFri, 13 Sep 2024 04:00:00 +0000Conference ForumFor more information, go to theconferenceforum.org 1473genentech,immuno oncology,immuno oncology 360,io360,ira mellmanfalsefullhttps://www.spreaker.com/episode/the-personal-impact-of-a-clinical-trial--63244549http://www.blogtalkradio.com/pharmatalk/2024/09/12/the-personal-impact-of-a-clinical-trialThu, 12 Sep 2024 04:00:00 +0000Conference ForumFor more information, go to theconferenceforum.org1190clinical research,clinical trial,patient advocacy,patient advocate,patients as partnersfalsefullhttps://www.spreaker.com/episode/the-future-of-patient-centricity-advancing-frameworks-to-achieve-greater-impact--63244548http://www.blogtalkradio.com/pharmatalk/2024/08/08/the-future-of-patient-centricity-advancing-frameworks-to-achieve-greater-impactThu, 08 Aug 2024 04:00:00 +0000Conference ForumFor more information, visit patientsaspartners.org. 1842clinical research,clinical trials,patients as partners,patients as partners europe,patients as partners in clinicfalsefullhttps://www.spreaker.com/episode/using-ai-to-accelerate-the-next-generation-of-oncology-immunotherapies--63244561http://www.blogtalkradio.com/pharmatalk/2024/08/07/using-ai-to-accelerate-the-next-generation-of-oncology-immunotherapiesWed, 07 Aug 2024 04:00:00 +0000Conference ForumFor more information, go to IO360summit.com. 2562immuno oncology,immunotherapy,io,io360,oncologyfalsefullhttps://www.spreaker.com/episode/immuno-oncology-cell-therapy-data-analytics-what-and-how-to-measure--63244542http://www.blogtalkradio.com/pharmatalk/2024/07/29/immuno-oncology-cell-therapy-data-analytics-what-and-how-to-measureMon, 29 Jul 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org. 1284cell therapy,immuno-oncology,immunotherapy,io,oncologyfalsefullhttps://www.spreaker.com/episode/what-to-expect-at-craaco-clinical-research-as-a-care-option-2024-in-5-minutes--63244528http://www.blogtalkradio.com/pharmatalk/2024/07/25/what-to-expect-at-craaco-clinical-research-as-a-care-option-2024-in-5-minutesThu, 25 Jul 2024 13:30:00 +0000Conference ForumSummary: The 2024 CRAACO: Clinical Research as a Care Option conference is a unique opportunity for pharma, healthcare and patients to come together and address how we can integrate healthcare and clinical research to improve patient access to...261clinical research,clinical trials,craaco,healthcare,hospitalsfalsefullhttps://www.spreaker.com/episode/how-to-enhance-clinical-trial-participation-in-diverse-linguistic-backgrounds--63244552http://www.blogtalkradio.com/pharmatalk/2024/07/23/how-to-enhance-clinical-trial-participation-in-diverse-linguistic-backgroundsTue, 23 Jul 2024 04:00:00 +0000Conference ForumFor more information, visit patientsaspartners.org. 2218clinical trial participation,clinical trials,diverse linguistic backgrounds,patients as partners,patients as partners in clinicfalsefullhttps://www.spreaker.com/episode/patient-engagement-advocate-on-collaborating-successfully-with-pharma--63244562http://www.blogtalkradio.com/pharmatalk/2024/07/16/patient-engagement-advocate-on-collaborating-successfully-with-pharmaTue, 16 Jul 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org. 1448clinical trials,kayentis,patient centricity,patient engagement,patient involvementfalsefullhttps://www.spreaker.com/episode/what-to-expect-at-dpharm-2024-with-dpharm-directors--63244555http://www.blogtalkradio.com/pharmatalk/2024/07/09/what-to-expect-at-dpharm-2024-with-dpharm-directorsTue, 09 Jul 2024 04:00:00 +0000Conference ForumFor more information, visit DPHARMconference.com. 596disruptive innovation,disruptive innovations to adva,dpharm,dpharm 2024,dpharm disruptive innovationsfalsefullhttps://www.spreaker.com/episode/astellas-head-of-patient-centricity-on-patient-centric-medicine-development--63244564http://www.blogtalkradio.com/pharmatalk/2024/07/08/astellas-head-of-patient-centricity-on-patient-centric-medicine-developmentMon, 08 Jul 2024 04:00:00 +0000Conference ForumFor more information, visitpatientsaspartners.org1502astellas,drug development,medicine development,patient centricity,patient focused drug developmefalsefullhttps://www.spreaker.com/episode/preferences-in-decentralization-and-digitalization-of-pediatric-clinical-trials--63244556http://www.blogtalkradio.com/pharmatalk/2024/06/24/preferences-in-decentralization-and-digitalization-of-pediatric-clinical-trialsMon, 24 Jun 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org. 1518clinical trials,patient preference digitalizat,patient preferences,patients as partners eu,patients as partners in clinicfalsefullhttps://www.spreaker.com/episode/what-cmos-need-to-know-about-partnering-with-hospitals-clinical-research-sites--63244563http://www.blogtalkradio.com/pharmatalk/2024/06/07/what-cmos-need-to-know-about-partnering-with-hospitals-clinical-research-sitesFri, 07 Jun 2024 04:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360° and its associated editorials, podcasts and webcasts, please visit CMO360.org1893biotech,chief medical officer,clinical trials,cmo,pharmafalsefullhttps://www.spreaker.com/episode/how-cmos-build-a-network-of-consultants--63244537http://www.blogtalkradio.com/pharmatalk/2024/06/07/how-cmos-build-a-network-of-consultantsFri, 07 Jun 2024 04:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360° and its associated editorials, podcasts and webcasts, please visit CMO360.org1693biotech,chief medical officer,cmo,networking,pharmafalsefullhttps://www.spreaker.com/episode/cmo-insights-and-advice-on-tailoring-your-pitch-to-investors--63244567http://www.blogtalkradio.com/pharmatalk/2024/06/06/cmo-insights-and-advice-on-tailoring-your-pitch-to-investorsThu, 06 Jun 2024 04:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360° and its associated editorials, podcasts and webcasts, please visit CMO360.org1886biotech,chief medical officer,cmo,investors,pharmafalsefullhttps://www.spreaker.com/episode/transitioning-from-early-stage-to-registrational-pivotal-stage-development--63244540http://www.blogtalkradio.com/pharmatalk/2024/06/06/transitioning-from-early-stage-to-registrationalpivotal-stage-developmentThu, 06 Jun 2024 04:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360° and its associated editorials, podcasts and webcasts, please visit CMO360.org1888biotech,chief medical officer,clinical trials,cmo,pharmafalsefullhttps://www.spreaker.com/episode/using-sustainability-to-empower-patient-engagement-goals-in-medicine-development--63244571http://www.blogtalkradio.com/pharmatalk/2024/06/05/using-sustainability-to-empower-patient-engagement-goals-in-medicine-developmentWed, 05 Jun 2024 04:00:00 +0000Conference ForumFor more information, visit patientsaspartners.org. 2316clinical research,clinical trials,patient engagement,patients as partners,sustainabilityfalsefullhttps://www.spreaker.com/episode/discoveries-from-the-clinic-that-help-inform-io-cell-therapy-moving-forward--63244554http://www.blogtalkradio.com/pharmatalk/2024/06/05/discoveries-from-the-clinic-that-help-inform-io-cell-therapy-moving-forwardWed, 05 Jun 2024 04:00:00 +0000Conference ForumFor more information, visit IO360summit.com. 1658cell therapy,immuno-oncology,immuno-oncology 360,immunotherapy,io360falsefullhttps://www.spreaker.com/episode/maximizing-regulatory-interactions--63244558http://www.blogtalkradio.com/pharmatalk/2024/06/04/maximizing-regulatory-interactionsTue, 04 Jun 2024 04:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360° and its associated editorials, podcasts and webcasts, please visit CMO360.org1699biotech,chief medical officer,cmo,pharma,regulatory affairsfalsefullhttps://www.spreaker.com/episode/the-cmo-as-a-translational-scientist--63244532http://www.blogtalkradio.com/pharmatalk/2024/06/04/the-cmo-as-a-translational-scientistTue, 04 Jun 2024 04:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360° and its associated editorials, podcasts and webcasts, please visit CMO360.org1519biotech,chief medical officer,cmo,pharma,translational sciencefalsefullhttps://www.spreaker.com/episode/optimizing-the-integration-of-mobile-and-patient-facing-tech-in-clinical-trials--63244559http://www.blogtalkradio.com/pharmatalk/2024/05/02/optimizing-the-integration-of-mobile-and-patient-facing-tech-in-clinical-trialsThu, 02 May 2024 04:00:00 +0000Conference ForumFor more information, visit patientsaspartners.org.2200clinical research,clinical trial,patient participant,patients as partners,patients as partners in clinicfalsefullhttps://www.spreaker.com/episode/delivering-exceptional-clinical-trial-experiences-for-patients--63244539http://www.blogtalkradio.com/pharmatalk/2024/05/02/delivering-exceptional-clinical-trial-experiences-for-patientsThu, 02 May 2024 04:00:00 +0000Conference ForumFor more information, visit DPHARMconference.com.2320clinical trial design,dharm disruptive innovations,disruptive innovations,dpharm,modernizing clinical researchfalsefullhttps://www.spreaker.com/episode/ctdna-potential-for-prognostic-stratification-tumor-insights-drug-development--63244560http://www.blogtalkradio.com/pharmatalk/2024/05/01/ctdna-potential-for-prognostic-stratification-tumor-insights-drug-developmentWed, 01 May 2024 04:00:00 +0000Conference ForumFor more information, visit IO360summit.com. 2484cancer,immuno oncology,immuno oncology 360,immunotherapy,io360falsefullhttps://www.spreaker.com/episode/what-to-expect-at-the-2024-patients-as-partners-eu-conference--63244575http://www.blogtalkradio.com/pharmatalk/2024/04/23/what-to-expect-at-the-2024-patients-as-partners-eu-conferenceTue, 23 Apr 2024 12:00:00 +0000Conference ForumValerie Bowling, Executive Director of the Conference Forum, discusses what attendees can expect at the 8th annual Patients as Partners EU conference, including keynotes, key topics, and the wide breadth of pharma companies present.  For more...378falsefullhttps://www.spreaker.com/episode/taking-lessons-from-manufacturing-immunotherapies-to-accelerate-development--63244588http://www.blogtalkradio.com/pharmatalk/2024/04/12/taking-lessons-from-manufacturing-immunotherapies-to-accelerate-developmentFri, 12 Apr 2024 04:00:00 +0000Conference ForumFor more information, visit IO360summit.com.2606cell therapy,cell therapy products,immuno-oncology,manufacturing,manufacturing cell therapyfalsefullhttps://www.spreaker.com/episode/enhancing-solubility-with-novel-excipient-technologies--63244541http://www.blogtalkradio.com/pharmatalk/2024/04/08/enhancing-solubility-with-novel-excipient-technologiesMon, 08 Apr 2024 04:00:00 +0000Conference ForumAs new drugs in development have poorer solubility and bioavailability, there is a need for novel solubility enhancing polymers to improve drug loading and improve patient adherence. In this podcast, Nick DiFranco explains some of the shortcomings of...1803biotech,drug delivery,excipients,pharma,poddfalsefullhttps://www.spreaker.com/episode/measuring-the-value-of-dcts-and-hybrid-models--63244574http://www.blogtalkradio.com/pharmatalk/2024/04/02/measuring-the-value-of-dcts-and-hybrid-modelsTue, 02 Apr 2024 04:00:00 +0000Conference ForumFor more information, visit DPHARMconference.com. 1866clinical trial,dct,decentralized clinical trial,dpharm,hybrid clinical trialfalsefullhttps://www.spreaker.com/episode/navigating-and-adopting-innovation-in-a-post-pandemic-world--63244546http://www.blogtalkradio.com/pharmatalk/2024/03/29/navigating-and-adopting-innovation-in-a-post-pandemic-worldFri, 29 Mar 2024 04:00:00 +0000Conference ForumFor more information, visit DPHARMconference.com.1552clinical research,disruptive innovation,dpharm,post pandemicfalsefullhttps://www.spreaker.com/episode/turning-a-search-for-lung-cancer-biomarkers-into-a-patient-empowerment-community--63244572http://www.blogtalkradio.com/pharmatalk/2024/03/15/turning-a-search-for-lung-cancer-biomarkers-into-a-patient-empowerment-communityFri, 15 Mar 2024 04:00:00 +0000Conference ForumSummary: In this podcast, Terri Conneran tells the story of how her cancer diagnosis and a search for relevant biomarkers turned into KRAS Kickers, a cancer research advocate community.   For more information on PharmaTalk Radio podcasts, visit...1254clinical research as a care op,craaco,kras,kras kickers,lung cancerfalsefullhttps://www.spreaker.com/episode/engaging-all-stakeholders-for-clinical-trial-patient-engagement-and-value--63244568http://www.blogtalkradio.com/pharmatalk/2024/03/12/engaging-all-stakeholders-for-clinical-trial-patient-engagement-and-valueTue, 12 Mar 2024 04:00:00 +0000Conference ForumFor more information, visit theconferenceforum.org. 3231clinical research,clinical trials,papus,patient engagement in clinical,patients as partnersfalsefullhttps://www.spreaker.com/episode/optimizing-medicine-development-for-real-world-efficacy-in-patients--63244585http://www.blogtalkradio.com/pharmatalk/2024/02/26/optimizing-medicine-development-for-real-world-efficacy-in-patientsMon, 26 Feb 2024 05:00:00 +0000Conference ForumAbout the episode:  It's estimated that only 20% of health outcomes are due to clinical care, with the remaining 80% as a result of social determinants of health. Medicine development leaders must understand the broader context of patient lives in...1454luminous effect,medicine development,patient insights,patients as partners,real worldfalsefullhttps://www.spreaker.com/episode/how-cmos-can-support-the-overarching-process-of-a-fundraising--63244586http://www.blogtalkradio.com/pharmatalk/2024/01/30/how-cmos-can-support-the-overarching-process-of-a-fundraisingTue, 30 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.1580biotech,chief medical officer,cmo360,finance,investorsfalsefullhttps://www.spreaker.com/episode/prioritizing-development-programs-that-align-with-fundraising-catalysts--63244565http://www.blogtalkradio.com/pharmatalk/2024/01/30/prioritizing-development-programs-that-align-with-fundraising-catalystsTue, 30 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.1858biotech,chief medical officer,clinical development,cmo360falsefullhttps://www.spreaker.com/episode/interacting-with-different-types-of-investors-as-a-cmo--63244594http://www.blogtalkradio.com/pharmatalk/2024/01/29/interacting-with-different-types-of-investors-as-a-cmoMon, 29 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.2454biotech,chief medical officer,cmo360,investorsfalsefullhttps://www.spreaker.com/episode/developing-internal-and-external-communication-strategies--63244592http://www.blogtalkradio.com/pharmatalk/2024/01/29/developing-internal-and-external-communication-strategiesMon, 29 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.1873biotech,chief medical officer,cmo360,communicationsfalsefullhttps://www.spreaker.com/episode/what-cmos-need-to-know-about-medical-affairs--63244606http://www.blogtalkradio.com/pharmatalk/2024/01/28/what-cmos-need-to-know-about-medical-affairsSun, 28 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.1835biotech,chief medical officer,cmo360,medical affairsfalsefullhttps://www.spreaker.com/episode/achieving-targeted-delivery-of-gene-editing-therapies--63244578http://www.blogtalkradio.com/pharmatalk/2024/01/09/achieving-targeted-delivery-of-gene-editing-therapiesTue, 09 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1771biotech,drug delivery,gene therapy,partnership,poddfalsefullhttps://www.spreaker.com/episode/the-promise-and-challenges-of-ultrasound-mediated-delivery--63244566http://www.blogtalkradio.com/pharmatalk/2024/01/09/the-promise-and-challenges-of-ultrasound-mediated-deliveryTue, 09 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1811biotech,drug delivery,partnerships,pharma,poddfalsefullhttps://www.spreaker.com/episode/the-future-of-digital-technology-in-the-connected-device-space--63244581http://www.blogtalkradio.com/pharmatalk/2024/01/08/the-future-of-digital-technology-in-the-connected-device-spaceMon, 08 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1872connected devices,digital health,drug delivery,pharma,poddfalsefullhttps://www.spreaker.com/episode/new-approaches-in-cns-pns-delivery--63244576http://www.blogtalkradio.com/pharmatalk/2024/01/08/new-approaches-in-cnspns-deliveryMon, 08 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1721brain delivery,cns,drug delivery,podd,therapeuticsfalsefullhttps://www.spreaker.com/episode/precision-ophthalmic-delivery--63244584http://www.blogtalkradio.com/pharmatalk/2024/01/07/precision-ophthalmic-deliverySun, 07 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1737biotech,drug delivery,partnership,pharma,poddfalsefullhttps://www.spreaker.com/episode/delivery-challenges-from-the-oncology-pipeline--63244573http://www.blogtalkradio.com/pharmatalk/2024/01/07/delivery-challenges-from-the-oncology-pipelineSun, 07 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1867drug delivery,oncology,partnership,pharma,poddfalsefullhttps://www.spreaker.com/episode/novel-nasal-products-and-formulations--63244613http://www.blogtalkradio.com/pharmatalk/2024/01/04/novel-nasal-products-and-formulationsThu, 04 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1834biotech,drug delivery,partnership,pharma,poddfalsefullhttps://www.spreaker.com/episode/overcoming-barriers-to-adoption-of-transdermal-delivery--63244593http://www.blogtalkradio.com/pharmatalk/2024/01/04/overcoming-barriers-to-adoption-of-transdermal-deliveryThu, 04 Jan 2024 05:00:00 +0000Conference ForumTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.1764biotech,drug delivery,partnership,pharma,poddfalsefullhttps://www.spreaker.com/episode/addressing-the-clinical-operations-workforce-gap--63244615http://www.blogtalkradio.com/pharmatalk/2023/12/20/addressing-the-clinical-operations-workforce-gapWed, 20 Dec 2023 05:00:00 +0000Conference ForumLearn more about the DPHARM: Disruptive Innovations to Modernize Clinical Research conference, visit DPHARMconference.com. 1833clinical trials,disruptive innovation,dpharm,modernizing clinical researchfalsefullhttps://www.spreaker.com/episode/evolving-us-clinical-trial-infrastructure-for-better-trials-emergency-response--63244580http://www.blogtalkradio.com/pharmatalk/2023/12/20/evolving-us-clinical-trial-infrastructure-for-better-trials-emergency-responseWed, 20 Dec 2023 05:00:00 +0000Conference ForumTo learn more about the DPHARM: Disruptive Innovations to Modernize Clinical Research conference, visit DPHARMconference.com. 1839clinical research,disruptive innovations,dpharmfalsefullhttps://www.spreaker.com/episode/community-organization-perspectives-on-improving-clinical-trial-initiatives--63244630http://www.blogtalkradio.com/pharmatalk/2023/12/14/community-organization-perspectives-on-improving-clinical-trial-initiativesThu, 14 Dec 2023 05:00:00 +0000Conference ForumFor more information on Patients as Partners in Clinical Research, visit patientsaspartnersconference.com. 3739patients as partners,patients as partners in clinic,patients as partners usfalsefullhttps://www.spreaker.com/episode/patients-on-how-r-d-organizations-can-better-operationalize-trials-for-patients--63244614http://www.blogtalkradio.com/pharmatalk/2023/12/14/patients-on-how-rd-organizations-can-better-operationalize-trials-for-patientsThu, 14 Dec 2023 05:00:00 +0000Conference ForumLearn more about Patients as Partners in Clinical Research at patientsaspartnersconference.com. 2291patients as partners,patients as partners in clinicfalsefullhttps://www.spreaker.com/episode/novartis-approach-to-making-patients-feel-valued-in-clinical-research--63244604http://www.blogtalkradio.com/pharmatalk/2023/10/26/novartis-approach-to-making-patients-feel-valued-in-clinical-researchThu, 26 Oct 2023 04:00:00 +0000Conference ForumLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com978clinical research as a care op,craacofalsefullhttps://www.spreaker.com/episode/how-henry-ford-health-integrated-clinical-trials-into-clinical-care--63244587http://www.blogtalkradio.com/pharmatalk/2023/10/26/how-henry-ford-health-integrated-clinical-trials-into-clinical-careThu, 26 Oct 2023 04:00:00 +0000Conference ForumLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com2072clinical research as a care op,craacofalsefullhttps://www.spreaker.com/episode/reimbursement-challenges-with-clinical-trials--63244627http://www.blogtalkradio.com/pharmatalk/2023/10/25/reimbursement-challenges-with-clinical-trialsWed, 25 Oct 2023 04:00:00 +0000Conference ForumLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com1288clinical research as a care op,craacofalsefullhttps://www.spreaker.com/episode/democratizing-access-enabling-all-care-locations-to-be-research-locations--63244547http://www.blogtalkradio.com/pharmatalk/2023/10/25/democratizing-access-enabling-all-care-locations-to-be-research-locationsWed, 25 Oct 2023 04:00:00 +0000Conference ForumLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com2281clinical research as a care op,craacofalsefullhttps://www.spreaker.com/episode/strategies-for-building-a-successful-clinical-research-team-in-the-care-setting--63244589http://www.blogtalkradio.com/pharmatalk/2023/10/24/strategies-for-building-a-successful-clinical-research-team-in-the-care-settingTue, 24 Oct 2023 04:00:00 +0000Conference ForumLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com2333clinical research as a care op,craacofalsefullhttps://www.spreaker.com/episode/how-to-optimize-inventory-and-sample-management-for-clinical-trial-health--63244637http://www.blogtalkradio.com/pharmatalk/2023/10/04/how-to-optimize-inventory-and-sample-management-for-clinical-trial-healthWed, 04 Oct 2023 04:00:00 +0000Conference ForumIn this Episode: As clinical trials become more complex, sampling schemes keep pace. That makes proper sample and inventory management so crucial.  Slope's Hope Meely and Kyle Baker shed light on the intricacies and the complexities related to...1392clinical trial,disruptive innovation,dpharm,modernizing clinical trials,the conference forumfalsefullhttps://www.spreaker.com/episode/ensuring-that-sites-are-set-up-for-trial-success-using-data-and-technology--63244610http://www.blogtalkradio.com/pharmatalk/2023/08/29/ensuring-that-sites-are-set-up-for-trial-success-using-data-and-technologyTue, 29 Aug 2023 04:00:00 +0000Conference ForumAbout the Episode: For those of us who work in clinical trials, we know all too well that the majority of sites don't hit recruitment targets, resulting in costly delays and burnout from sites and patients.  Tegan Mead and Julie Mansson, both at...1645clinical research as a care op,clinical research site,craaco,javara,the conference forumfalsefullhttps://www.spreaker.com/episode/innovating-patient-recruitment-a-conversation-with-bbk-worldwide-founders--63244656http://www.blogtalkradio.com/pharmatalk/2023/08/07/innovating-patient-recruitment-a-conversation-with-bbk-worldwide-foundersMon, 07 Aug 2023 04:00:00 +0000Conference ForumInnovating Patient Recruitment: A Conversation with BBK Worldwide Founders Joan F. Bachenheimer and Bonnie A. Brescia   The Conference Forum moderates a webcast featuring Joan F. Bachenheimer and Bonnie A. Brescia, the founders of BBK Worldwide, who...1609bbk worldwide,clinical research,clinical trials,patients as partners,the conference forumfalsefullhttps://www.spreaker.com/episode/10th-annual-mobile-tech-in-clinical-trials-what-to-expect-in-under-10-minutes--63244553http://www.blogtalkradio.com/pharmatalk/2023/07/28/10th-annual-mobile-tech-in-clinical-trials-what-to-expect-in-under-10-minutesFri, 28 Jul 2023 12:00:00 +0000Conference ForumDirectors, Valerie Bowling and Kate Woda, discuss what to expect at the upcoming 10th annual Mobile Tech in Clinical Trials conference taking place on September 19, 2023 in Boston, MA.511clinical trials,conference,digital technology,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/craaco-director-s-note-podcast-on-what-to-expect-in-under-6-minutes--63244590http://www.blogtalkradio.com/pharmatalk/2023/05/10/craaco-directors-note-podcast-on-what-to-expect-in-under-6-minutesWed, 10 May 2023 12:00:00 +0000Conference ForumDirector, Valerie Bowling, reviews what to expect at the upcoming Clinical Research as a Care Option (CRAACO) conference taking place on May 22-23 at the Sheraton Imperial Hotel in Raleigh-Durham, NC.321clinical research,clinical trials,conference,healthcare,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/current-challenges-in-vaccine-delivery-and-distribution--63244617http://www.blogtalkradio.com/pharmatalk/2023/01/23/current-challenges-in-vaccine-delivery-and-distributionMon, 23 Jan 2023 14:00:00 +0000Conference ForumIn this podcast, you will hear a panel discussion moderated by Paul Jansen from the 2022 PODD Conference regarding the biggest challenges as well as future solutions to vaccine administration and distribution. Panelists include: Jeffrey T Blue,...1691drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/providing-the-right-level-of-value-to-the-patient-that-creates-value--63244579http://www.blogtalkradio.com/pharmatalk/2023/01/20/providing-the-right-level-of-value-to-the-patient-that-creates-valueFri, 20 Jan 2023 12:30:00 +0000Conference ForumIn this podcast, you will hear a panel discussion moderated by Mark DeStefano, Teva, from the 2022 PODD Conference regarding balancing the level of connected activity with user needs, determining how broadly or specifically to use connectivity and...1642drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/enhancing-the-interferon-pathway-to-attack-cancer--63244616http://www.blogtalkradio.com/pharmatalk/2023/01/19/enhancing-the-interferon-pathway-to-attack-cancerThu, 19 Jan 2023 14:30:00 +0000Conference Forum  Why is enhancing the interferon pathway an attractive approach for treating cancer?What are the novel therapeutic approaches being investigated to harness the innate immune system to enhance the interferon pathway to treat cancer?What are the...1142immuno-oncology,io360,takedafalsefullhttps://www.spreaker.com/episode/innovative-crispr-based-editing-to-create-off-the-shelf-immune-cell-therapies--63244623http://www.blogtalkradio.com/pharmatalk/2023/01/18/innovative-crispr-based-editing-to-create-off-the-shelf-immune-cell-therapiesWed, 18 Jan 2023 14:30:00 +0000Conference ForumIn this talk, first recorded at the 2022 IO360° Summit, Dr Rachel Haurwitz, CEO, Caribou Biosciences, addresses the big picture view of where the cell therapy field is going and how innovative CRISPR-based editing will help with the treatment of...1537cell therapy,immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/investment-trends-in-io--63244624http://www.blogtalkradio.com/pharmatalk/2023/01/17/investment-trends-in-ioTue, 17 Jan 2023 14:30:00 +0000Conference ForumModerated by: Axel Hoos, MD, PhD, CEO, Scorpion Therapeutics Panelists: Jonathan Fassberg, Vice Chairman of Healthcare Investment Banking, OppenheimerIrina Margine, PhD, Principal, Biotech Private Equity, Wellington ManagementAsthika Goonewardene,...2688immuno-oncology,investment,investors,io360falsefullhttps://www.spreaker.com/episode/investment-and-collaboration-strategies-in-cell-and-gene-therapy--63244557http://www.blogtalkradio.com/pharmatalk/2023/01/16/investment-and-collaboration-strategies-in-cell-and-gene-therapyMon, 16 Jan 2023 17:30:00 +0000Conference ForumThis panel, first recorded at the 2022 IO360° Summit addressed: What are the risks and implications of investing in cell/gene therapy companies who have no clinical data from programs available?Venture company perspectives on what they are investing...2498cell therapy,gene therapy,immuno-oncology,investment,io360falsefullhttps://www.spreaker.com/episode/mechanisms-of-immune-evasion-mediated-by-hypoxia-inducible-factors--63244607http://www.blogtalkradio.com/pharmatalk/2023/01/14/mechanisms-of-immune-evasion-mediated-by-hypoxia-inducible-factorsSat, 14 Jan 2023 16:00:00 +0000Conference ForumIn this session, first recorded at the 2022 IO360° Summit, Dr Semenza will talk about how his work is impacting cancer immunotherapy. Dr Semenza’s groundbreaking discovery of hypoxia-inducible factors paves the way for the development of drugs that...1375immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/neoadjuvant-immune-checkpoint-blockade-a-window-into-treatment-response-and-pri--63244619http://www.blogtalkradio.com/pharmatalk/2023/01/13/neoadjuvant-immune-checkpoint-blockade-a-window-into-treatment-response-and-priFri, 13 Jan 2023 18:00:00 +0000Conference ForumNeoadjuvant (pre-surgical) immune checkpoint blockade may prevent cancer relapse and progression.This treatment approach is now FDA-approved for resectable triple-negative breast cancer, and hundreds of clinical trials in other cancers are...1580checkpoints,immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/regeneron-s-approach-to-strategic-collaborations-licensing-and-business-dev--63244569http://www.blogtalkradio.com/pharmatalk/2023/01/12/regenerons-approach-to-strategic-collaborations-licensing-and-business-devThu, 12 Jan 2023 17:30:00 +0000Conference ForumNouhad Husseini, MBA, SVP, Business Development and Corporate Strategy, Regeneron Pharmaceuticals with Allan Shaw, CFO / Founder & Senior Managing Director, Portage Biotech / Shaw Strategic Capital, LLC Learn more about the IO360 Summit at...1292immuno-oncology,io360,regeneronfalsefullhttps://www.spreaker.com/episode/panel-targeted-radiotherapy-and-the-impact-on-io--63244577http://www.blogtalkradio.com/pharmatalk/2023/01/11/panel-targeted-radiotherapy-and-the-impact-on-ioWed, 11 Jan 2023 14:30:00 +0000Conference ForumWhat is the impact of targeted radiotherapy on the immune system?What are the implications for combination IO?Current approaches and future direction Moderated by: Michael Groaning, PhD, Global Medical Affairs Lead, Genitourinary, Amgen Panelists:...1825immuno-oncology,io360,radiotherapyfalsefullhttps://www.spreaker.com/episode/what-s-next-on-the-io-radar-top-10-recommendations-from-dr-andrew-baum-citi--63244635http://www.blogtalkradio.com/pharmatalk/2023/01/10/whats-next-on-the-io-radar-top-10-recommendations-from-dr-andrew-baum-citiTue, 10 Jan 2023 15:00:00 +0000Conference ForumLearn more about the IO360° Summit at www.io360summit.com1586analyst,immuno-oncology,investor,io360falsefullhttps://www.spreaker.com/episode/keynote-fireside-chat-with-dr-robert-langer-and-dr-ester-caffarel-salvador--63244596http://www.blogtalkradio.com/pharmatalk/2023/01/10/keynote-fireside-chat-with-dr-robert-langer-and-dr-ester-caffarel-salvadorTue, 10 Jan 2023 12:30:00 +0000Conference ForumIn this podcast, you will hear a keynote fireside discussion with Dr Robert Langer, MIT, and Dr Ester Caffarel-Salvador, Chiesi USA, from the 2022 PODD Conference regarding current projects in the Langer Lab, how COVID affected the lab’s dynamics and...2110drug delivery,partnership opportunities,podd,robert langerfalsefullhttps://www.spreaker.com/episode/panel-role-of-china-in-the-bd-process--63244583http://www.blogtalkradio.com/pharmatalk/2023/01/09/panel-role-of-china-in-the-bd-processMon, 09 Jan 2023 16:00:00 +0000Conference ForumThis panel, first recorded at the 2021 Immuno-Oncology 360° Summit, will bring together chinese biotechs to share how they are partnering with additional IO companies to advance cancer treatments for patients. This will include partnering strategies...1827immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/gaining-hard-to-reach-patients-input-during-the-global-covid-pandemic--63244599http://www.blogtalkradio.com/pharmatalk/2023/01/06/gaining-hard-to-reach-patients-input-during-the-global-covid-pandemicFri, 06 Jan 2023 13:00:00 +0000Conference ForumIn this session, GSK shares how they delivered on patient and caregiver engagements, especially with communities experiencing the highest COVID burden. They gained insights on study designs, educational pieces and captured patient experiences to...1118clinical research,clinical trials,patients as partnersfalsefullhttps://www.spreaker.com/episode/how-janssen-is-collaboratively-working-with-patients-and-sites-to-advance-dcts--63244620http://www.blogtalkradio.com/pharmatalk/2023/01/05/how-janssen-is-collaboratively-working-with-patients-and-sites-to-advance-dctsThu, 05 Jan 2023 13:00:00 +0000Conference ForumIn this session, Janssen shares how they are collaboratively working with patients and sites to advance DCTs and will share engagement methodologies, what they have learned from the perspective of participants and sites, and the direction this has...1078clinical research,clinical trials,patients as partnersfalsefullhttps://www.spreaker.com/episode/how-merck-is-partnering-with-communities-to-support-clinical-research--63244660http://www.blogtalkradio.com/pharmatalk/2023/01/04/how-merck-is-partnering-with-communities-to-support-clinical-researchWed, 04 Jan 2023 13:00:00 +0000Conference ForumMerck’s iLab53 (a modular 39-foot mobile unit) was used to bring clinical research into community settings as an effort to increase clinical trial awareness and engagement. More specifically: How the iLab53 was created and implemented How Merck is...1220clinical research,clinical trials,merck,patients as partnersfalsefullhttps://www.spreaker.com/episode/sanofi-s-new-initiatives-firmly-embedding-patient-experience-perspectives--63244611http://www.blogtalkradio.com/pharmatalk/2023/01/03/sanofis-new-initiatives-firmly-embedding-patient-experience-perspectivesTue, 03 Jan 2023 14:30:00 +0000Conference ForumIn this session, Sanofi shares how they created and implemented an end-to-end fully integrated patient informed R&D organization that works directly with patients as advisors in 100% of development staged programs from discovery and supporting...1237clinical research,clinical trials,patients as partners,sanofifalsefullhttps://www.spreaker.com/episode/reflections-on-alnylam-and-conquering-delivery--63244629http://www.blogtalkradio.com/pharmatalk/2023/01/03/reflections-on-alnylam-and-conquering-deliveryTue, 03 Jan 2023 12:30:00 +0000Conference ForumIn this podcast, you will hear a keynote presentation from Dr John Maraganore from the 2022 PODD Conference regarding lessons learned from his 19 years as CEO of Alnylam Pharmaceuticals, leading a team that conquered some very difficult drug delivery...1842drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/patient-involvement-legal-barriers-to-be-aware-of-and-pathways-to-overcome-them--63244618http://www.blogtalkradio.com/pharmatalk/2023/01/02/patient-involvement-legal-barriers-to-be-aware-of-and-pathways-to-overcome-themMon, 02 Jan 2023 14:30:00 +0000Conference ForumLegal barriers exist for many good reasons, but can block our pathway in making the changes needed to help patients in the current climate. The panel addresses: Protocols that require approval from legal and complianceR&D and compliance, breaking...2512clinical research,clinical trials,patients as partnersfalsefullhttps://www.spreaker.com/episode/next-generation-immune-checkpoints-deciphering-key-roles-in-the-tme--63244631http://www.blogtalkradio.com/pharmatalk/2023/01/02/next-generation-immune-checkpoints-deciphering-key-roles-in-the-tmeMon, 02 Jan 2023 13:30:00 +0000Conference ForumLearn more about the IO360° Summit at www.io360summit.com862immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/merck-reporting-on-site-monitoring-performance-and-database-lock--63244632http://www.blogtalkradio.com/pharmatalk/2022/12/31/merck-reporting-on-site-monitoring-performance-and-database-lockSat, 31 Dec 2022 13:00:00 +0000Conference ForumIn this session recorded at DPHARM 2021, Merck shares about their proprietary Site Monitoring and Reporting Tool (SMART), an iOS Apple iPad technology that enables “monitoring and deviation management” before, during and after COVID-19. Merck talks...2768falsefullhttps://www.spreaker.com/episode/the-role-of-rwd-in-the-development-of-remdesivir--63244625http://www.blogtalkradio.com/pharmatalk/2022/12/30/the-role-of-rwd-in-the-development-of-remdesivirFri, 30 Dec 2022 13:00:00 +0000Conference ForumIn this session from DPHARM 2021, Gilead shares how they designed, developed and obtained Emergency Use Authorization and Full Approval for Remdesivir for the treatment of COVID-19 in record time. Key topics: How they built new capabilities at an...2441falsefullhttps://www.spreaker.com/episode/de-risking-combination-product-development-involving-l-volume-sub-formulations--63244661http://www.blogtalkradio.com/pharmatalk/2022/12/30/de-risking-combination-product-development-involving-l-volume-sub-formulationsFri, 30 Dec 2022 12:30:00 +0000Conference ForumIn this podcast, you will hear a presentation with Peter Skutnik, BD Medical-Pharmaceutical Systems and Wendy D Woodley, BD Technologies & Innovation, from the 2022 PODD Conference regarding challenges in combination product development,...1220drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/how-regeneron-got-an-fda-approved-therapy-for-covid-in-record-time--63244628http://www.blogtalkradio.com/pharmatalk/2022/12/29/how-regeneron-got-an-fda-approved-therapy-for-covid-in-record-timeThu, 29 Dec 2022 13:00:00 +0000Conference ForumIn this session from DPHARM 2021, Regeneron's Bari Kowal sits down with Craig Lipset to discuss: Driving greater efficiencies in a pandemicA fresh look at solving problemsPrioritizing priorities Speakers: Bari Kowal, Senior Vice President, Head...1825falsefullhttps://www.spreaker.com/episode/remote-monitoring-to-improve-transitioning-home-and-reducing-risk-of-readmission--63244663http://www.blogtalkradio.com/pharmatalk/2022/12/28/remote-monitoring-to-improve-transitioning-home-and-reducing-risk-of-readmissionWed, 28 Dec 2022 13:00:00 +0000Conference ForumIn this session recorded at DPHARM 2022, Memorial Sloan Kettering Cancer Center shares about their Connected Care protocol. Digital monitoring of patients has the potential to better the delivery of cancer care through improved patient-provider...1153falsefullhttps://www.spreaker.com/episode/the-pfizer-pledge-getting-to-60-remote-clinical-trials-in-2022--63244679http://www.blogtalkradio.com/pharmatalk/2022/12/27/the-pfizer-pledge-getting-to-60-remote-clinical-trials-in-2022Tue, 27 Dec 2022 13:00:00 +0000Conference ForumIn this session recorded at DPHARM 2022, panelists from Pfizer discuss: Understanding the key steps Pfizer is taking to make remote clinical trials a reality for patientsExploring the cross functional team approach to scaling remote clinical trials...1838falsefullhttps://www.spreaker.com/episode/benchmarking-clinical-operations-for-digital-maturity--63244591http://www.blogtalkradio.com/pharmatalk/2022/12/26/benchmarking-clinical-operations-for-digital-maturityMon, 26 Dec 2022 13:00:00 +0000Conference ForumThis session was recorded at DPHARM 2022. As the life sciences industry’s focus on digital transformation advances at a rapid pace, the opportunity to understand how well your organization stacks up to the rest of the industry around digital maturity...2142falsefullhttps://www.spreaker.com/episode/innovative-trial-designs-to-reduce-patient-site-and-investigator-burden--63244638http://www.blogtalkradio.com/pharmatalk/2022/12/23/innovative-trial-designs-to-reduce-patient-site-and-investigator-burdenFri, 23 Dec 2022 13:00:00 +0000Conference ForumThis is a session recorded from DPHARM 2022. As the competition to recruit patients for clinical trials increases and sites are burdened by staffing shortages, technology shifts and more, how can innovative trial designs reduce patient, site and...1927falsefullhttps://www.spreaker.com/episode/addressing-the-lack-of-structured-clean-patient-data--63244603http://www.blogtalkradio.com/pharmatalk/2022/12/22/addressing-the-lack-of-structured-clean-patient-dataThu, 22 Dec 2022 13:00:00 +0000Conference ForumIn this session recorded at DPHARM 2022, moderated by Pfizer's Amy Cramer, the panelists discuss patient data. Often the elephant in the room that hinders the advancement of innovation in clinical trials for the benefit of patients in the lack of...1438falsefullhttps://www.spreaker.com/episode/fireside-leadership-lessons-driving-innovation-to-support-patients-and-sites--63244641http://www.blogtalkradio.com/pharmatalk/2022/12/21/fireside-leadership-lessons-driving-innovation-to-support-patients-and-sitesWed, 21 Dec 2022 13:00:00 +0000Conference ForumIn this session recorded at DPHARM 2022, Pfizer's Judy Sewards is joined by Patient Advocate Barry Nelson. Judy Sewards was one of the top 30 leaders who played a critical role in the success of Pfizer’s Covid-19 vaccine clinical trial program. In...1848falsefullhttps://www.spreaker.com/episode/why-rare-disease-therapeutics-need-early-market-access-planning--63244612http://www.blogtalkradio.com/pharmatalk/2022/12/21/why-rare-disease-therapeutics-need-early-market-access-planningWed, 21 Dec 2022 05:00:00 +0000Conference ForumAbout The Episode When developing and bringing a therapeutic for a rare disease to market, sponsors should think with the end in mind and plan for payer requirements early in protocol design. The economic and clinical value evidence required by...1818market access,payer,rare disease,rare disease therapeutic,therapeuticfalsefullhttps://www.spreaker.com/episode/effective-concentration-for-a-longer-period-with-long-acting-injectables--63244665http://www.blogtalkradio.com/pharmatalk/2022/12/20/effective-concentration-for-a-longer-period-with-long-acting-injectablesTue, 20 Dec 2022 14:00:00 +0000Conference ForumIn this podcast, you will hear a presentation from Dr Liping Zhou, AstraZeneca, from the 2022 PODD Conference regarding formulation techniques and developability considerations for LAI peptide delivery, with a case study example. To learn more about...1297drug delivery,injectables,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/moderna-on-innovating-clinical-trial-partnerships-to-expand-access--63244602http://www.blogtalkradio.com/pharmatalk/2022/12/20/moderna-on-innovating-clinical-trial-partnerships-to-expand-accessTue, 20 Dec 2022 13:00:00 +0000Conference ForumIn this session recorded at DPHARM 2022, Moderna discusses its recent partnership with CVS Health to bring its clinical trial closer to patients and expand patient access into more communities. Review the complexities of forming a new partnership and...883falsefullhttps://www.spreaker.com/episode/regeneron-and-novartis-on-innovating-to-accommodate-growing-pipelines--63244633http://www.blogtalkradio.com/pharmatalk/2022/12/19/regeneron-and-novartis-on-innovating-to-accommodate-growing-pipelinesMon, 19 Dec 2022 13:00:00 +0000Conference ForumIn this session recorded at DPHARM 2022, Bari Kowal, SVP & Head, Development Operations and Portfolio Management, Regeneron, moderates a panel discussion on: Examining how modernizations like the implementation of AI/ML, RWE, DE&I, DCTs impact...1707falsefullhttps://www.spreaker.com/episode/development-of-the-lipid-nanoparticles--63244595http://www.blogtalkradio.com/pharmatalk/2022/12/19/development-of-the-lipid-nanoparticlesMon, 19 Dec 2022 12:30:00 +0000Conference ForumIn this podcast, you will hear a keynote presentation from Dr Peter Cullis, UBC, from the 2021 PODD Conference regarding the path of discovery and innovation that led to the lipid nanoparticle delivery system driving one of the most successful...2108drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/targeting-tgf-beta-in-io-mechanisms-challenges-and-opportunities--63244634http://www.blogtalkradio.com/pharmatalk/2022/12/14/targeting-tgf-beta-in-io-mechanisms-challenges-and-opportunitiesWed, 14 Dec 2022 19:00:00 +0000Conference ForumLearn more about the IO360° Summit at www.io360summit.com1155immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/biomarkers-in-io-challenges-and-putative-benefits-of-multi-omics-technologies--63244676http://www.blogtalkradio.com/pharmatalk/2022/12/12/biomarkers-in-io-challenges-and-putative-benefits-of-multi-omics-technologiesMon, 12 Dec 2022 14:30:00 +0000Conference ForumEvaluating single cell omics to understand the heterogeneity in immune and tumor cellsMulti-omic biomarkers for patient selection in solid tumor IO: is there a path to more personalized therapy?In an era of ‘targeted’ therapies against cell-intrinsic...2522immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/chair-s-opening-presentation-with-barbara-lueckel-summary--63244636http://www.blogtalkradio.com/pharmatalk/2022/12/12/chairs-opening-presentation-with-barbara-lueckel-summaryMon, 12 Dec 2022 11:00:00 +0000Conference ForumIn this podcast, you will hear a presentation from Dr Barbara Lueckel, Roche Pharma Partnering, from the 2021 PODD Conference summarizing trends, approvals and pipelines within the drug delivery space. To learn more about the PODD Conference, please...1251barbara lueckel,drug delivery,partnership opportunities,podd,rochefalsefullhttps://www.spreaker.com/episode/a-decade-after-checkpoints-what-do-we-know-what-do-we-need-to-know-and-getting--63244667http://www.blogtalkradio.com/pharmatalk/2022/12/08/a-decade-after-checkpoints-what-do-we-know-what-do-we-need-to-know-and-gettingThu, 08 Dec 2022 16:00:00 +0000Conference ForumDan Chen, MD, PhD, Founder, Engenuity Life Sciences Learn more about the IO360° Summit at www.io360summit.com1268immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/achieving-diversity-and-inclusion-in-oncology-clinical-trials--63244645http://www.blogtalkradio.com/pharmatalk/2022/12/07/achieving-diversity-and-inclusion-in-oncology-clinical-trialsWed, 07 Dec 2022 14:30:00 +0000Conference ForumThis panel, first recorded at the 2022 IO360° Summit, reported on advances in achieving more diversity and inclusion in oncology clinical trials. Moderated by: Adrelia Allen, PharmD, Director, Clinical Trial Patient Diversity, Global Clinical Trial...3063immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/how-long-acting-implantables-are-taking-extended-drug-release-to-the-next-level--63244640http://www.blogtalkradio.com/pharmatalk/2022/12/07/how-long-acting-implantables-are-taking-extended-drug-release-to-the-next-levelWed, 07 Dec 2022 05:00:00 +0000Conference ForumAbout The Episode With pharma’s focus on the extension of drug release windows, new technologies are needed that can lengthen that duration. Today, Zach Fletcher of Trelleborg Healthcare & Medical provides an insight into how the emerging field...1201drug delivery,drug delivery technology,long acting drug delivery,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/advancements-in-cart-for-the-treatment-of-glioblastoma--63244598http://www.blogtalkradio.com/pharmatalk/2022/12/06/advancements-in-cart-for-the-treatment-of-glioblastomaTue, 06 Dec 2022 14:30:00 +0000Conference ForumCAR T cells for solid tumors: Lessons learned from on-going clinical trials in glioblastoma.Interplay between CAR T cells and the endogenous immune systemNext-generation CAR designs to overcome barriers for solid tumor CAR therapy Christine Brown,...732cell therapy,gene therapy,immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/from-carer-to-trailblazer-one-man-s-fight-to-impact-clinical-research--63244639http://www.blogtalkradio.com/pharmatalk/2022/12/06/from-carer-to-trailblazer-one-mans-fight-to-impact-clinical-researchTue, 06 Dec 2022 12:30:00 +0000Conference ForumWhen Claas Röhl’s 12-year old daughter was an infant, she was diagnosed with Neurofibromatosis Type 1 (NF), a rare genetic disorder that causes tumors to form along nerves. With no prior background in research, Claas founded NF Kinder and became an...1205patients as partners eufalsefullhttps://www.spreaker.com/episode/cell-gene-therapy-current-landscape-lessons-learned-and-paths-forward--63244646http://www.blogtalkradio.com/pharmatalk/2022/12/05/cell-gene-therapy-current-landscape-lessons-learned-and-paths-forwardMon, 05 Dec 2022 14:30:00 +0000Conference ForumWhere have we come over the past 5 yearsWhat are the approvals and approval activity over the past year?What are the challenges and issues?What have we learned?What are the real important technologies that are being developed that might help transform...1220cell therapy,gene therapy,immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/what-to-expect-at-the-io360-summit-in-6-minutes--63244597http://www.blogtalkradio.com/pharmatalk/2022/12/05/what-to-expect-at-the-io360-summit-in-6-minutesMon, 05 Dec 2022 14:00:00 +0000Conference ForumKate Woda, IO360° Conference Director, gives a 6 minute overview on what you can expect at the 9th annual IO360° Summit taking place February 7-10 in Brooklyn, NY. Keynotes Include: Dr Carolyn Bertozzi, Stanford University on Bioorthogonal and Click...353carolyn bertozzi,immuno-oncology,io360,isabelle rivière,marcela mausfalsefullhttps://www.spreaker.com/episode/solving-for-the-digital-divide-building-trust-with-mobile-tech-for-patients--63244649http://www.blogtalkradio.com/pharmatalk/2022/12/02/solving-for-the-digital-divide-building-trust-with-mobile-tech-for-patientsFri, 02 Dec 2022 13:00:00 +0000Conference ForumThere are many reasons why patients don’t trust or feel comfortable using a digital/mobile device. Implementing mobile technologies in clinical trials can sometimes create barriers to participation amongst patients who struggle to access them, are...2854falsefullhttps://www.spreaker.com/episode/how-moderna-built-a-digital-organization-to-transform-how-clinical-research-gets--63244647http://www.blogtalkradio.com/pharmatalk/2022/12/01/how-moderna-built-a-digital-organization-to-transform-how-clinical-research-getsThu, 01 Dec 2022 13:00:00 +0000Conference ForumModerna shares how they created and implemented their digital-first organizational infrastructure that has transformed the way clinical research is getting done. They will discuss their approach to agility, delivering value early and often. They will...1279falsefullhttps://www.spreaker.com/episode/roche-s-industry-overview-on-the-drug-delivery-landscape-2022--63244601http://www.blogtalkradio.com/pharmatalk/2022/11/30/roches-industry-overview-on-the-drug-delivery-landscape-2022Wed, 30 Nov 2022 14:00:00 +0000Conference ForumMark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, Roche1338drug delivery,partnership opportunities,podd,rochefalsefullhttps://www.spreaker.com/episode/leveraging-mobile-technologies-in-the-development-of-novel-digital-endpoints--63244680http://www.blogtalkradio.com/pharmatalk/2022/11/30/leveraging-mobile-technologies-in-the-development-of-novel-digital-endpointsWed, 30 Nov 2022 13:00:00 +0000Conference ForumAbbVie’s Head of Digital Science, Michelle Crouthamel, joins Mobile Technologies in Clinical Trials to discuss how AbbVie has implemented digital health technologies to digitize measurements that can improve existing endpoints, uncover new endpoints...1300falsefullhttps://www.spreaker.com/episode/how-mobile-tech-is-enabling-smarter-trial-designs-for-better-data-and-access--63244600http://www.blogtalkradio.com/pharmatalk/2022/11/29/how-mobile-tech-is-enabling-smarter-trial-designs-for-better-data-and-accessTue, 29 Nov 2022 13:00:00 +0000Conference ForumSpeakers: Sandeep Bhat, Senior Leader, Digital Health Partnerships and Digital Engagement, Global Clinical Operations, GSKDan Karlin, MD, CMO, MindMed1328falsefullhttps://www.spreaker.com/episode/fda-update-on-digital-health-technologies-in-clinical-trials-draft-guidance--63244605http://www.blogtalkradio.com/pharmatalk/2022/11/28/fda-update-on-digital-health-technologies-in-clinical-trials-draft-guidanceMon, 28 Nov 2022 13:00:00 +0000Conference ForumMobile in Clinical Trials is joined by the FDA who will provide updates on the draft guidance issued December 2021 that provides recommendations for clinical trial sponsors, investigators, sites on using DHTs to collect data remotely from clinical...2524falsefullhttps://www.spreaker.com/episode/taking-patient-involvement-in-clinical-publications-to-new-heights--63244650http://www.blogtalkradio.com/pharmatalk/2022/11/28/taking-patient-involvement-in-clinical-publications-to-new-heightsMon, 28 Nov 2022 12:30:00 +0000Conference ForumFor many years, Pfizer has been a leader in the writing of plain language summaries. Now they’re partnering with diverse patient advocates to develop guidance on how to co-author scientific publications that are relevant to patients and written in...1073patients as partners eufalsefullhttps://www.spreaker.com/episode/partnering-with-your-compliance-teams-to-advance-meaningful-collaboration--63244648http://www.blogtalkradio.com/pharmatalk/2022/11/21/partnering-with-your-compliance-teams-to-advance-meaningful-collaborationMon, 21 Nov 2022 12:30:00 +0000Conference ForumCompliance with rules and regulations in patient engagement while necessary can also be an impediment to meaningful collaboration. We’ll hear from companies that have taken steps to work through compliance challenges internally and the efforts by...1619patients as partners eufalsefullhttps://www.spreaker.com/episode/what-statisticians-wish-they-could-tell-their-chief-medical-officers--63244654http://www.blogtalkradio.com/pharmatalk/2022/11/17/what-statisticians-wish-they-could-tell-their-chief-medical-officersThu, 17 Nov 2022 13:00:00 +0000Conference ForumAbout the Episode In this podcast, you will hear a panel discussion moderated by Dr Sheela Kolluri, Teva Pharmaceuticals, from the 2022 Chief Medical Officer Summit 360° regarding what CMOs need to know about statistics, strategies for clinical...1907biotech,biotechnology,leadership,pharmaceutical,r&dfalsefullhttps://www.spreaker.com/episode/tackling-the-manufacturing-complexity-of-complex-to-deliver-pipelines--63244674http://www.blogtalkradio.com/pharmatalk/2022/11/16/tackling-the-manufacturing-complexity-of-complex-to-deliver-pipelinesWed, 16 Nov 2022 15:30:00 +0000Conference ForumIn this podcast, you will hear a panel discussion moderated by Dr David Chen, Bill & Melinda Gates Medical Research Institute, from the 2022 PODD Conference regarding managing systems standards of new formulations and modalities and developing...1798drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/misaligned-incentives-physician-perspectives-on-the-integration-of-craaco--63244609http://www.blogtalkradio.com/pharmatalk/2022/11/16/misaligned-incentives-physician-perspectives-on-the-integration-of-craacoWed, 16 Nov 2022 13:00:00 +0000Conference ForumIn this session, moderator Craig Lipset speaks with Dr Suzanne Steinbaum on: Patient preferences for learning about researchBarriers for physicians in exploring research as an option for their patientsPlaces where health systems can helpBarriers for...2281falsefullhttps://www.spreaker.com/episode/rewriting-the-way-we-work-together-to-integrate-clinical-care-and-research--63244687http://www.blogtalkradio.com/pharmatalk/2022/11/15/rewriting-the-way-we-work-together-to-integrate-clinical-care-and-researchTue, 15 Nov 2022 13:00:00 +0000Conference ForumDr Simeone, the national PI leader on the adaptive platform trial on metastatic pancreatic cancer, Precision Promise, share her vision on embarking upon and building a new clinical-trial ecosystem. Speaker: Diane M Simeone, MD, Perlmutter Professor...1754falsefullhttps://www.spreaker.com/episode/volunteering-for-a-vaccine-trial-tackling-racial-disparities-in-healthcare--63244664http://www.blogtalkradio.com/pharmatalk/2022/11/14/volunteering-for-a-vaccine-trial-tackling-racial-disparities-in-healthcareMon, 14 Nov 2022 13:00:00 +0000Conference ForumUniversity Hospital’s Chief Strategic Integration and Health Equity Officer, Dr Chris Pernell, participated in the Moderna COVID vaccine trial. Dr Pernell tells us what we can do to improve health equity in care and research. Speakers Sharon Hanlon,...1814falsefullhttps://www.spreaker.com/episode/how-amgen-is-rising-above-with-clinical-trial-diversity--63244608http://www.blogtalkradio.com/pharmatalk/2022/11/14/how-amgen-is-rising-above-with-clinical-trial-diversityMon, 14 Nov 2022 12:30:00 +0000Conference ForumAmgen leadership joins Patients as Partners to discuss their RISE (Representation in Clinical Research) Initiative that is transforming clinical trial diversity at Amgen. Key topics include: The development of RISE, what it took to get off the ground...1729amgen,clinical trials,patients as partnersfalsefullhttps://www.spreaker.com/episode/a-vision-for-the-integration-of-clinical-research-and-care--63244668http://www.blogtalkradio.com/pharmatalk/2022/11/11/a-vision-for-the-integration-of-clinical-research-and-careFri, 11 Nov 2022 13:00:00 +0000Conference ForumDrs Janet Woodcock and Laura Esserman discuss why integrating clinical research and care is so critical and explore how we can get patients more access to clinical trials. Together they address: What is missing for the vision of integrating care and...2083falsefullhttps://www.spreaker.com/episode/addressing-barriers-to-patient-community-access-through-non-profit-partnerships--63244651http://www.blogtalkradio.com/pharmatalk/2022/11/10/addressing-barriers-to-patient-community-access-through-non-profit-partnershipsThu, 10 Nov 2022 13:00:00 +0000Conference ForumNon-profits can influence the community in a way that sponsors and site organizations cannot. In this session, Javara and Greater Gift present a partnership case study and show how they were able to achieve community access as a team. Speakers:...1226falsefullhttps://www.spreaker.com/episode/educating-patients-and-non-research-physicians-on-navigating-clinical-research--63244689http://www.blogtalkradio.com/pharmatalk/2022/11/09/educating-patients-and-non-research-physicians-on-navigating-clinical-researchWed, 09 Nov 2022 13:00:00 +0000Conference ForumIn this session, panelists share best practices in raising awareness for clinical trials and improving patient satisfaction by educating patients and non-research physicians on the clinical trial process. Speakers: Lora Black, RN, MPH, OCN, CCRP,...1931falsefullhttps://www.spreaker.com/episode/long-acting-injectables-for-biologics--63244652http://www.blogtalkradio.com/pharmatalk/2022/11/09/long-acting-injectables-for-biologicsWed, 09 Nov 2022 11:00:00 +0000Conference ForumIn this podcast, you will hear a panel discussion moderated by Dr Cindy Wu, AbbVie, from the 2022 PODD Conference regarding opportunities for long acting injectable biologics, stability, manufacturing processes, storage, release periods, and new...1604drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/where-and-how-dcts-can-truly-enable-and-close-the-gaps-between-research-and-care--63244671http://www.blogtalkradio.com/pharmatalk/2022/11/08/where-and-how-dcts-can-truly-enable-and-close-the-gaps-between-research-and-careTue, 08 Nov 2022 13:00:00 +0000Conference ForumIn this session, panelists from pharma and healthcare share perspectives on innovations in decentralized clinical trial technologies that have and have not worked during and throughout COVID. They also discuss: How we are bringing forth trial options...1819falsefullhttps://www.spreaker.com/episode/partnering-with-health-systems-to-enhance-diverse-patient-access-in-trials--63244688http://www.blogtalkradio.com/pharmatalk/2022/11/07/partnering-with-health-systems-to-enhance-diverse-patient-access-in-trialsMon, 07 Nov 2022 13:00:00 +0000Conference ForumUsing specific trials as examples, Dr Chetan Karyekar shares how Janssen Immunology is partnering with academic and community health systems to enhance diversity in clinical trials through recruitment strategies, outreach to local institutions,...1055falsefullhttps://www.spreaker.com/episode/novartis-approach-to-patient-engagement--63244622http://www.blogtalkradio.com/pharmatalk/2022/11/07/novartis-approach-to-patient-engagementMon, 07 Nov 2022 12:30:00 +0000Conference ForumMarc Boutin, JD, Global Head, Patient Engagement, Novartis Moderated by: Sarah Krüg, CEO/Founder, Cancer101/Health Collaboratory Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org2429falsefullhttps://www.spreaker.com/episode/workforce-planning-reducing-churn-to-support-and-promote-craaco--63244693http://www.blogtalkradio.com/pharmatalk/2022/11/04/workforce-planning-reducing-churn-to-support-and-promote-craacoFri, 04 Nov 2022 12:00:00 +0000Conference ForumIn this session, panelists share challenges and new initiatives to support building the clinical researcher workforce, workforce planning and flexibility. They address: Efforts to train new clinical researchersMaintaining a remote vs in office hybrid...1920falsefullhttps://www.spreaker.com/episode/guest-keynote-connecting-communities-with-the-ceo-of-etsy--63244653http://www.blogtalkradio.com/pharmatalk/2022/11/03/guest-keynote-connecting-communities-with-the-ceo-of-etsyThu, 03 Nov 2022 12:00:00 +0000Conference ForumIn this fireside discussion, Josh Silverman shares the story of how Etsy built a platform to connect sellers and consumers to diverse, local and global communities and the impact on equal access and the democratization of talent. He shares some...1547falsefullhttps://www.spreaker.com/episode/making-institutional-change-to-offer-clinical-research-options-in-health-systems--63244683http://www.blogtalkradio.com/pharmatalk/2022/11/02/making-institutional-change-to-offer-clinical-research-options-in-health-systemsWed, 02 Nov 2022 12:00:00 +0000Conference ForumIn this session recorded at CRAACO 2022, Dr Byrd shares insights on how to provide a wider offering of clinical research options to diverse populations by developing workstreams and policies addressing upstream issues including clinical researcher and...1832falsefullhttps://www.spreaker.com/episode/microgravity-to-develop-crystalline-monoclonal-antibodies-for-subcutaneous--63244692http://www.blogtalkradio.com/pharmatalk/2022/11/02/microgravity-to-develop-crystalline-monoclonal-antibodies-for-subcutaneousWed, 02 Nov 2022 11:30:00 +0000Conference ForumIn this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies...1069drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/cmo-ceo-fireside-discussion-on-working-through-challenges--63244691http://www.blogtalkradio.com/pharmatalk/2022/11/01/cmo-ceo-fireside-discussion-on-working-through-challengesTue, 01 Nov 2022 12:00:00 +0000Conference ForumIn this fireside chat recorded at CMO Summit 2022, Drs Alise Reicin and Marcella Ruddy discuss what makes their collaboration work and advice on what not to do as an MD CEO and CMO. Speakers: Alise Reicin, MD, CEO & President, Tectonic...1225falsefullhttps://www.spreaker.com/episode/building-trust-to-ensure-diversity-equity-inclusion-in-clinical-research--63244695http://www.blogtalkradio.com/pharmatalk/2022/10/31/building-trust-to-ensure-diversity-equity-inclusion-in-clinical-researchMon, 31 Oct 2022 11:30:00 +0000Conference ForumCommunity engagement is a massive challenge when it comes to diversity, equity and inclusion. This session will evaluate what has not worked and focus on the learnings so pharma/biotech can more successfully engage with under-represented communities...2772community engagement,patient advocacy,patient engagment,patients as partners,patient voicefalsefullhttps://www.spreaker.com/episode/drug-delivery-pipeline-and-technologies-a-year-in-review--63244655http://www.blogtalkradio.com/pharmatalk/2022/10/26/drug-delivery-pipeline-and-technologies-a-year-in-reviewWed, 26 Oct 2022 11:30:00 +0000Conference ForumIn this podcast, you will hear a presentation from Kurt Sedo of PharmaCircle at the 2022 PODD Conference summarizing trends, approvals and pipelines within the drug delivery space. To learn more about the PODD Conference, please visit...984drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/how-eli-lilly-is-diversifying-and-engaging-patients-using-dct-capabilities--63244621http://www.blogtalkradio.com/pharmatalk/2022/10/24/how-eli-lilly-is-diversifying-and-engaging-patients-using-dct-capabilitiesMon, 24 Oct 2022 11:30:00 +0000Conference ForumCraig Davenport, Senior Director, Site Engagement, Eli Lilly Moderated by: Marilyn Metcalf, PhD, Senior Director, Patient-Focused Development, Global Medical, GSK Learn more about the Patients as Partners in Clinical Research conference...1427decentralized clinical trials,patient engagement,patients as partnersfalsefullhttps://www.spreaker.com/episode/advice-for-partnering-between-innovator-drug-delivery-companies-and-big-pharma--63244686http://www.blogtalkradio.com/pharmatalk/2022/10/19/advice-for-partnering-between-innovator-drug-delivery-companies-and-big-pharmaWed, 19 Oct 2022 13:30:00 +0000Conference ForumIn this podcast, you will hear a panel discussion moderated by John Merhige, Credence MedSystems from the 2022 PODD Conference regarding implementable guidance for both pharma companies and delivery companies looking to partner including: The...1721drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/fighting-to-be-a-true-stakeholder-in-clinical-care-and-the-impact-on-diversity--63244626http://www.blogtalkradio.com/pharmatalk/2022/10/17/fighting-to-be-a-true-stakeholder-in-clinical-care-and-the-impact-on-diversityMon, 17 Oct 2022 11:30:00 +0000Conference ForumWe are honored to open Patients as Partners with Karen Peterson, patient #1 in a metastatic triple-negative breast cancer immunotherapy combination trial at NYU Langone Cancer Center. In this fireside chat, she provides personal insights on her trial...1626patient advocate,patient engagement,patients as partners,patient voicefalsefullhttps://www.spreaker.com/episode/the-first-90-days-as-a-cmo--63244697http://www.blogtalkradio.com/pharmatalk/2022/10/14/the-first-90-days-as-a-cmoFri, 14 Oct 2022 12:00:00 +0000Conference ForumAs each CMO role is different, it is critical for both first-time and seasoned CMOs to identify the role and develop a plan to ensure a successful transition. In this session recorded at CMO Summit 2021, panelists explore: What to look for in a...1882falsefullhttps://www.spreaker.com/episode/r-d-veteran-on-leading-a-biotech-through-founding-ipo-and-acquisition--63244694http://www.blogtalkradio.com/pharmatalk/2022/10/14/rd-veteran-on-leading-a-biotech-through-founding-ipo-and-acquisitionFri, 14 Oct 2022 12:00:00 +0000Conference ForumDr Viney joine the CMO Summit 360° in 2021 to share her incredible journey in drug discovery and development, founding and leading Pandion Therapeutics and joining the advisory boards of multiple biotech companies. Speakers: Jo Viney, PhD, President...1806falsefullhttps://www.spreaker.com/episode/building-up-a-company-through-to-commercialization-and-beyond--63244662http://www.blogtalkradio.com/pharmatalk/2022/10/13/building-up-a-company-through-to-commercialization-and-beyondThu, 13 Oct 2022 12:00:00 +0000Conference ForumIn this session recorded at CMO Summit 2021, hear from Dr Ron Cohen about his journey founding and building Acorda Therapeutics and leading the company as an MD CEO for 26 years. Dr Cohen also shares advice on how CMOs can best collaborate with their...2037falsefullhttps://www.spreaker.com/episode/best-practices-for-cross-functional-communication-strategies-for-the-cmo--63244658http://www.blogtalkradio.com/pharmatalk/2022/10/12/best-practices-for-cross-functional-communication-strategies-for-the-cmoWed, 12 Oct 2022 12:00:00 +0000Conference ForumIt is vital for the CMO to have excellent communication awareness and skills to communicate externally with KOLs, investors, the scientific community and more. In this session, recorded at CMO Summit 2022, seasoned CMOs share their best practices and...1673falsefullhttps://www.spreaker.com/episode/nicholas-warne-drug-delivery-industry--63244642http://www.blogtalkradio.com/pharmatalk/2022/10/12/nicholas-warne-drug-delivery-industryWed, 12 Oct 2022 11:30:00 +0000Conference ForumIn this podcast, you will hear a zeitgeist fireside discussion with Dr Nicholas Warne, Pfizer, from the 2022 PODD Conference regarding what the drug delivery industry learned from COVID-19, his view of RNA and LNP technologies, and building on...1587drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/managing-the-partnership-between-big-and-small-pharma--63244699http://www.blogtalkradio.com/pharmatalk/2022/10/10/managing-the-partnership-between-big-and-small-pharmaMon, 10 Oct 2022 12:00:00 +0000Conference ForumThis session recorded at CMO Summit 2022 addresses the role of the CMO in how to best manage the relationship between your biotech and big pharma. More specifically: What are the leadership skills needed?Where are the friction points and how do you...1464falsefullhttps://www.spreaker.com/episode/infusing-patient-perspectives-across-all-of-pfizer--63244673http://www.blogtalkradio.com/pharmatalk/2022/10/10/infusing-patient-perspectives-across-all-of-pfizerMon, 10 Oct 2022 11:30:00 +0000Conference ForumPfizer’s VP, Patient Advocacy, Emma Andrews, joins Patients as Partners US to provide her insights on the following: Internal and external collaborations to advance patient-focused programs across the enterprise Patient centricity within clinical...1938patient advocacy,patient engagment,patients as partnersfalsefullhttps://www.spreaker.com/episode/the-changing-environment-around-accelerated-approvals-and-regulatory-pathways--63244698http://www.blogtalkradio.com/pharmatalk/2022/10/07/the-changing-environment-around-accelerated-approvals-and-regulatory-pathwaysFri, 07 Oct 2022 12:00:00 +0000Conference ForumIn this session recorded at CMO Summit 2022, panelists share strategy trends and opportunities around accelerated approvals and regulatory designations. Additionally, they discuss: How to approach the FDA based on the different types of meetingsHow...1250falsefullhttps://www.spreaker.com/episode/positioning-yourself-for-board-roles-and-what-to-expect-as-a-cmo-in-biotech--63244704http://www.blogtalkradio.com/pharmatalk/2022/10/06/positioning-yourself-for-board-roles-and-what-to-expect-as-a-cmo-in-biotechThu, 06 Oct 2022 12:00:00 +0000Conference ForumIn this session recorded at CMO Summit 2022, Board members share their experiences and discuss how CMOs can think about Board role opportunities including: Knowing why you want a seat on a Board and what you bring to the tableThe skills needed to...1951falsefullhttps://www.spreaker.com/episode/biotech-financing-options-and-their-implications--63244643http://www.blogtalkradio.com/pharmatalk/2022/10/06/biotech-financing-options-and-their-implicationsThu, 06 Oct 2022 12:00:00 +0000Conference ForumIn this session recorded at CMO Summit 2022, the panel discusses: What CMOs need to know about series funding, crossover and IPOHow to think about when to engage in these financing options based on the company stage, milestones, and budgetHow CMOs can...2374falsefullhttps://www.spreaker.com/episode/building-a-work-culture-that-attracts-and-retains-talent-in-biotech--63244724http://www.blogtalkradio.com/pharmatalk/2022/10/05/building-a-work-culture-that-attracts-and-retains-talent-in-biotechWed, 05 Oct 2022 12:00:00 +0000Conference ForumIn this session recorded at CMO Summit 2022, the panel discusses: How to onboard hires who don’t have industry experienceRetaining talent and managing expectationsThe role of flexible working models, title inflation, non-monetary incentives, etc. in...1639falsefullhttps://www.spreaker.com/episode/exploring-ways-to-reduce-costs-of-developing-manufacturing-drug-delivery-tech--63244708http://www.blogtalkradio.com/pharmatalk/2022/10/05/exploring-ways-to-reduce-costs-of-developing-manufacturing-drug-delivery-techWed, 05 Oct 2022 11:30:00 +0000Conference ForumIn this podcast, you will hear a panel discussion moderated by Dr Mahesh Chaubal, Baxter International, from the 2022 PODD Conference regarding opportunities to lower costs of development and manufacturing of drug delivery technologies through working...1870drug delivery,partnership opportunities,poddfalsefullhttps://www.spreaker.com/episode/taking-on-the-cmo-role-at-moderna-and-looking-to-the-future-of-biotech-r-d--63244678http://www.blogtalkradio.com/pharmatalk/2022/10/04/taking-on-the-cmo-role-at-moderna-and-looking-to-the-future-of-biotech-rdTue, 04 Oct 2022 12:00:00 +0000Conference ForumIn this session recorded at CMO Summit 2022, Dr Paul Burton shares his experience leading Moderna as CMO since June 2021: Transitioning from pharma to biotechLeveraging data science and digital technologies to reimagine medical engagementThoughts on...1567falsefullhttps://www.spreaker.com/episode/what-cmos-must-know-about-how-patient-engagement-supports-the-entire-biotech--63244681http://www.blogtalkradio.com/pharmatalk/2022/10/03/what-cmos-must-know-about-how-patient-engagement-supports-the-entire-biotechMon, 03 Oct 2022 12:00:00 +0000Conference ForumThis session recorded at CMO Summit 2022 gives CMOs an update on current views on patient-centric medicine development, what it really means and the benefits for both the patient and trial. More specifically: Achieving timely recruitment by better...1910falsefullhttps://www.spreaker.com/episode/operationalizing-the-integration-of-patient-insights--63244705http://www.blogtalkradio.com/pharmatalk/2022/10/03/operationalizing-the-integration-of-patient-insightsMon, 03 Oct 2022 11:30:00 +0000Conference ForumBoehringer Ingelheim shares their initiatives on systematically operationalizing patient engagement within their drug development lifecycle. Case examples will be shared that demonstrate: • How they are building patient insights into their...1214patient engagement,patients as partners,patient voicefalsefullhttps://www.spreaker.com/episode/how-sites-using-their-own-technology-for-research-benefits-all-stakeholders--63244682http://www.blogtalkradio.com/pharmatalk/2022/09/29/how-sites-using-their-own-technology-for-research-benefits-all-stakeholdersThu, 29 Sep 2022 04:00:00 +0000Conference ForumAbout The Episode As technology advances in clinical research manage operational workflows, others arise as research sites juggle non-integrated technology systems deployed by sponsors and CROs, slowing operations and duplicating work. In this...1631advarra,clinical research sites,site-centric,site technology,trial technologyfalsefullhttps://www.spreaker.com/episode/adjusting-your-ecoa-strategy-for-patient-centricity-expert-advice--63244715http://www.blogtalkradio.com/pharmatalk/2022/09/26/adjusting-your-ecoa-strategy-for-patient-centricity-expert-adviceMon, 26 Sep 2022 04:00:00 +0000Conference ForumAbout The Episode As patient-centricity influences every part of the clinical trial process, sponsors may be surprised at how they impact eCOA strategy.  On this episode, THREAD Research's Chris Watson and Rebecca Tomalty share their expertise and...1446clinical outcome assessment,coa,ecoa,electronic clinical outcome as,thread researchfalsefullhttps://www.spreaker.com/episode/sandoz-s-chief-operating-officer-discusses-the-new-initiative-act4biosimilars--63244719http://www.blogtalkradio.com/pharmatalk/2022/08/31/sandozs-chief-operating-officer-discusses-the-new-initiative-act4biosimilarsWed, 31 Aug 2022 04:00:00 +0000Conference ForumAbout This Episode:  What is in the future for biosimilars?  In this episode, Pierre Bourdage, Chief Operating Officer at Sandoz, lays out the promise and potential of biosimilars, and the important role they play in healthcare system...1810biologic,chief medical officer summit,dpharm,pharmatalk radio,sandozfalsefullhttps://www.spreaker.com/episode/a-natural-language-collaboration-that-helps-cancer-patients-navigate-treatment--63244666http://www.blogtalkradio.com/pharmatalk/2022/08/31/a-natural-language-collaboration-that-helps-cancer-patients-navigate-treatmentWed, 31 Aug 2022 04:00:00 +0000Conference ForumAbout This Episode:  DataArt's engineering capabilities with xCures' oncology expertise created a Natural Language Processing tool. This collaboration tackles the difficult task of ingesting a patient's health records, parsing free-text cancer notes,...1745dataart,dpharm,io360,natural language processing,xcuresfalse11fullhttps://www.spreaker.com/episode/12th-annual-dpharm-in-under-10-minutes--63244702http://www.blogtalkradio.com/pharmatalk/2022/08/06/12th-annual-dpharm-in-under-10-minutesSat, 06 Aug 2022 13:00:00 +0000Conference ForumDPHARM Directors, Valerie Bowling and Tracey Kimball, provide a brief overview of what to expect at the 12th annual DPHARM: Disruptive Innovations to Modernize Clinical Research conference. Get 10% off with code TEML.560clinical research,clinical trials,conference,innovationfalsefullhttps://www.spreaker.com/episode/director-s-notes-on-what-to-expect-at-craaco-clinical-research-as-a-care-option--63244711http://www.blogtalkradio.com/pharmatalk/2022/08/04/directors-notes-on-what-to-expect-at-craaco-clinical-research-as-a-care-optionThu, 04 Aug 2022 13:30:00 +0000Conference ForumIn this 9 minute webinar, CRAACO® Conference Producer, Andrew Goldstein is joined by Executive Director, Valerie Bowling where they give a summary on what you can expect at the CRAACO: Clinical Research as a Care Option conference. Embedding clinical...525clinical research,clinical research as a care op,clinical trials,craacofalsefullhttps://www.spreaker.com/episode/what-to-expect-at-mobile-tech-in-clinical-trials-2022--63244644http://www.blogtalkradio.com/pharmatalk/2022/08/02/what-to-expect-at-mobile-tech-in-clinical-trials-2022Tue, 02 Aug 2022 13:00:00 +0000Conference ForumDirectors Valerie Bowling and Kate Woda provide a quick overview on what to expect at the 9th annual Mobile Tech in Clinical Trials in under 9 minutes. Get 10% off with code TEML.534conference,digital,mobilefalsefullhttps://www.spreaker.com/episode/5-minute-overview-podcast-on-what-to-expect-at-podd-drug-delivery--63244706http://www.blogtalkradio.com/pharmatalk/2022/07/19/5-minute-overview-podcast-on-what-to-expect-at-podd-drug-deliveryTue, 19 Jul 2022 12:30:00 +0000Conference ForumIn this podcast, Valerie Bowling, Director of the PODD: Partnership Opportunities in Drug Delivery conference gives a 5 minute overview on what you can expect at the 12th annual PODD taking place October 24-25 at the Westin Copley Place in Boston....315business development,drug delivery,networking,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/key-role-of-strategy-and-media-in-improving-clinical-trial-enrollment-diversity--63244690http://www.blogtalkradio.com/pharmatalk/2022/05/19/key-role-of-strategy-and-media-in-improving-clinical-trial-enrollment-diversityThu, 19 May 2022 04:00:00 +0000Conference ForumSummary: Join us for an important discussion about the necessity to adjust and adopt media and research strategies to ensure clinical trial recruitment of diverse populations. PharmaTalkRadio’s Valerie Bowling speaks with BBK Worldwide industry...1025clinical recruitment,clinical research,patient centricity,patient engagement,patients as partnersfalsefullhttps://www.spreaker.com/episode/how-cmos-can-evaluate-potential-outsourcing-partners-effectively--63244669http://www.blogtalkradio.com/pharmatalk/2022/05/02/how-cmos-can-evaluate-potential-outsourcing-partners-effectivelyMon, 02 May 2022 13:00:00 +0000Conference ForumAbout the Episode: The number of biotech companies out there makes the struggle to find good talent and good outsourcing partners more difficult and more expensive. As a biotech CMO, working with a CRO more worried about delivering their margins than...1933biotech,clinical trials,drug development,pharmaceutical,pharmaceuticalsfalsefullhttps://www.spreaker.com/episode/is-the-end-of-sdtm-in-sight--63244707http://www.blogtalkradio.com/pharmatalk/2022/05/02/is-the-end-of-sdtm-in-sightMon, 02 May 2022 04:00:00 +0000Conference ForumAbout This Episode:  Dr Derk Arts, Founder and CEO of Castor, lays out what he views as the next phase of data presentation to regulatory agencies, moving away from the standard SDTM (study data tabulation model) into something that more accurately...1432dpharm,dpharm disruptive innovations,rdf,sdtm,study data tabulation modelfalsefullhttps://www.spreaker.com/episode/what-adapting-during-covid-19-taught-us-about-innovating-drug-development--63244709http://www.blogtalkradio.com/pharmatalk/2022/04/27/what-adapting-during-covid-19-taught-us-about-innovating-drug-developmentWed, 27 Apr 2022 13:00:00 +0000Conference ForumCOVID-19 changed the clinical research landscape by proving the use and efficacy of DCTs, patient-centricity and adaptive designs. Dr Ubavka DeNoble, Executive Vice President of Biotech Operations and Senior Medical Officer of Parexel Biotech shares...1517clinical research,clinical trials,covid,covid-19,pandemicfalsefullhttps://www.spreaker.com/episode/a-vision-for-the-future-of-drug-delivery-patients-interacting-less-with-disease--63244696http://www.blogtalkradio.com/pharmatalk/2022/04/15/a-vision-for-the-future-of-drug-delivery-patients-interacting-less-with-diseaseFri, 15 Apr 2022 04:00:00 +0000Conference ForumAbout This Episode:  What is the future of drug delivery for patients, and how do we get there?  In this episode, Dr Shawn Davis, who leads the Drug Delivery team of the Biopharmaceuticals Development organization at AstraZeneca, lays out a bold...1515astrazeneca,drug delivery,partnership opportunities in d,podd,podd conferencefalsefullhttps://www.spreaker.com/episode/how-listening-tech-disrupts-clinical-research-to-create-patient-centric-trials--63244710http://www.blogtalkradio.com/pharmatalk/2022/04/14/how-listening-tech-disrupts-clinical-research-to-create-patient-centric-trialsThu, 14 Apr 2022 04:00:00 +0000Conference ForumAbout This Episode:  Current efforts to source and disseminate patient insights in clinical trial planning are expensive and time-consuming.  In this episode, Fabio Gratton, CEO and Co-Founder of InVibe, which was recently acquired by THREAD...1555dpharm,dpharm disruptive innovations,invibe,mobile in clinical trials,thread researchfalsefullhttps://www.spreaker.com/episode/on-the-ground-perspective-on-putting-decentralized-strategies-in-clinical-trials--63244657http://www.blogtalkradio.com/pharmatalk/2022/04/14/on-the-ground-perspective-on-putting-decentralized-strategies-in-clinical-trialsThu, 14 Apr 2022 04:00:00 +0000Conference ForumAbout the Episode:  Creating options for patients with decentralized clinical trials can provide tremendous benefits for certain patients and indications. In this podcast, Labcorp’s Linda Ross, Associate Director of Commercial Strategy, Decentralized...1516dct,decentralized clinical trial,dpharm,dpharm disruptive innovations,labcorpfalsefullhttps://www.spreaker.com/episode/biotech-ceo-keynote-dr-ron-cohen-from-chief-medical-officer-summit-360-2021--63244701http://www.blogtalkradio.com/pharmatalk/2022/02/17/biotech-ceo-keynote-dr-ron-cohen-from-chief-medical-officer-summit-360-2021Thu, 17 Feb 2022 19:00:00 +0000Conference ForumIn this podcast, hear a keynote session from the 2021 Chief Medical Officer Summit 360˚ with Dr Ron Cohen on his journey founding and building Acorda Therapeutics and leading the company as an MD CEO for 26 years. Dr Cohen also shares advice on how...2085ceo,chief medical officer,chief medical officer collabor,chief medical officer summit,professional developmentfalsefullhttps://www.spreaker.com/episode/r-d-veteran-keynote-dr-jo-viney-from-chief-medical-officer-summit-360-2021--63244700http://www.blogtalkradio.com/pharmatalk/2022/02/17/rd-veteran-keynote-dr-jo-viney-from-chief-medical-officer-summit-360-2021Thu, 17 Feb 2022 19:00:00 +0000Conference ForumDr Viney joined the CMO Summit 360° in October 2021 to share her incredible journey in drug discovery and development, founding and leading Pandion Therapeutics and joining the advisory boards of multiple biotech companies.  Learn more about the 10th...1845biotech,chief medical officer,chief medical officer summit,ipo,r&dfalsefullhttps://www.spreaker.com/episode/10th-annual-chief-medical-officer-summit-360-in-a-nutshell--63244703http://www.blogtalkradio.com/pharmatalk/2022/02/15/10th-annual-chief-medical-officer-summit-360-in-a-nutshellTue, 15 Feb 2022 13:00:00 +0000Conference ForumConference Producer, Andrew Goldstein, walks through what you can expect to learn and who you'll hear from at the upcoming Chief Medical Officer Summit 360º taking place April 4-5, 2022 in Boston, MA, including: Clinical development and...336biotech,biotechnology,chief medical officer,clinical trials,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/the-case-for-sites-using-their-own-tech-to-accelerate-research-and-reduce-burden--63244716http://www.blogtalkradio.com/pharmatalk/2022/01/20/the-case-for-sites-using-their-own-tech-to-accelerate-research-and-reduce-burdenThu, 20 Jan 2022 05:00:00 +0000Conference ForumAbout the Episode:  In this podcast, we discuss the topic of clinical sites shifting to using the own technologies in sponsored trials and how it can advance (and maintain the pace of) clinical research. Our guest, Bryan Spielman, Chief Growth...1434advarra,clinical research,disruptive innovation,dpharm,dpharm disruptive innovationfalsefullhttps://www.spreaker.com/episode/5-talks-to-watch-and-why-at-io360-2022-with-strategic-advisor-dr-dan-chen--63244659http://www.blogtalkradio.com/pharmatalk/2022/01/18/5-talks-to-watch-and-why-at-io360-2022-with-strategic-advisor-dr-dan-chenTue, 18 Jan 2022 05:00:00 +0000Conference ForumAbout the Episode:  Daniel Chen, MD, PhD, Immuno-Oncology 360º 2022 Strategic Advisor, Physician Scientist, Cancer Immunotherapy and Board of Directors, Society for Immunotherapy of Cancer (SITC) and co-author of the Cancer Immunity Cycle, discusses...1405cancer,immunooncology,immunooncology360,io360,oncologyfalse11fullhttps://www.spreaker.com/episode/8th-annual-immuno-oncology-360-summit-what-to-expect-in-7-minutes--63244672http://www.blogtalkradio.com/pharmatalk/2022/01/02/8th-annual-immuno-oncology-360-summit-what-to-expect-in-7-minutesSun, 02 Jan 2022 14:00:00 +0000Conference ForumThis 7 minute podcast summarizes what you can expect at the 8th annual Immuno-Oncology 360° conference. IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider...395cell therapy,discovery science,immuno-oncology,io360,preclinical sciencefalsefullhttps://www.spreaker.com/episode/patients-as-partners-eu-2022-in-5-minutes--63244677http://www.blogtalkradio.com/pharmatalk/2021/12/17/patients-as-partners-eu-2022-in-5-minutesFri, 17 Dec 2021 13:00:00 +0000Conference ForumConference Producer, Mark Scherzer, talks through what to expect at the upcoming Patients as Partners EU virtual conference taking place 24-25 January 2022.  The 6th annual conference will bring together pharma, biotech, CROs and technologists to...318conference,patient advocacy,patients,patients as partners,virtualfalsefullhttps://www.spreaker.com/episode/how-artificial-intelligence-is-creating-better-clinical-trials-with-saama--63244718http://www.blogtalkradio.com/pharmatalk/2021/12/03/how-artificial-intelligence-is-creating-better-clinical-trials-with-saamaFri, 03 Dec 2021 05:00:00 +0000Conference ForumAbout the Episode: How can artificial intelligence maintain the pace of clinical trials from the COVID-19 pandemic to bring therapeutics to patients faster? Suresh Katta, CEO and founder of Saama Technologies, sits down to discuss exactly how...1693artificial intelligence,clinical research innovation,disruptive innovations in clin,dpharm,saama technologiesfalse11fullhttps://www.spreaker.com/episode/making-the-leap-from-iv-to-subcutaneous-with-halozyme-s-enhanze-technology--63244721http://www.blogtalkradio.com/pharmatalk/2021/11/23/making-the-leap-from-iv-to-subcutaneous-with-halozymes-enhanze-technologyTue, 23 Nov 2021 05:00:00 +0000Conference ForumAbout the Episode: How can therapeutics like biologics and small molecule drugs evolve in their delivery? Finn Doyle, SVP and General Manager of ENHANZE® at Halozyme, sits down to discuss exactly how these innovative therapeutics can be delivered...1260enhanze,halozyme,partnership opportunities in d,podd,subcutaneous drug deliveryfalsefullhttps://www.spreaker.com/episode/j-j-vision-on-progress-in-eyecare-and-meeting-the-needs-of-future-patients--63244684http://www.blogtalkradio.com/pharmatalk/2021/10/21/jj-vision-on-progress-in-eyecare-and-meeting-the-needs-of-future-patientsThu, 21 Oct 2021 04:00:00 +0000Conference ForumAbout the Episode: What does the future of eyecare look like? How does a global company stay innovative? Listen to this podcast to hear Dr Xiao-Yu Song, Johnson & Johnson Vision, providing the latest information on J&J Vision's new products,...1328disruptive innovation,dpharm,dpharm: disruptive innovations,jnj,johnson & johnsonfalsefullhttps://www.spreaker.com/episode/flexible-data-collection-and-best-dct-strategies-advice-from-an-expert--63244723http://www.blogtalkradio.com/pharmatalk/2021/10/18/flexible-data-collection-and-best-dct-strategies-advice-from-an-expertMon, 18 Oct 2021 04:00:00 +0000Conference ForumAbout the Episode: As the COVID-19 pandemic encourages the widespread adoption of decentralized clinical trial models, there are opportunities to optimize existing processes to make clinical research easier for sites and sponsors to conduct, and for...1774clinical ink,decentralized clinical trials,mobile in clinical trials,pharmatalk radio,remote data capturefalsefullhttps://www.spreaker.com/episode/building-a-successful-relationship-with-your-development-partner--63244713http://www.blogtalkradio.com/pharmatalk/2021/10/05/building-a-successful-relationship-with-your-development-partnerTue, 05 Oct 2021 15:30:00 +0000Conference ForumWhile the idea that trust between sponsors and development partners is integral to success is well known, actually building that relationship requires real effort and empathy from both groups. Today, Dr Skip Sands, Senior Vice President and Senior...920chief medical officer,chief medical officer summit,cmo summit,parexel biotech,skip sandsfalsefullhttps://www.spreaker.com/episode/9th-annual-chief-medical-officer-summit-360-overview-in-5-minutes--63244720http://www.blogtalkradio.com/pharmatalk/2021/08/27/9th-annual-chief-medical-officer-summit-360-overview-in-5-minutesFri, 27 Aug 2021 12:00:00 +0000Conference ForumIn this podcast, Conference Producer, Andrew Goldstein, reviews what to expect at the 9th annual Chief Medical Officer Summit 360°. The conference will take place October 14-15, 2021 in Boston, MA also with virtual attendance options.  Learn more...308biotech,chief medical officer,chief medical officer summit,cmo360,pharmafalsefullhttps://www.spreaker.com/episode/10-year-review-on-drug-delivery--63244675http://www.blogtalkradio.com/pharmatalk/2021/08/17/10-year-review-on-drug-deliveryTue, 17 Aug 2021 14:30:00 +0000Conference ForumIn this podcast, first presented at the PODD: Partnership Opportunities in Drug Delivery 2020 conference, you will hear Dr Barbara Lueckel, Roche Pharma Partnering provide her annual review on the drug delivery industry including notable highlights...1699drug delivery,partnership opportunities in d,podd,podd2021,rochefalsefullhttps://www.spreaker.com/episode/8th-annual-mobile-in-clinical-trials-in-5-minutes--63244670http://www.blogtalkradio.com/pharmatalk/2021/08/04/8th-annual-mobile-in-clinical-trials-in-5-minutesWed, 04 Aug 2021 12:00:00 +0000Conference ForumIn this podcast, Conference producer, Mark Scherzer, reviews what to expect at the 8th annual Mobile in Clinical Trials conference. The conference will take place September 27, 2021 in Boston, MA also with virtual attendance options. Learn more here.324clinical trials,digital,mobile,technology,virtualfalsefullhttps://www.spreaker.com/episode/podd-2021-in-7-minutes-with-director-valerie-bowling--63244714http://www.blogtalkradio.com/pharmatalk/2021/07/27/podd-2021-in-7-minutes-with-director-valerie-bowlingTue, 27 Jul 2021 17:00:00 +0000Conference ForumIn this podcast, Valerie Bowling, Director of the PODD Drug Delivery conference gives a run down summarizing what is being featured at the 11th annual event.  Learn more about the conference taking place October 28-29, 2021 at poddconference.com377drug delivery,partnership opportunities,podd,podd2021falsefullhttps://www.spreaker.com/episode/ferring-on-creating-a-first-in-class-microbiome-based-therapeutic--63244712http://www.blogtalkradio.com/pharmatalk/2021/07/19/ferring-on-creating-a-first-in-class-microbiome-based-therapeuticMon, 19 Jul 2021 04:00:00 +0000Conference ForumDisruptions in the microbiome are increasingly being linked to an associated risk for serious illnesses, opening up vast potential to create a new category of innovative microbiome-based live biotherapeutics to help people live better lives and...1388c difficile,ferring pharmaceuticals,microbiome,microbiota,therapeuticfalse11fullhttps://www.spreaker.com/episode/dpharm-in-10-minutes-with-director-valerie-bowling--63244685http://www.blogtalkradio.com/pharmatalk/2021/07/12/dpharm-in-10-minutes-with-director-valerie-bowlingMon, 12 Jul 2021 12:00:00 +0000Conference ForumDPHARM Executive Director, Valerie Bowling gives a 10 minute run down on what you can expect from DPHARM 2021. Learn more about the conference taking place Septmeber 28-29, 2021 at DPHARMconference.com.571clinical research,clinical trials,conference,dpharm,innovationfalsefullhttps://www.spreaker.com/episode/the-biotech-incubator-helping-entrepreneurs-launch-companies-to-advance-health--63244717http://www.blogtalkradio.com/pharmatalk/2021/07/07/the-biotech-incubator-helping-entrepreneurs-launch-companies-to-advance-healthWed, 07 Jul 2021 04:00:00 +0000Conference ForumThis PharmaTalk Radio episode features Dr Shawn Carbonell, CEO and co-founder of Brazen Bio.  In this conversation, Dr Carbonell describes how the Brazen Incubator, a turn-key biotech startup incubator, hopes to help fledgling entrepreneurs, the...1089biotech,biotech entrepreneurs,brazen bio,clinical research,entrepreneurfalse11fullhttps://www.spreaker.com/episode/how-and-when-to-pursue-decentralized-clinical-trials-conversation-with-experts--63244722http://www.blogtalkradio.com/pharmatalk/2021/06/15/how-and-when-to-pursue-decentralized-clinical-trials-conversation-with-expertsTue, 15 Jun 2021 04:00:00 +0000Conference ForumIn this conversation between two decentralized clinical trial experts, John Reites, CEO of THREAD, and Andy Iverson, Clinical Outcomes Solutions lead at Medtronic, are discussing decentralized clinical trials: where they don’t work yet and how that...1691clinical research innovation,clinical trials,dcts,decentralized clinical trials,digital in researchfalsefullhttps://www.spreaker.com/episode/how-to-utilize-technology-to-truly-increase-diversity-in-clinical-trials--63245286http://www.blogtalkradio.com/pharmatalk/2021/04/15/how-to-utilize-technology-to-truly-increase-diversity-in-clinical-trialsThu, 15 Apr 2021 04:00:00 +0000Conference ForumLearn lessons from a healthcare communications and clinical trial recruitment expert about addressing health disparities in racial and ethnic minorities, utilizing technology to precisely raise awareness, and bridging the digital divide, and how to: ...1647clinical research,diversity,diversity in clinical research,patient engagement,patients as partnersfalse11fullhttps://www.spreaker.com/episode/insights-from-craaco-2020-and-looking-to-the-future--63245290http://www.blogtalkradio.com/pharmatalk/2021/04/09/insights-from-craaco-2020-and-looking-to-the-futureFri, 09 Apr 2021 12:00:00 +0000Conference ForumIn this podcast, Roger Boutin, VP of Communications at SCORR Marketing discusses the results of an audience survey from the 2020 CRAACO: Clinical Research as a Care Option Conference. The poll focused on the areas of: Patient Input and...1017clinical research,clinical trials,craaco,patients,pollingfalsefullhttps://www.spreaker.com/episode/the-practical-implementation-of-sensors-in-the-changing-drug-development-world--63245294http://www.blogtalkradio.com/pharmatalk/2021/01/22/the-practical-implementation-of-sensors-in-the-changing-drug-development-worldFri, 22 Jan 2021 05:00:00 +0000Conference ForumIn this conversation, you'll learn lessons of how to implement sensors for the most impact in your clinical trials. Join three sensor experts as they discuss: What phases of clinical trials are more suited for sensor useHow to select and integrate the...1375digital devices,digital monitoring,remote monitoring,sensors,sponsorfalse11fullhttps://www.spreaker.com/episode/patients-as-partners-europe-2021-overview-in-5-minutes--63245297http://www.blogtalkradio.com/pharmatalk/2021/01/11/patients-as-partners-europe-2021-overview-in-5-minutesMon, 11 Jan 2021 13:00:00 +0000Conference ForumPatients as Partners Europe conference producer, Mark Scherzer, provides an overview of the upcoming virtual conference agenda to take place 25-26 January 2021. Hear about the sessions, keynotes, interactive opportunities, and what you will walk away...329falsefullhttps://www.spreaker.com/episode/innovations-novel-approaches-in-io-imaging-assessing-responses--63245287http://www.blogtalkradio.com/pharmatalk/2020/12/27/innovations-novel-approaches-in-io-imaging-assessing-responsesSun, 27 Dec 2020 17:30:00 +0000Conference ForumIn this podcast, you will hear a panel discussion moderated by Dr Annette Schmid, Takeda Pharmaceuticals from the 2020 IO360° Summit regarding innovations and novel approaches in IO imaging and assessing responses. Panelists inclue: Gregory...1882imaging,immuno-oncology,io360,merck,merck kgaafalsefullhttps://www.spreaker.com/episode/hla-loss-and-the-impact-on-immunotherapy--63245314http://www.blogtalkradio.com/pharmatalk/2020/12/27/hla-loss-and-the-impact-on-immunotherapySun, 27 Dec 2020 16:30:00 +0000Conference ForumLoss of the HLA locus impairs presentation of tumor antigens and is frequently found in advanced cancers. This talk presented by Dr Lee Albacker, Foundation Medicine and first recorded at the 2020 IO360° Summit, will describe the landscape of HLA loss...1260foundation medicine,hla loss,immuno-oncology,io360,solid tumorfalsefullhttps://www.spreaker.com/episode/cell-gene-therapy-debate-intrinsic-editing-vs-systemic-combination--63245302http://www.blogtalkradio.com/pharmatalk/2020/12/27/cell-gene-therapy-debate-intrinsic-editing-vs-systemic-combinationSun, 27 Dec 2020 01:30:00 +0000Conference ForumIn this podcast first recorded at the 2020 IO360° Summit, Dr Aiman Shalabi, GSK, moderated a cell and gene therapy debate on intrinsic editing vs systemic combination  Participants included: Mark O’Hara, MD, University of PennsylvaniaSaul Priceman,...1265cell therapy,gene therapy,immuno-oncology,io360,university of pennsylvaniafalsefullhttps://www.spreaker.com/episode/operational-dynamics-of-implementing-managing-basket-trials--63245320http://www.blogtalkradio.com/pharmatalk/2020/12/27/operational-dynamics-of-implementing-managing-basket-trialsSun, 27 Dec 2020 00:00:00 +0000Conference ForumIn this podcast, first recorded at the IO360° 2020 Summit, Dr Millie Schultz, Seattle Genetics, discusses operational dynamics of implementing and managing basket trials. Discussion points include: What are the operational complexities of basket...1070falsefullhttps://www.spreaker.com/episode/overcoming-site-regulatory-issues-to-optimize-clinical-quality--63245308http://www.blogtalkradio.com/pharmatalk/2020/12/11/overcoming-site-regulatory-issues-to-optimize-clinical-qualityFri, 11 Dec 2020 05:00:00 +0000Conference ForumHow two companies collaborated on a master trial to drastically improve site startup speed, reduce delays and optimize CRA productivity.    In this podcast, Rick Arlow, Complion, and Dr Len Rosenberg, Leukemia and Lymphoma Society, discuss their...1844cra productivity,optimizing clinical research,site delays,study startups,technology solutionfalse11fullhttps://www.spreaker.com/episode/evolution-of-regulatory-policy-for-cell-gene-therapy--63245328http://www.blogtalkradio.com/pharmatalk/2020/11/03/evolution-of-regulatory-policy-for-cellgene-therapyTue, 03 Nov 2020 19:00:00 +0000Conference ForumIn this podcast, first recorded at the 2021 IO360° Summit, Dr Peter Marks, Center for Biologics Evaluation and Research (CBER), FDA, moderated a panel on the evolution of regulatory policy for cell/gene therapy. Discussion points include: What are...2647cell & gene therapy day,friends of cancer research,io360,lonza pharma & biotech,university of pennsylvaniafalsefullhttps://www.spreaker.com/episode/centralized-vs-decentralized-manufacturing--63245299http://www.blogtalkradio.com/pharmatalk/2020/11/03/centralized-vs-decentralized-manufacturingTue, 03 Nov 2020 13:00:00 +0000Conference ForumIn this podcast first recorded at the 2020 IO360° Summit, Michael Paglia, ElevateBio, moderated a cell & gene therapy debate on centralized vs decentralized manufacturing. Participants included: Boro Dropulić, PhD, Lentigen Patrick Hanley,...1680cell & gene therapy day,cell therapy,centralized manufacturing,gene therapy,io360falsefullhttps://www.spreaker.com/episode/next-generation-bispecifics-in-solid-tumors--63245334http://www.blogtalkradio.com/pharmatalk/2020/11/02/next-generation-bispecifics-in-solid-tumorsMon, 02 Nov 2020 15:00:00 +0000Conference ForumIn this podcast, you will hear a panel discussion moderated by Dr Priti Hegde, Foundation Medicine, from the 2020 IO360° Summit regarding next generation bispecifics in solid tumors. Discussion questions include: What is happening in hematology...1939amgen,immuno-oncology,io360,pfizer,regeneron pharmaceuticalsfalsefullhttps://www.spreaker.com/episode/ariella-chivil-s-immunotherapy-trial-pathway--63245289http://www.blogtalkradio.com/pharmatalk/2020/11/02/ariella-chivils-immunotherapy-trial-pathwayMon, 02 Nov 2020 12:00:00 +0000Conference ForumIn this podcast, you will hear a fireside discussion from the 2020 IO360° Summit featuring cancer survivor and advocate, Ariella Chivil who walked the audience through her immunotherapy trial pathway alongside patient advocate, Cindy Geoghegan, who...1668clinical trial,immunotherapy,io360,patient advocate,patient voicefalsefullhttps://www.spreaker.com/episode/insitu-vaccinations-vs-systemic-neo-epitope-vaccinations--63245322http://www.blogtalkradio.com/pharmatalk/2020/10/30/insitu-vaccinations-vs-systemic-neo-epitope-vaccinationsFri, 30 Oct 2020 19:00:00 +0000Conference ForumIn this podcast first recorded at the 2020 IO360° Summit, Asthika Goonewardene, SunTrust Robinson Humphrey, moderated a cancer immunotherapy debate on insitu vaccinations vs systemic neo-epitope vaccinations. Participants included: Charles Drake,...1763falsefullhttps://www.spreaker.com/episode/what-do-next-generation-of-immunotherapies-need-to-look-like-to-move-the-needle--63245324http://www.blogtalkradio.com/pharmatalk/2020/10/30/what-do-next-generation-of-immunotherapies-need-to-look-like-to-move-the-needleFri, 30 Oct 2020 11:30:00 +0000Conference ForumThe frenzy of deals around IO programs and companies has led to what could be referred to as “BD outpacing science.” That might be said too of the combination trials that have displayed varied results, with a few showing clear benefit, some being...3115agenus bio,cello health bioconsulting,immuno-oncology,immunotherapies,io360falsefullhttps://www.spreaker.com/episode/using-sensor-technology-to-deploy-decentralized-trials-and-improve-patient-care--63245291http://www.blogtalkradio.com/pharmatalk/2020/10/29/using-sensor-technology-to-deploy-decentralized-trials-and-improve-patient-careThu, 29 Oct 2020 04:00:00 +0000Conference ForumIn this PharmaTalk episode, get guidance from patient innovation and technology experts about the proper ways of harnessing technology in order to deploy Decentralized Clinical Trials and improve patient care. Specifically, in this episode Rosamund...1361clinical operations,clinical trials,patient experience,remote monitoring,sensor technologyfalse11fullhttps://www.spreaker.com/episode/current-issues-and-potential-solutions-for-site-audit-readiness-and-monitoring--63245330http://www.blogtalkradio.com/pharmatalk/2020/10/26/current-issues-and-potential-solutions-for-site-audit-readiness-and-monitoringMon, 26 Oct 2020 04:00:00 +0000Conference ForumIn this PharmaTalk episode, learn what can be done to enhance site audit readiness and monitoring.    Rick Arlow, CEO of Complion, recently spoke with DPHARM quarterly newsletter writer, Danny McCarthy, to discuss: Why he believes that the...1456clinical operations,eregulatory,site audit,site audit readiness,site monitoringfalse11fullhttps://www.spreaker.com/episode/5-minute-overview-of-8th-annual-cmo-summit-360--63245295http://www.blogtalkradio.com/pharmatalk/2020/10/19/5-minute-overview-of-8th-annual-cmo-summit-360Mon, 19 Oct 2020 13:00:00 +0000Conference ForumIn this podcast, conference producer, Andrew Goldstein, provides a brief overview of what to expect at the 8th annual Chief Medical Officer Summit 360º. The 2020 program will attract the largest gathering of physicians in biotech on October 26-27,...340falsefullhttps://www.spreaker.com/episode/the-future-of-clinical-research-and-the-innovation-from-the-covid-19-pandemic--63245292http://www.blogtalkradio.com/pharmatalk/2020/10/07/the-future-of-clinical-research-and-the-innovation-from-the-covid-19-pandemicWed, 07 Oct 2020 04:00:00 +0000Conference ForumIn this PharmaTalk podcast, Benjamine Liu, DPhil, CEO of TrialSpark, discusses the impacts of COVID-19 on the future of clinical research and the innovation being created as a result. Ben recently spoke at DPHARM: Disruptive Innovations to Advance...1196artificial intelligence,disruptive innovation,dpharm,natural language processing,trialsparkfalsefullhttps://www.spreaker.com/episode/connecting-care-and-research-for-the-patient-with-a-decentralized-trial-model--63245301http://www.blogtalkradio.com/pharmatalk/2020/09/30/connecting-care-and-research-for-the-patient-with-a-decentralized-trial-modelWed, 30 Sep 2020 04:00:00 +0000Conference ForumIn this PharmaTalk episode, John Potthoff, PhD, CEO of Elligo Health Research explains the benefits of decentralized clinical trials.  He recently spoke with CRAACO quarterly news writer, Danny McCarthy to discuss why he believes that decentralized...1507clinical research,clinical research as a care op,craaco,decentralized trials,pharmatalkfalse11fullhttps://www.spreaker.com/episode/remote-monitoring-for-clinical-research-in-the-digital-age--63245326http://www.blogtalkradio.com/pharmatalk/2020/09/18/remote-monitoring-for-clinical-research-in-the-digital-ageFri, 18 Sep 2020 04:00:00 +0000Conference ForumIn this PharmaTalk podcast, MaryAnne Rizk, PhD, of IQVIA, leads a multi-perspective panel discussion on monitoring in the digital age as data becomes the new currency.  Together they discuss how AI and ML are empowering sponsors and sites to predict...1451artificial intelligence,data,machine learning,modernization,remote monitoringfalsefullhttps://www.spreaker.com/episode/solving-for-the-patient-retention-problem-in-clinical-research--63245332http://www.blogtalkradio.com/pharmatalk/2020/09/09/solving-for-the-patient-retention-problem-in-clinical-researchWed, 09 Sep 2020 04:00:00 +0000Conference ForumIn this PharmaTalk episode, Thomas Klein, founder and CEO of Be the Partner, discusses how to implement new retention and engagement methods to stop patients from "vanishing" in the clinical trial process. Mr Klein sat down with PharmaTalk's Danny...1195be the partner,clinical research,clinical trials,patient engagement,patient portalfalse11fullhttps://www.spreaker.com/episode/io-combinations-360-overview-in-7-minutes--63245298http://www.blogtalkradio.com/pharmatalk/2020/09/08/io-combinations-360-overview-in-7-minutesTue, 08 Sep 2020 18:00:00 +0000Conference ForumKate Woda, IO Combinations 360° Conference Director, gives a 7 minute overview on what you can expect at the 5th annual IO Combinations 360° conference taking place October 1-2 virtually. 2020 Key Topics: Discovery / Preclinical...417immuno-oncology,immuno therapy,io combinations 360falsefullhttps://www.spreaker.com/episode/enabling-clinical-trial-continuity-with-live-video-visits--63245340http://www.blogtalkradio.com/pharmatalk/2020/09/08/enabling-clinical-trial-continuity-with-live-video-visitsTue, 08 Sep 2020 17:00:00 +0000Conference ForumIn this PharmaTalk podcast, Kelly McKee of Medidata leads a multi-perspective panel discussion on the challenges and opportunities of adopting a decentralized model for clinical trials and ensuring clinical trial continuity with live video visits. ...1679decentralized,medidata,telehealth,telemedicine,video visitsfalse11fullhttps://www.spreaker.com/episode/roche-s-dr-barbara-lueckel-s-opening-remarks-and-the-2018-year-in-review--63245333http://www.blogtalkradio.com/pharmatalk/2020/08/26/roches-dr-barbara-lueckels-opening-remarks-and-the-2018-year-in-reviewWed, 26 Aug 2020 11:00:00 +0000Conference ForumChair of the Partnership Opportunities in Drug Delivery (PODD) event, Dr Barbara Lueckel, Global Head of Research Technologies Partnering at Roche, presents an annual year-in-review of the drug delivery landscape from 2018. Dr Lueckel’s opening...1421barbara lueckel,drug delivery,partnership opportunities in d,podd,rochefalsefullhttps://www.spreaker.com/episode/how-a-gene-therapy-for-duchenne-muscular-dystrophy-came-to-be--63245339http://www.blogtalkradio.com/pharmatalk/2020/08/25/how-a-gene-therapy-for-duchenne-muscular-dystrophy-came-to-beTue, 25 Aug 2020 04:00:00 +0000Conference ForumThis podcast dives into the history of creating a gene therapeutic for Duchenne Muscular Dystrophy. Dr Richard Jude Samulski has been studying gene therapy and the use of the AAV vector for decades. Recently, preliminary results from Pfizer were...1655dmd,duchenne muscular dystrophy,gene therapy,pharmatalkradio,richard jude samulskifalse11fullhttps://www.spreaker.com/episode/how-a-covid-19-research-study-was-formed-with-oracle-javara-and-wake-forest--63245303http://www.blogtalkradio.com/pharmatalk/2020/07/27/how-a-covid-19-research-study-was-formed-with-oracle-javara-and-wake-forestMon, 27 Jul 2020 04:00:00 +0000Conference ForumThis podcast tells the story of how a community-based COVID-19 research study was formed from a partnership between Oracle Health Sciences, Javara Research and Wake Forest Baptist Health, with the end goal of using regional infection patterns to...1464community-based,community health,covid-19,oracle health sciences,research studyfalse11fullhttps://www.spreaker.com/episode/io-biomarker-discovery-personalized-cancer-therapy-development-with-personalis--63245304http://www.blogtalkradio.com/pharmatalk/2020/06/19/io-biomarker-discovery-personalized-cancer-therapy-development-with-personalisFri, 19 Jun 2020 04:00:00 +0000Conference ForumPharmaTalk Radio’s Kate Woda welcomes guest, Erin Newburn, Director and Field Applications Scientist at Personalis on the topic of IO Biomarker Discovery and Personalized Cancer Therapy and how Personalis is enabling this.  Guest Bio: Erin Newburn,...1676biomarker discovery,cancer,immuno-oncology,personalis,personalized cancer therapy defalsefullhttps://www.spreaker.com/episode/the-impact-of-covid-19-on-clinical-trials-where-are-we-and-where-are-we-going--63245345http://www.blogtalkradio.com/pharmatalk/2020/06/18/the-impact-of-covid-19-on-clinical-trials-where-are-we-and-where-are-we-goingThu, 18 Jun 2020 18:30:00 +0000Conference ForumAs the country goes through the phases of reopening, what does that mean for the patient and site experience in clinical trials? PharmaTalkRadio’s Valerie Bowling discusses the future of clinical trials with Dr Ray Dorsey, Matt Kibby and Craig Lipset....1891bbk,clinical research post covid-1,clinical trials,dr ray dorsey,the conference forumfalsefullhttps://www.spreaker.com/episode/7th-annual-mobile-in-clinical-trials-overview-in-under-5-minutes--63245309http://www.blogtalkradio.com/pharmatalk/2020/06/18/7th-annual-mobile-in-clinical-trials-overview-in-under-5-minutesThu, 18 Jun 2020 12:00:00 +0000Conference ForumIn this podcast, Mark Scherzer, producer of Mobile in Clinical Trials gives an overview of what to expect at the 2020 virtual conference. The 7th annual meeting is co-chaired by Bayer's Michelle Shogren and Healthmode's Dan Karlin and reports on the...275clinical research,clinical trials,digital,mobile,researchfalsefullhttps://www.spreaker.com/episode/kpis-that-support-innovation-for-patient-engagement--63245346http://www.blogtalkradio.com/pharmatalk/2020/05/10/kpis-that-support-innovation-for-patient-engagementSun, 10 May 2020 15:00:00 +0000Conference ForumIn this podcast, first recorded at the 2019 DPharm: Disruptive Innovations conference, Takeda's Dr Andrew Plump and Dr Jessica Scott discuss how they have developed KPIs that support innovation for patient-engagement. Dr Plump leads Takeda's global...1578clinical research,clinical trials,innovation,pharmaceutical,r&dfalsefullhttps://www.spreaker.com/episode/starbucks-innovation-for-the-end-user-experience--63245305http://www.blogtalkradio.com/pharmatalk/2020/05/09/starbucks-innovation-for-the-end-user-experienceSat, 09 May 2020 15:00:00 +0000Conference ForumIn this podcast, first presented at the 9th annual DPharm: Disruptive Innovations conference, Starbucks' Robert Mercer sits down with Eli Lilly's Joe Kim to discuss the end-user experience in mobile technology. This out-of-industry example covers how...1240clinical research,clinical trials,innovation,mobile,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/transparency-and-the-future-of-patient-expectations--63245341http://www.blogtalkradio.com/pharmatalk/2020/05/09/transparency-and-the-future-of-patient-expectationsSat, 09 May 2020 12:00:00 +0000Conference ForumIn this podcast, first presented at the 9th annual DPharm: Disruptive Innovations conference, Healthgrades' founder Kerry Hicks sits down with Craig Lipset for a keynote discussion on transparency and the future of patient expectations. "Everyone...1292clinical trials,health,innovation,patients,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/turning-genes-into-medicines-gene-therapy-for-genetic-disease--63245311http://www.blogtalkradio.com/pharmatalk/2020/05/08/turning-genes-into-medicines-gene-therapy-for-genetic-diseaseFri, 08 May 2020 18:30:00 +0000Conference ForumOne of the goals of the Human Genome Project was to improve therapeutic options for those born with serious inherited diseases. Today gene therapy is beginning to realize this promise, with the ever-increasing level of clinical investigation in the...1764gene therapy,human genome project,partnership opportunities in d,podd,spark therapeuticsfalsefullhttps://www.spreaker.com/episode/formulation-device-lifecycle-management-for-biotherapeutics--63245351http://www.blogtalkradio.com/pharmatalk/2020/05/08/formulation-device-lifecycle-management-for-biotherapeuticsFri, 08 May 2020 12:30:00 +0000Conference ForumSubcutaneous (SC) delivery has become the norm for treating diseases such as Rheumatoid arthritis and multiple sclerosis, and there remains great potential to offer home- or even self-administered SC delivery for several other biotherapeutics. Given...2487device lifecycle management,formulation,partnership opportunities in d,podd,subcutaneous deliveryfalsefullhttps://www.spreaker.com/episode/future-outlook-for-novel-drug-delivery--63245318http://www.blogtalkradio.com/pharmatalk/2020/05/07/future-outlook-for-novel-drug-deliveryThu, 07 May 2020 15:30:00 +0000Conference ForumThis podcast, first recorded at the 2019 PODD: Partnership Opportunities in Drug Delivery conference explores the value of drug delivery technologies both to patients and pharma with a focus on the future direction of the field. This will include a...2536battelle,partnership opportunities in d,pfizer,podd,sanofifalsefullhttps://www.spreaker.com/episode/modality-fluid-development-evolving-pipelines-and-drug-delivery-solutions--63245300http://www.blogtalkradio.com/pharmatalk/2020/05/07/modality-fluid-development-evolving-pipelines-and-drug-delivery-solutionsThu, 07 May 2020 12:00:00 +0000Conference ForumMerck has a long history of being open to utilizing a wide range of delivery technologies for both enabling and life cycle management. In this leadership keynote, first recorded at the 2019 PODD: Partnership Opportunities in Drug Delivery...1564drug delivery solutions,merck,modality fluid development,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/medtech-fireside-chat-the-journey-of-an-emerging-medical-device-company--63245321http://www.blogtalkradio.com/pharmatalk/2020/05/06/medtech-fireside-chat-the-journey-of-an-emerging-medical-device-companyWed, 06 May 2020 21:30:00 +0000Conference ForumIn this podcast, first recorded at the 2019 PODD: Partnership Opportunities in Drug Delivery conference, John Merhige, Credence MedSystems, Inc and Mathias Romacker, formly with Pfizer discuss the journey of an emerging medical device company from a...1257credence medsystems,emerging medical device compan,partnership opportunities in d,pfizer,poddfalsefullhttps://www.spreaker.com/episode/case-study-forming-and-managing-a-drug-delivery-alliance--63245358http://www.blogtalkradio.com/pharmatalk/2020/05/06/case-study-forming-and-managing-a-drug-delivery-allianceWed, 06 May 2020 18:30:00 +0000Conference ForumEffective drug delivery collaborations combine a wide range of experiences and viewpoints with common goals to achieve successful clinical and regulatory outcomes. But the path to developing this eventual relationship is not without challenges, as...1891bms,bristol-myers squibb,halozyme therapeutics,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/supporting-business-models-for-scaled-connected-health-drug-delivery-products--63245306http://www.blogtalkradio.com/pharmatalk/2020/05/05/supporting-business-models-for-scaled-connected-health-drug-delivery-productsTue, 05 May 2020 23:00:00 +0000Conference ForumHow are industry leaders looking to bridge the gap from pilot systems to scaled solutions in the market? In this podcast, first recorded at the 2019 PODD: Partnership Opportunities in Drug Delivery conference, a panel of Connected Health leaders in...1721partnership opportunities in d,phillips-medisize,podd,roche,takedafalsefullhttps://www.spreaker.com/episode/utilizing-digital-health-data-to-improve-management-prevention-wellness--63245312http://www.blogtalkradio.com/pharmatalk/2020/05/05/utilizing-digital-health-data-to-improve-management-prevention-wellnessTue, 05 May 2020 21:30:00 +0000Conference ForumGiven the increase in focus on digital health and connected device development to improve "patient centricity" and the user experience, there is a large amount of clarity and evidence needed on how to truly ladder in these efforts to achieve the...1158connected device development,digital health data,eli lilly and company,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/understanding-jansen-s-metaphyseal-chondrodysplasia--63245577http://www.blogtalkradio.com/pharmatalk/2020/05/05/understanding-jansens-metaphyseal-chondrodysplasiaTue, 05 May 2020 16:30:00 +0000Conference ForumIn the fourth episode of our series highlighting rare diseases, Conference Forum reporter Danny McCarthy sits down with Neena Nizar, EdD, Founder and Executive Director of the Jansen's Foundation, to discuss Jansen's Metaphyseal Chondrodysplasia. ...1419jansen's metaphyseal chondrody,patient advocate,patients as partners,rare disease,the conference forumfalse14fullhttps://www.spreaker.com/episode/the-collective-struggle-to-evolve-data-and-analytics-culture-capabilities--63245376http://www.blogtalkradio.com/pharmatalk/2020/05/04/the-collective-struggle-to-evolve-data-and-analytics-culture-capabilitiesMon, 04 May 2020 15:00:00 +0000Conference ForumIn this podcast, first presented at the 9th annual DPharm: Disruptive Innovations conference, Cellarity's Milind Kamkolkar presents on the collective struggle to evolve a drug development organization's data and analytics culture and capabilities....1645clinical research,clinical trials,data,innovation,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/re-thinking-clinical-development-using-historical-data-to-transform-trials--63245317http://www.blogtalkradio.com/pharmatalk/2020/05/04/re-thinking-clinical-development--using-historical-data-to-transform-trialsMon, 04 May 2020 12:00:00 +0000Conference ForumIn this podcast, first presented at the 9th annual DPharm: Disruptive Innovations conference, Genentech's Aaron Mann discusses the use of historical data to transform clinical trials and how to rethink clinical development. Speaker: Aaron Mann,...965clinical research,clinical trials,data,innovation,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/the-evolution-of-using-real-world-data-to-create-trial-readiness-cohorts--63245331http://www.blogtalkradio.com/pharmatalk/2020/05/03/the-evolution-of-using-real-world-data-to-create-trial-readiness-cohortsSun, 03 May 2020 15:00:00 +0000Conference ForumIn this podcast, first presented at the 9th annual DPharm: Disruptive Innovations conference, Johnson & Johnson's Dr Martine Lewi discusses the evolution of their use of Real-World Data in their clinical programs. Including: What is the state of...939clinical research,clinical trials,innovation,janssen,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/the-pd-fidi-developing-a-digital-endpoint-for-parkinson-s-disease--63245353http://www.blogtalkradio.com/pharmatalk/2020/05/03/the-pd-fidi-developing-a-digital-endpoint-for-parkinsons-diseaseSun, 03 May 2020 12:00:00 +0000Conference ForumIn this podcast, first presented at the 9th annual DPharm: Disruptive Innovations conference, Sanofi's Laura Kling discusses developing a digital endpoint for Parkinson's Disease using wearables.  Speaker: Laura Kling, Director, Digital Innovation,...572clinical research,clinical trials,digital,innovation,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/planning-for-and-addressing-missing-data-in-mobile-clinical-trials--63245316http://www.blogtalkradio.com/pharmatalk/2020/05/02/planning-for-and-addressing-missing-data-in-mobile-clinical-trialsSat, 02 May 2020 15:00:00 +0000Conference ForumThis podcast presents a session on planning for and addressing missing data form the 2019 Mobile in Clinical Trials conference.  When a protocol dictates a set period of time for data collection, what happens when there's a gap in the data due to...1865data,digital,digital health,mobile,virtualfalsefullhttps://www.spreaker.com/episode/balancing-innovation-with-solid-common-sense-to-deliver-innovative-medicines--63245354http://www.blogtalkradio.com/pharmatalk/2020/05/02/balancing-innovation-with-solid-common-sense-to-deliver-innovative-medicinesSat, 02 May 2020 12:00:00 +0000Conference ForumIn this podcast, first presented at the 9th annual DPharm: Disruptive Innovations conference, Merck's Mark Travers presents a cornerstone discussion on Balancing Innovation with Solid Common Sense to Deliver Innovative Medicines. Merck is walking the...1437clinical research,clinical trials,innovation,merck,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/virtual-trials-what-are-we-striving-for-and-measurements-of-success--63245360http://www.blogtalkradio.com/pharmatalk/2020/05/01/virtual-trials-what-are-we-striving-for-and-measurements-of-successFri, 01 May 2020 18:00:00 +0000Conference ForumThis podcast presents a panel discussion from the 2019 Mobile in Clinical Trials conference on what we are striving for and measurements of success in virtual trials. Discussion points include: How is it getting our of pilotville?What is the barrier...2360clinical trials,digital,mobile,pharmaceutical,virtualfalsefullhttps://www.spreaker.com/episode/escaping-pilotville-how-to-scale-mobile-digital-deployment-in-clinical-trials--63245325http://www.blogtalkradio.com/pharmatalk/2020/05/01/escaping-pilotville-how-to-scale-mobile-digital-deployment-in-clinical-trialsFri, 01 May 2020 12:00:00 +0000Conference ForumThis podcast presents a session from the 2019 Mobile in Clinical Trials conference on Escaping Pilotville: How to Scale Mobile/Digital Deployment in Clinical Trials. Discussion points include: What KPIs are used to evaluate success/failure of a...1530clinical research,clinical trials,digital,mobile,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/merck-s-strategy-to-mobilize-mobile-efforts-and-engineer-for-scale--63245335http://www.blogtalkradio.com/pharmatalk/2020/04/30/mercks-strategy-to-mobilize-mobile-efforts-and-engineer-for-scaleThu, 30 Apr 2020 18:00:00 +0000Conference ForumThis podcast presents a session from Merck on Mobilizing Mobile Efforts and Engineering for Scale at the 2019 Mobile in Clinical Trials conference.  Mobile tool/device implementation has been widely accepted, tested, and piloted in clinical research....961biotech,digital,digital health,mobile,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/what-does-a-successful-digital-trial-look-like--63245336http://www.blogtalkradio.com/pharmatalk/2020/04/30/what-does-a-successful-digital-trial-look-likeThu, 30 Apr 2020 12:00:00 +0000Conference ForumThis podcast presents a panel discussion on What a Successful Digital Trial Looks Like from the 2019 Mobile in Clinical Trials conference. Including: What is a digital trial?Is a common definition needed in order to scale for success?What does success...1970clinical research,clinical trials,digital,mobile,virtualfalsefullhttps://www.spreaker.com/episode/advocating-for-people-managing-hermansky-pudlak-syndrome--63245362http://www.blogtalkradio.com/pharmatalk/2020/04/29/advocating-for-people-managing-hermansky-pudlak-syndrome-1Wed, 29 Apr 2020 18:00:00 +0000Conference ForumIn the third episode of our series highlighting rare diseases, Conference Forum reporter Danny McCarthy sits down with Fernando Albertorio, PhD, to discuss Hermansky-Pudlak Syndrome.  Dr Albertorio is co-founder of Sunu, Inc, which creates wearable,...1284hermansky-pudlak syndrome,patient advocacy,rare diseasefalse13fullhttps://www.spreaker.com/episode/maintaining-clinical-trial-patient-engagement-in-covid-with-be-the-partner--63245344http://www.blogtalkradio.com/pharmatalk/2020/04/29/maintaining-clinical-trial-patient-engagement-in-covid-with-be-the-partnerWed, 29 Apr 2020 14:30:00 +0000Conference ForumThe COVID-19 pandemic has meant that, more and more, clinical trials are being disrupted or interrupted completely. Without the continuous momentum and contact, trials will lose patients as gaps in studies lengthen.  To combat that, Be the Partner...1078be the partner,bridge,clinical trial,communication,covidfalse11fullhttps://www.spreaker.com/episode/setting-up-therapeutic-vaccine-programs-for-covid-19-lessons-learned--63245359http://www.blogtalkradio.com/pharmatalk/2020/04/28/setting-up-therapeutic-vaccine-programs-for-covid-19-lessons-learnedTue, 28 Apr 2020 20:00:00 +0000Conference ForumPharmaTalk Radio's Valerie Bowling welcomes guest, Kent Thoelke, EVP and CSO at PRA Health Sciences on his experience in rapidly setting up both therapeutic and vaccine focused programs for COVID-19. More specifically, they discuss lessons learned,...2560biotech,clinical research,coronavirus,covid-19,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/understanding-spinal-muscular-atrophy-a-chief-scientific-officer-s-perspective--63245338http://www.blogtalkradio.com/pharmatalk/2020/04/14/understanding-spinal-muscular-atrophy-a-chief-scientific-officers-perspectiveTue, 14 Apr 2020 17:00:00 +0000Conference ForumIn the second episode of a three-part series dedicated to highlighting rare disease, Conference Forum reporter Danny McCarthy sits down with C Frank Bennett, PhD, of Ionis Pharmaceuticals, to discuss Spinal Muscular Atrophy. Dr Bennett is Executive...1324conference forum,ionis pharmaceuticals,pharma perspective on rare dis,spinal muscular atrophy,spinrazafalse12fullhttps://www.spreaker.com/episode/changing-how-we-treat-systemic-sclerosis--63245337http://www.blogtalkradio.com/pharmatalk/2020/03/19/changing-how-we-treat-systemic-sclerosisThu, 19 Mar 2020 15:30:00 +0000Conference ForumIn this three-part series dedicated to the physician's perspective on living with a rare disease, Conference Forum reporter Danny McCarthy sits down with Tracy Frech, MD, to discuss Systemic Sclerosis. Tracy Frech, MD, is a rheumatologist at the...1429conference forum,corbus pharmaceuticals,physican perspective on living,scleroderma,systemic sclerosisfalse11fullhttps://www.spreaker.com/episode/new-opportunities-for-cell-therapy-combinations--63245368http://www.blogtalkradio.com/pharmatalk/2020/03/10/new-opportunities-for-cell-therapy-combinationsTue, 10 Mar 2020 13:00:00 +0000Conference ForumIn this podcast moderated by Dr Michael Kalos, Janssen Oncology, you will hear a panel discussion from the 2019 IO Combinations 360° conference. Topic points include: What are the new opportunities in cell therapy for combinations?What the challenges...2704adaptive biotechnologies,car,cell therapy,io combinations 360°,tcrfalsefullhttps://www.spreaker.com/episode/pd1-resistance-with-a-multi-omic-approach--63245369http://www.blogtalkradio.com/pharmatalk/2020/03/10/pd1-resistance-with-a-multi-omic-approachTue, 10 Mar 2020 12:30:00 +0000Conference ForumAnti-PD-1 therapy has transformed cancer care but most patients do not respond. It is increasingly clear that there will be no single biomarker of response to a PD-1, and that a multi-omic approach will be required. In this podcast, first recorded at...1446io combinations 360°,parker institute,pd1 resistance,tumor immunobiologyfalsefullhttps://www.spreaker.com/episode/updates-on-parp-inhibition--63245371http://www.blogtalkradio.com/pharmatalk/2020/03/09/updates-on-parp-inhibitionMon, 09 Mar 2020 19:30:00 +0000Conference ForumIn this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Darren Hodgson, AstraZeneca presented updates on PARP inhibition. Topics include: Strategies to target homologous recombination repair deficiencyMonotherapy...1486astrazeneca,io combinations 360°,parp inhibitionfalsefullhttps://www.spreaker.com/episode/leveraging-the-tumor-microenvironment-for-io-therapy--63245347http://www.blogtalkradio.com/pharmatalk/2020/03/08/leveraging-the-tumor-microenvironment-for-io-therapySun, 08 Mar 2020 13:00:00 +0000Conference ForumFirst recorded at the 4th annual IO Combinations 360° conference, this talk provided by Dr Kenneth Hance, GSK addresses agonistic strategies, T and NK cell redirection and the use of genetic/phenotypic assocations to identify novel target space in IO....1092gsk,immuno-oncology,io combinations 360°,nk cell,t cellfalsefullhttps://www.spreaker.com/episode/updates-on-bintrafusp-alfa-m7824-clinical-data--63245342http://www.blogtalkradio.com/pharmatalk/2020/03/07/updates-on-bintrafusp-alfam7824-clinical-dataSat, 07 Mar 2020 14:00:00 +0000Conference ForumIn this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Laureen Ojalvo, EMD Serono provides an overview of the moleculte Bintrafusp alfa/M7824. This molecule is an innovative, first-in-class bifunctional fusion protein...1406anti-pd-l1,emd serono,io combinations 360°,tgf-ßriifalsefullhttps://www.spreaker.com/episode/nktr-214-harnessing-the-il-2-pathway-in-combination-immunotherapies--63245343http://www.blogtalkradio.com/pharmatalk/2020/03/06/nktr-214-harnessing-the-il-2-pathway-in-combination-immunotherapiesFri, 06 Mar 2020 20:30:00 +0000Conference ForumIn this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Willem Overwijk, Nektar Therapeutics discusses Bempegaldesleukin (NKTR-214): harnessing the IL-2 pathway in combination immunotherapies. Topics include:...1161bempegaldesleukin,combination immunotherapies,io combinations 360°,nektar therapeutics,nktr-214falsefullhttps://www.spreaker.com/episode/advancing-bispecifics-for-combination-immunotherapy--63245374http://www.blogtalkradio.com/pharmatalk/2020/03/02/advancing-bispecifics-for-combination-immunotherapyMon, 02 Mar 2020 12:30:00 +0000Conference ForumFirst recorded at the fourth annual IO Combinations 360° conference, this panel moderated by Dr Daniel Chen, IGM Biosciences discusses advancing bispecifics for combination immunotherapy. This discussion covers the following topics: What are the types...2558amgen,bispecifics,combination immunotherapy,io combinations 360,pfizerfalsefullhttps://www.spreaker.com/episode/how-ai-machine-learning-and-big-data-are-used-to-inform-combinations--63245366http://www.blogtalkradio.com/pharmatalk/2020/03/01/how-ai-machine-learning-and-big-data-are-used-to-inform-combinationsSun, 01 Mar 2020 10:30:00 +0000Conference ForumIn this podcast, you will hear a panel discussion from the 2019 IO Combinations 360° conference regarding how AI, machine learning and big data are used to inform combinations. Moderated by Matthew Albert, MD, PhD, Insitro Panelists: Edward Bowen,...3043ai,artificial intelligence,big data,io combinations 360,machine learningfalsefullhttps://www.spreaker.com/episode/weighing-your-options-in-considering-clinical-trials-from-a-patient-perspective--63245348http://www.blogtalkradio.com/pharmatalk/2020/02/20/weighing-your-options-in-considering-clinical-trials-from-a-patient-perspectiveThu, 20 Feb 2020 13:00:00 +0000Conference ForumIn this podcast, you will hear a panel discussion from the 2019 Clinical Research as a Care Option (CRAACO) conference with patients and advocates on weighing your care options and considering participation in a clinical trial. Some points include,...1905clinical care,clinical research,clinical trials,craaco,patientsfalsefullhttps://www.spreaker.com/episode/understanding-the-goals-of-care-vs-research--63245356http://www.blogtalkradio.com/pharmatalk/2020/02/19/understanding-the-goals-of-care-vs-researchWed, 19 Feb 2020 14:30:00 +0000Conference ForumIn this podcast, you will hear a panel discussion from the 2019 Clinical Research as a Care Option (CRAACO) conference on Understanding the Goals of Care Vs Research. The panelists explore points including, Goals for care vs goals for...1622clinical care,clinical research,clinical trials,craaco,healthcarefalsefullhttps://www.spreaker.com/episode/6-min-podcast-on-what-to-expect-at-the-7th-annual-patients-as-partners--63245389http://www.blogtalkradio.com/pharmatalk/2020/02/18/6-min-podcast-on-what-to-expect-at-the-7th-annual-patients-as-partnersTue, 18 Feb 2020 14:00:00 +0000Conference ForumThis 6 minute podcast summarizes what you can expect during the virtual Patients as Partners conference. Key topic areas include: BioPharma Strategies on Applying Patient Engagement Initiatives and Demonstrating ImpactDirect-to-Patient Clinical...343clinical trials,patient centricity,patient data ownership,patient engagement,patients as partners usfalsefullhttps://www.spreaker.com/episode/how-to-integrate-industry-sponsored-clinical-trials-into-your-health-system--63245349http://www.blogtalkradio.com/pharmatalk/2020/02/18/how-to-integrate-industry-sponsored-clinical-trials-into-your-health-systemTue, 18 Feb 2020 13:00:00 +0000Conference ForumIn this podcast, you will hear a session from the 2019 Clinical Research as a Care Option (CRAACO) conference on How to Integrate Industry-Sponsored Clinical Trials Into Your Health System to Give Patients the Best Options. Points include, How to...1348clinical care,clinical research,clinical trials,craaco,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/how-sanford-health-systems-increased-clinical-trial-participation-to-10--63245377http://www.blogtalkradio.com/pharmatalk/2020/02/17/how-sanford-health-systems-increased-clinical-trial-participation-to-10Mon, 17 Feb 2020 13:00:00 +0000Conference ForumIn this podcast, you will hear a case study presentation from the 2019 Clinical Research as a Care Option (CRAACO) conference on how Sanford Health Systems has increased their clinical trial participation from 3% to 10% over the last 8 years by...1679clinical care,clinical research,clinical trials,healthcare,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/keynote-surgeon-s-perspective-on-integrating-clinical-care-clinical-research--63245391http://www.blogtalkradio.com/pharmatalk/2020/02/14/keynote-surgeons-perspective-on-integrating-clinical-care-clinical-researchFri, 14 Feb 2020 13:00:00 +0000Conference ForumIn this podcast, you will hear a keynote presentation from the 2019 Clinical Research as a Care Option (CRAACO) conference. Dr Laura Esserman, the architect behind the I-SPY 2 TRIALTM has achieved remarkable progress with this clinical trial in...2355clinical care,clinical research,clinical trials,craaco,ucsffalsefullhttps://www.spreaker.com/episode/how-wilmington-health-is-streamlining-integration-of-clinical-research-care--63245372http://www.blogtalkradio.com/pharmatalk/2020/02/13/how-wilmington-health-is-streamlining-integration-of-clinical-research-careThu, 13 Feb 2020 14:30:00 +0000Conference ForumIn this podcast, you will hear a session from the 2019 Clinical Research as a Care Option (CRAACO) conference. Jeff James, CEO of Wilmington Health, presented a case study on how they are streamlining the processes behind integrating clinical care and...1819clinical care,clinical research,clinical trials,craaco,healthcarefalsefullhttps://www.spreaker.com/episode/addressing-barriers-health-systems-face-in-integrating-clinical-care-research--63245375http://www.blogtalkradio.com/pharmatalk/2020/02/12/addressing-barriers-health-systems-face-in-integrating-clinical-care-researchWed, 12 Feb 2020 13:00:00 +0000Conference ForumAt the 2019 Clinical Research as a Care Option (CRAACO) conference, a panel discussed Barriers Health Systems Face in Integrating Clinical Care & Research, including: Financial barriers – Speaking to administration’s bottom lineHistorical barriers...1478clinical care,clinical research,clinical trials,craaco,healthcarefalsefullhttps://www.spreaker.com/episode/effectively-democratizing-access-to-clinical-trials-for-all--63245393http://www.blogtalkradio.com/pharmatalk/2020/02/11/effectively-democratizing-access-to-clinical-trials-for-allTue, 11 Feb 2020 13:00:00 +0000Conference ForumIn this podcast, you will hear a discussion from the 2019 Clinical Research as a Care Option (CRAACO) conference on Effectively Democratizing Access to Clinical Trials. This panel covers how making clinical research a care option is the ultimate...1666clinical research,clinical trials,craaco,healthcare,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/delivering-an-innovative-patient-centric-delivery-system--63245380http://www.blogtalkradio.com/pharmatalk/2020/02/06/delivering-an-innovative-patient-centric-delivery-systemThu, 06 Feb 2020 16:30:00 +0000Conference ForumA new way of doing business was required to achieve the mission of serving patients suffering from rheumatoid arthritis. In this podcast, first recorded at the 2nd annual Drug Delivery West conference, William (Bill) Rich, Amgen and Daniele Fazio,...1310amgen,drug delivery,drug delivery west,flex,rheumatoid arthritisfalsefullhttps://www.spreaker.com/episode/ophthalmology-exploring-other-routes-of-administration--63245500http://www.blogtalkradio.com/pharmatalk/2020/02/06/ophthalmology-exploring-other-routes-of-administrationThu, 06 Feb 2020 14:30:00 +0000Conference ForumIn this podcast, first recorded at the 2nd annual Drug Delivery West conference, Dr James Cunningham, Allergan leads a panel on exploring other routes of administration for ophthalmology. Discussion points include: Barries/challenges associated with...2568allergan,drug delivery,drug delivery west,novartis,ophthalmologyfalsefullhttps://www.spreaker.com/episode/transforming-cardiovascular-treatment-with-pulmonary-delivery--63245401http://www.blogtalkradio.com/pharmatalk/2020/02/05/transforming-cardiovascular-treatment-with-pulmonary-deliveryWed, 05 Feb 2020 19:00:00 +0000Conference ForumFirst recorded at the 2nd annual Drug Delivery West conference, Dr Carlos Schuler, InCarda Therapeutics discusses transforming cardiovascular treatment with pulmonary delivery. This podcast discusses: Pioneering a novel approach for treating...939cardiovascular treatment,drug delivery,drug delivery west,incarda therapeutics,pulmonary deliveryfalsefullhttps://www.spreaker.com/episode/mri-guided-focused-ultrasound-and-the-delivery-of-therapeutics-to-the-brain--63245352http://www.blogtalkradio.com/pharmatalk/2020/02/05/mri-guided-focused-ultrasound-and-the-delivery-of-therapeutics-to-the-brainWed, 05 Feb 2020 14:30:00 +0000Conference ForumIn this podcast, first recorded at the 2nd annual Drug Delivery West conference, Dr Isabelle Aubert, University of Toronto, provides an introduction to MRI-guided focused ultrasound (MRIgFUS) and reviews applications in preclinical models of...1895dr isabell aubert,drug delivery,drug delivery west,mrigfus,university of torontofalsefullhttps://www.spreaker.com/episode/better-strategies-to-inform-patients-on-clinical-research-trial-participation--63245381http://www.blogtalkradio.com/pharmatalk/2020/01/23/better-strategies-to-inform-patients-on-clinical-research-trial-participationThu, 23 Jan 2020 14:30:00 +0000Conference ForumBringing clinical research as a care option to patients is arguably the greatest change we can collaborate on to give patients the best choices of care and to help make clinical trial options easier for providers to access. This panel, moderated by Dr...2391clinical research,clinical trial,craaco,patients as partners us,trial participationfalsefullhttps://www.spreaker.com/episode/chief-patient-advocate-officer-driving-culture-change-from-the-top-down--63245399http://www.blogtalkradio.com/pharmatalk/2020/01/23/chief-patient-advocateofficer-driving-culture-change-from-the-top-downThu, 23 Jan 2020 14:00:00 +0000Conference ForumIn this fireside chat, moderated by Ken Getz, Tufts CSDD/CISCRP and recorded at the 6th annual Patients as Partners US conference discusses the following: How do you create a culture that enables new strategic, operating and organizational models to...1865chief patient advocate,chief patient officer,patient-centric,patient involvement,patients as partners usfalsefullhttps://www.spreaker.com/episode/how-novartis-includes-patient-input-into-all-aspects-of-a-clinical-study--63245350http://www.blogtalkradio.com/pharmatalk/2020/01/22/how-novartis-includes-patient-input-into-all-aspects-of-a-clinical-studyWed, 22 Jan 2020 14:30:00 +0000Conference ForumThis case study presented by Thérèse Johnsen, Novartis and first recorded at the 6th annual Patients as Partners US conference, discusses how the patient perspective was included from the earliest planning of a clinical trial and how it impacted the...1427clinical trial,clinical trial design,patient perspective,patients as partners us,patient voicefalsefullhttps://www.spreaker.com/episode/patients-as-partners-in-clinical-research-eu-5-min-upcoming-conf-summary--63245396http://www.blogtalkradio.com/pharmatalk/2020/01/06/patients-as-partners-in-clinical-research-eu-5-min-upcoming-conf-summaryMon, 06 Jan 2020 05:00:00 +0000Conference ForumThis 5 minute podcast summary helps prepare listeners on what they can expect at the4th Annual Patients as Partners Europe event, taking place January 27th and 28th in London. The venue is the Millennium Gloucester Hotel. In a nutshell, Patient as...394clinical trials,patient-centricity,patient recruitment,patients as partners eu,patients as partners europefalsefullhttps://www.spreaker.com/episode/partnering-with-patients-on-clinical-development-protocols--63245411http://www.blogtalkradio.com/pharmatalk/2019/12/20/partnering-with-patients-on-clinical-development-protocolsFri, 20 Dec 2019 20:00:00 +0000Conference ForumLinda Kollmar, Executive Director, Scientific Medical Patient Perspective - Oncology, Merck, shares with the audience at the 6th annual Patients as Partners US conference, Merck's strategy for bringing on a patient, as an equal stakeholder of their...1101clinical trial design,merck,patient perspective,patients as partners,patients as partners usfalsefullhttps://www.spreaker.com/episode/improving-clinical-research-and-trials-through-pharma-advocacy-partnerships--63245429http://www.blogtalkradio.com/pharmatalk/2019/12/19/improving-clinical-research-and-trials-through-pharmaadvocacy-partnershipsThu, 19 Dec 2019 21:00:00 +0000Conference ForumThis podcast moderated by Mary Murray, BMS and recorded at the 6th annual Patients as Partners US conference discusses Improving Clinical Research and Trials Though Effective Pharma/Advocacy Partnerships. Topics include: What are the key elements...2528clinical research,clinical trials,patient engagement,patients as partners,patients as partners usfalsefullhttps://www.spreaker.com/episode/engaging-with-communities-to-educate-and-enroll-diverse-populations--63245367http://www.blogtalkradio.com/pharmatalk/2019/12/19/engaging-with-communities-to-educate-and-enroll-diverse-populationsThu, 19 Dec 2019 14:00:00 +0000Conference ForumThis podcast, first recorded at the 6th annual Patients as Partners US conference and moderated by Jan Nissen, Merck discusses the complexities of diversity and waht actions we can take to raise clinical trial awareness and enrollment that is...2373clinical trial awareness,clinical trials,patients as partners,patients as partners usfalsefullhttps://www.spreaker.com/episode/mapping-out-the-patient-decision-journey--63245357http://www.blogtalkradio.com/pharmatalk/2019/12/18/mapping-out-the-patient-decision-journeyWed, 18 Dec 2019 13:30:00 +0000Conference ForumIf you truly want to bring patients in as stakeholders, we have to start at the beginning by understanding patients, their lifestyles and how the trial protocols are developed to reflect that. This session moderated by Dr Marilyn Metcalf, GSK...2110clinical trial participation,clinical trials,patient decision,patients as partners,patients as partners usfalsefullhttps://www.spreaker.com/episode/fda-patient-engagement-synergistic-efforts--63245379http://www.blogtalkradio.com/pharmatalk/2019/12/17/fda-patient-engagement-synergistic-effortsTue, 17 Dec 2019 15:00:00 +0000Conference ForumThis multi-center FDA podcast moderated by Anindita Saha, (CDRH) FDA and first recorded at the 6th annual Patients as Partners US conference, focuses on patient engagement and regulatory decision making. This podcast discusses: What is each center...2600fda,patient engagement,patients as partners,patients as partners us,regulatory decision makingfalsefullhttps://www.spreaker.com/episode/the-democratization-of-patient-data-ownership-returning-results--63245398http://www.blogtalkradio.com/pharmatalk/2019/12/16/the-democratization-of-patient-data-ownership-returning-resultsMon, 16 Dec 2019 13:30:00 +0000Conference ForumIn this series, first recorded at the 6th annual Patients as Partners US conference, is led by Craig Lipset, formerly with Pfizer discusses the ideas of patients 'donating' data, patient data ownership, data rights, and why this is a disruptive force...4243clinical trials,data rights,patient data ownership,patients as partners,patients as partners usfalsefullhttps://www.spreaker.com/episode/cell-gene-therapy-day-overview-in-4-minutes--63245410http://www.blogtalkradio.com/pharmatalk/2019/12/04/cell-gene-therapy-day-overview-in-4-minutesWed, 04 Dec 2019 16:30:00 +0000Conference ForumIn this podcast, Kate Woda, Conference Director provides an overview of Cell & Gene Therapy Day in less than 4 minutes. Cell & Gene Therapy Day takes place on February 27, 2020 in New York City and convenes stakeholders spanning the science...186cell & gene therapy day,cell therapy,gene therapy,immuno-oncology,io360falsefullhttps://www.spreaker.com/episode/2020-immuno-oncology-360-summit-overview-in-10-minutes--63245355http://www.blogtalkradio.com/pharmatalk/2019/12/04/2020-immuno-oncology-360-summit-overview-in-10-minutesWed, 04 Dec 2019 15:30:00 +0000Conference ForumIn this 10 minute podcast, Kate Woda, Conference Director for IO360°, walks you through what to expect at 2020 IO360° Summit happening February 26-28, 2020 in New York City. IO360°convenes stakeholders spanning the science and business communities to...617allogene,citi,immuno-oncology 360,io360,stanford universityfalsefullhttps://www.spreaker.com/episode/fireside-chat-with-an-r-d-veteran--63245383http://www.blogtalkradio.com/pharmatalk/2019/12/03/fireside-chat-with-an-rd-veteranTue, 03 Dec 2019 17:30:00 +0000Conference ForumDr Jeffrey Chodakewitz, former EVP, Clinical Medicine and External Innovation, CMO at Vertex Pharmaceuticals, joins the Chief Medical Officer Summit for the first time to discuss his incredible journey as a CMO. Recorded at the 7th annual Chief...2090amag pharmaceuticals,chief medical officer,chief medical officer summit,cmo,vertex pharmaceuticalsfalsefullhttps://www.spreaker.com/episode/designing-clinical-trials-for-gene-therapy-a-paradigm-shift--63245432http://www.blogtalkradio.com/pharmatalk/2019/12/03/designing-clinical-trials-for-gene-therapy--a-paradigm-shiftTue, 03 Dec 2019 13:00:00 +0000Conference ForumThis session, recorded at the 7th annual Chief Medical Officer Summit and moderated by Dr Martin Childers, Asklepios BioPharmaceutical, discusses designing clinical trials for gene therapy. Topics covered include: How to utilize adaptive trial design...2425chief medical officer,chief medical officer summit,clinical trials,cmo,gene therapyfalsefullhttps://www.spreaker.com/episode/case-study-life-of-a-chief-medical-officer-pre-and-post-ipo--63245402http://www.blogtalkradio.com/pharmatalk/2019/12/02/case-study-life-of-a-chief-medical-officer-pre-and-post-ipoMon, 02 Dec 2019 18:30:00 +0000Conference ForumIn this talk, first recorded at the 7th annual Chief Medical Officer Summit, Dr Tal Zaks, Chief Medical Officer, Moderna Therapeutics shares his experience and lessons learned through one of the biggest transitions a Chief Medical Officer can make in...1907business development,chief medical officer,chief medical officer summit,clinical trials,moderna therapeuticsfalsefullhttps://www.spreaker.com/episode/how-the-cmo-of-sage-therapeutics-positioned-a-new-indication-for-fda-approval--63245442http://www.blogtalkradio.com/pharmatalk/2019/12/02/how-the-cmo-of-sage-therapeutics-positioned-a-new-indication-for-fda-approvalMon, 02 Dec 2019 13:00:00 +0000Conference ForumIn this session recorded at the 7th annual Chief Medical Officer Summit, Dr Steve Kanes, Chief Medical Officer, Sage Therapeutics, discusses how a company considered as an "up and comer" in the Cambridge biotech sector navigated the development and...2199biotech,chief medical officer,chief medical officer summit,fda,sage therapeuticsfalsefullhttps://www.spreaker.com/episode/addressing-the-talent-gap-in-biotech-recruit-and-retain--63245361http://www.blogtalkradio.com/pharmatalk/2019/12/02/addressing-the-talent-gap-in-biotech--recruit-and-retainMon, 02 Dec 2019 01:00:00 +0000Conference ForumIn an increasingly competitive market, there is a growing need for efficiency in attracting and retaining top talent. This session, recorded at the 7th annual Chief Medical Officer Summit, and moderated by Dr Julie Krop, AMAG Pharmaceuticals,...2232amag pharmaceuticals,chief medical officer,chief medical officer summit,cmo,recruitingfalsefullhttps://www.spreaker.com/episode/how-to-navigate-the-development-path-from-cmo-to-ceo--63245400http://www.blogtalkradio.com/pharmatalk/2019/12/01/how-to-navigate-the-development-path-from-cmo-to-ceoSun, 01 Dec 2019 18:00:00 +0000Conference ForumFirst recorded at the 7th annual Chief Medical Officer Summit, this session provides insight in what it takes and how to navigate and what to expect in the CEO role. Moderated by Dr Zain Kassam, Finch Therapeutics, this panel discusses: How can a CMO...1715ceo,chief medical officer,chief medical officer summit,cmo,finch therapeuticsfalsefullhttps://www.spreaker.com/episode/how-do-patients-become-partners-in-the-sharing-of-data-to-advance-science--63245414http://www.blogtalkradio.com/pharmatalk/2019/11/06/how-do-patients-become-partners-in-the-sharing-of-data-to-advance-scienceWed, 06 Nov 2019 13:00:00 +0000Conference ForumIn this podcast, hear a session from the 2019 Patients as Partners EU conference on How do Patients Become Partners in the Sharing of Data to Advance Science? How to encourage the sharing of suitably anonymized data to further medicines development...1349conference,data sharing,london,patient advocacy,patient engagementfalsefullhttps://www.spreaker.com/episode/best-practices-for-pharma-patient-advocacy-partnerships--63245387http://www.blogtalkradio.com/pharmatalk/2019/11/05/best-practices-for-pharma--patient-advocacy-partnershipsTue, 05 Nov 2019 13:00:00 +0000Conference ForumIn this podcast, hear a panel discussion presented at the 2019 Patients as Partners EU conference on Best Practices for Pharma - Patient Advocacy Partnerships.  Pharma and advocacy representatives discuss: • Advocacy point of view on is what pharma...1575patient advocacy,patient centricity,patient engagement,r&d,research and developmentfalsefullhttps://www.spreaker.com/episode/merck-s-next-phase-of-patient-centricity-in-r-d--63245425http://www.blogtalkradio.com/pharmatalk/2019/11/04/mercks-next-phase-of-patient-centricity-in-rdMon, 04 Nov 2019 13:00:00 +0000Conference ForumIn this podcast, hear a session from the 2019 Patients as Partners EU meeting where Merck's Vanessa Pott presented a case study on Innovative Medicines Development and Merck KGaA's next phase of Patient Centricity in R&D.  The 4th annual Patients...1345merck,patient advocacy,patient engagement,r&d,research and developmentfalsefullhttps://www.spreaker.com/episode/clinical-update-on-amg-420-an-anti-bcma-bite--63245433http://www.blogtalkradio.com/pharmatalk/2019/11/01/clinical-update-on-amg-420-an-anti-bcma-biteFri, 01 Nov 2019 16:00:00 +0000Conference ForumIn this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE® This talk addresses the: Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human...1397amgen,bcma bite,immuno-oncology,immuno-oncology 360,io360falsefullhttps://www.spreaker.com/episode/connecting-employee-centric-culture-to-patient-centric-culture--63245370http://www.blogtalkradio.com/pharmatalk/2019/11/01/connecting-employee-centric-culture-to-patient-centric-cultureFri, 01 Nov 2019 12:00:00 +0000Conference ForumAt the 2019 Patients as Partners EU meeting, Servier's Lode Dewulf presented a discussion on connecting employee-centric culture to patient-centric culture. This presentation covered the following points: • What impact can engaged employees have on...1207drug development,patient advocacy,patient engagement,research and developmentfalsefullhttps://www.spreaker.com/episode/eliciting-patient-experience-data-to-understand-medicines-benefits-disadvantages--63245382http://www.blogtalkradio.com/pharmatalk/2019/10/31/eliciting-patient-experience-data-to-understand-medicines-benefitsdisadvantagesThu, 31 Oct 2019 12:00:00 +0000Conference ForumIn this podcast, listen to a session from the 2019 Patients as Partners EU conference on Sanofi Eliciting Patient Experience Data During Clinical Trials to Better Understand Patient-Perceived Benefits and Disadvantages of their Drugs. Dr Aude Roborel...1205clinical operations,clinical trials,patient advocacy,patient engagement,sanofifalsefullhttps://www.spreaker.com/episode/understanding-the-language-of-patients-the-value-of-health-literacy--63245436http://www.blogtalkradio.com/pharmatalk/2019/10/30/understanding-the-language-of-patients--the-value-of-health-literacyWed, 30 Oct 2019 12:00:00 +0000Conference ForumIn this podcast, hear a session presented at the 2019 Patients as Partners EU conference on the Process to Understand the Language of Patients and the Value of Health Literacy. Who is responsible for delivering the why and how of getting involved in...1275clinical research,clinical trials,drug development,patient advocacy,patient engagementfalsefullhttps://www.spreaker.com/episode/ucb-and-parkinson-s-uk-collaboration-improve-a-trial-through-patient-involvement--63245403http://www.blogtalkradio.com/pharmatalk/2019/10/29/ucb-and-parkinsons-uk-collaboration-improve-a-trial-through-patient-involvementTue, 29 Oct 2019 12:00:00 +0000Conference ForumIn this podcast, hear a case study from the 2019 Patients as Partners EU conference on UCB and Parkinson's UK Working Together to Improve a Phase 2 Trial through Patient Involvement. In 2018, UCB and Parkinson’s UK co-developed a workshop to enable...1961conference,london,patient advocacy,patient engagement,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/improving-t-cell-therapies-via-next-generation-technologies--63245365http://www.blogtalkradio.com/pharmatalk/2019/10/17/improving-t-cell-therapies-via-next-generation-technologiesThu, 17 Oct 2019 04:00:00 +0000Conference ForumThe pipeline of adoptive T-cell therapies and other cell based immuno-oncology programs continues to expand with a number of modifications and improvements to the first generation programs. These platforms include improved spcificty and delivery -...2900immuno-oncology 360,io360,io therapeutics,t-cell therapies,tumor microenvironmentfalsefullhttps://www.spreaker.com/episode/monetizing-science-turning-an-asset-into-value-through-ipos--63245416http://www.blogtalkradio.com/pharmatalk/2019/10/16/monetizing-science-turning-an-asset-into-value-through-iposWed, 16 Oct 2019 17:30:00 +0000Conference ForumThis panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. ...2142immuno-oncology,immuno-oncology 360,io360,ipofalsefullhttps://www.spreaker.com/episode/ido-changes-the-t-cell-balance-in-the-tumor-microenvironment--63245441http://www.blogtalkradio.com/pharmatalk/2019/10/16/ido-changes-the-t-cell-balance-in-the-tumor-microenvironmentWed, 16 Oct 2019 16:30:00 +0000Conference ForumIn this talk recorded at the 5th annual IO360° Summit, Dr Charles Link Jr, Newlink Genetics, addresses how IDO changes the T-cell balance in the tumor microenvironment. This talk addresses how: IDO creates local immunosuppression by increasing T...986immuno-oncology 360,immunosuppression,io360,pdl-1,t-cellsfalsefullhttps://www.spreaker.com/episode/insights-from-deal-trends-betting-on-tumor-immunology--63245385http://www.blogtalkradio.com/pharmatalk/2019/08/29/insights-from-deal-trends-betting-on-tumor-immunologyThu, 29 Aug 2019 18:30:00 +0000Conference ForumIn this podcast from the 2019 Immuno-Oncology 360° conference, Cello Health BioConsulting's EVP, Oncology Practice Head, Dr Jeff Bockman discusses deal-making and investments in the I-O space to see what can be learned about the expanding and...1319cello health bioconsulting,immuno-oncology 360,investments,io360,jeff bockmanfalsefullhttps://www.spreaker.com/episode/living-with-alzheimer-s-from-a-young-patient-s-perspective--63245388http://www.blogtalkradio.com/pharmatalk/2019/08/23/living-with-alzheimers-from-a-young-patients-perspectiveFri, 23 Aug 2019 17:30:00 +0000Conference ForumPharma Talk Radio producer, Valerie Bowling recently spoke with a young Alzheimer's patient, Jeff Borghoff. Jeff was officially diagnosed with Alzheimers in 2016 and is an active and patiionate patient advocate. Jeff generously shares his experience...1117alzheimers,clinical research,clinical trials,dementia,patients as partnersfalsefullhttps://www.spreaker.com/episode/organizational-and-digital-restructuring-to-scale-mobile-clinical-trials--63245390http://www.blogtalkradio.com/pharmatalk/2019/08/23/organizational-and-digital-restructuring-to-scale-mobile-clinical-trialsFri, 23 Aug 2019 13:00:00 +0000Conference ForumIn this podcast from the 2018 Mobile in Clinical Trials conference, Mohammad Ali, Global Head Digital Trials- Global Clinical Operations, Boehringer-Ingelhiem and Joe Dustin, Principal, Mobile Health, Medidata Solutions discussed the internal...1293clinical operations,clinical sites,digital health,mobile in clinical trials,scalingfalsefullhttps://www.spreaker.com/episode/how-to-align-the-promise-of-technology-with-the-patient-voice--63245450http://www.blogtalkradio.com/pharmatalk/2019/08/22/how-to-align-the-promise-of-technology-with-the-patient-voiceThu, 22 Aug 2019 21:30:00 +0000Conference ForumIn this podcast from the 2018 Mobile in Clinical Trials conference, patient advocate, Cindy Geoghegan sat down with Dr Daniel Karlin, CEO, Healthmode and Deanna Lennon, Director of Business Development, Medable Inc for a discussion on aligning the...2093clinical operations,clinical sites,digital health,mobile in clinical trials,patients voicefalsefullhttps://www.spreaker.com/episode/the-role-of-digital-biomarkers-and-the-impact-on-drug-delivery--63245415http://www.blogtalkradio.com/pharmatalk/2019/08/22/the-role-of-digital-biomarkers-and-the-impact-on-drug-deliveryThu, 22 Aug 2019 16:30:00 +0000Conference ForumIn this podcast from the 2018 PODD: Partnership Opportunities in Drug Delivery conference, Dr Christopher Kovalchick, Chief Engineer, Drug Delivery & Devices R&D Innovation at Eli Lilly and Company presented on incorporating of digital...1069digital biomarkers,drug delivery,eli lilly and company,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/podd-partnership-opportunities-in-drug-delivery-2019-overview-in-4-minutes--63245438http://www.blogtalkradio.com/pharmatalk/2019/08/20/podd-partnership-opportunities-in-drug-delivery-2019-overview-in-4-minutesTue, 20 Aug 2019 15:00:00 +0000Conference ForumIn this podcast, Valerie Bowling, Director of PODD, walks you through what to expect at PODD 2019 in under 4 minutes. The 9th annual PODD conference features the following: Building a Company around a Transformative Drug Delivery Invention with MIT's...245business development,drug delivery,drug delivery solutions,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/a-patient-perspective-on-living-with-parkinson-s-disease-and-the-gdnf-trial--63245364http://www.blogtalkradio.com/pharmatalk/2019/08/19/a-patient-perspective-on-living-with-parkinsons-disease-and-the-gdnf-trialMon, 19 Aug 2019 15:00:00 +0000Conference ForumIt is estimated that between 7-10 million people, globally have Parkinson's disease.  Our guest on Pharma Talk Radio, Lesley Gosden is living with Parkinsons and she is an outstanding patient advocate, who experienced the GDNF clinical trial. In this...1499clinical research,clinical trials,parkinson's disease,patients as partners eu,pharma talk radiofalsefullhttps://www.spreaker.com/episode/the-future-of-mobile-data-in-clinical-trials-challenges-and-opportunities--63245446http://www.blogtalkradio.com/pharmatalk/2019/08/15/the-future-of-mobile-data-in-clinical-trials-challenges-and-opportunitiesThu, 15 Aug 2019 17:30:00 +0000Conference ForumIn this podcast from the 2018 Mobile in Clinical Trials conference, Dr Paul Glimcher, Julius Silver Professor of Neural Science and Physiology at NYU alongside Dr Daniel Karlin, CEO at Healthmode presented on the future of mobile data in clinical...959clinical operations,clinical sites,digital health,mobile in clinical trialsfalsefullhttps://www.spreaker.com/episode/eli-lilly-how-to-launch-multiple-mobile-devices-in-a-hybrid-setting--63245405http://www.blogtalkradio.com/pharmatalk/2019/08/15/eli-lilly-how-to-launch-multiple-mobile-devices-in-a-hybrid-settingThu, 15 Aug 2019 17:00:00 +0000Conference ForumIn this podcast from the 2018 Mobile in Clinical Trials conference, Eli Lilly's Joseph Kim, Sr Advisor, Clinical Operations and Digital Registry, Digital Health Office | Translational Technology & Innovation, reported on incorporating a variety of...1623clinical operations,clinical sites,mobile in clinical trialsfalsefullhttps://www.spreaker.com/episode/pfizer-s-atopic-dermatitis-clinical-trial-with-digital-wearable-technology--63245373http://www.blogtalkradio.com/pharmatalk/2019/08/08/pfizers-atopic-dermatitis-clinical-trial-with-digital-wearable-technology-1Thu, 08 Aug 2019 14:00:00 +0000Conference ForumIn this podcast from Mobile in Clinical Trials 2018, Pfizer's Project Team Lead, Early Clinical Development, Digital Medicine, Dr Carrie Northcott speaks about considerations and lessons learned from the validation, verification and use of digital...1339atopic dermatitis,clinical operations,clinical sites,mobile in clinical trialsfalsefullhttps://www.spreaker.com/episode/merck-s-digital-health-and-al-strategy-progress-report--63245449http://www.blogtalkradio.com/pharmatalk/2019/08/07/mercks-digital-health-and-al-strategy-progress-reportWed, 07 Aug 2019 14:00:00 +0000Conference ForumIn this session presented at the Mobile in Clinical Trials 2018 conference, Merck's Kai Bode and Jyoti Shah share an exciting update on the company's progress in implementing a digital health and AI strategy. Session takeaways include: What Merck is...866clinical operations,clinical sites,digital health,mobile in clinical trials,patients in clinical trialsfalsefullhttps://www.spreaker.com/episode/how-digital-biomarker-innovation-is-modernizing-clinical-endpoints--63245447http://www.blogtalkradio.com/pharmatalk/2019/07/31/how-digital-biomarker-innovation-is-modernizing-clinical-endpointsWed, 31 Jul 2019 12:00:00 +0000Conference ForumIn this session from DPharm 2018, Roche provides an update on the company's progress in how they are collecting data with sensor technology and turning it into a clinically meaningful endpoint with multiple indications, including Parkinson's disease...961biomarkers,clinical research,dpharmfalsefullhttps://www.spreaker.com/episode/regenerative-medicine-as-a-disrupter-in-clinical-trials--63245395http://www.blogtalkradio.com/pharmatalk/2019/07/30/regenerative-medicine-as-a-disrupter-in-clinical-trialsTue, 30 Jul 2019 12:00:00 +0000Conference ForumThis is a keynote session from DPharm 2018. Dr Atala, a renowned key opinion leader on the topic of regenerative medicine, brings the DPharm audience a fascinating presentation on how it's possible to reduce the number of patients needed in clinical...1876clinical trials,dpharm,regenerative medicinefalsefullhttps://www.spreaker.com/episode/6th-annual-mobile-in-clinical-trials-what-to-expect-in-4-minutes--63245457http://www.blogtalkradio.com/pharmatalk/2019/07/29/6th-annual-mobile-in-clinical-trials-what-to-expect-in-4-minutesMon, 29 Jul 2019 14:00:00 +0000Conference ForumThis 4 minute podcast summarizes what you can expect at the 6th annual Mobile in Clinical Trials conference. This event provides sessions on the latest progress in applying mobile applications and patient-facing technologies to connect and empower...236clinical operations,mobile in clinical trials,patients in clinical trials,reducing patient burden,wearables in clinical trialsfalsefullhttps://www.spreaker.com/episode/estonia-the-digital-republic-where-patients-own-their-data--63245404http://www.blogtalkradio.com/pharmatalk/2019/07/29/estonia-the-digital-republic-where-patients-own-their-dataMon, 29 Jul 2019 12:00:00 +0000Conference ForumAn Insight into Our Possible Future Faster than You Think This keynote session was presented at the 2018 DPharm conference. Estonia is now a digital republic with a virtual government, blockchained and secure. Our keynote guest from Estonia tells us...2112dpharm,estonia,patient datafalsefullhttps://www.spreaker.com/episode/co-creating-the-industry-s-scalable-solution-for-ehr--63245454http://www.blogtalkradio.com/pharmatalk/2019/07/28/co-creating-the-industrys-scalable-solution-for-ehrSun, 28 Jul 2019 12:00:00 +0000Conference ForumIn this session presented at the 2018 DPharm conference, Rob Goodwin and Amy Nordo share an exciting new collaboration - including industry and academia, as well as health authorities and leading technologists - positioned to break through the...1705clinical research,clinical trials,dpharm,duke,pfizerfalsefullhttps://www.spreaker.com/episode/bringing-blockchain-to-life-digitizing-clinical-supply-chain-in-trials--63245455http://www.blogtalkradio.com/pharmatalk/2019/07/27/bringing-blockchain-to-life-digitizing-clinical-supply-chain-in-trialsSat, 27 Jul 2019 13:00:00 +0000Conference ForumIn this podcast from DPharm 2018, Pfizer's VP of Clinical Supply Chain, Michael Ku, speaks about some of Pfizer's earliest work making blockchain real as well as some of their forward-leaning work digitizing supply chain for clinical trials. The 9th...1285blockchain,clinical trials,dpharm,pfizerfalsefullhttps://www.spreaker.com/episode/bayer-virtual-assistants-for-sites-and-patients-in-clinical-trials--63245413http://www.blogtalkradio.com/pharmatalk/2019/07/26/bayer-virtual-assistants-for-sites-and-patients-in-clinical-trialsFri, 26 Jul 2019 12:00:00 +0000Conference ForumIn this podcast from DPharm 2018, Bayer shares how they use virtual assistants and chatbots to support study teams, research sites, and patients. Learn how they are doing this and what you should consider. Speaker: Michelle Shogren, Head of...886bayer,chatbots,clinical research,dpharm,virtual assistantfalsefullhttps://www.spreaker.com/episode/dpharm-disruptive-innovations-in-clinical-trials-2019-overview-in-5-minutes--63245452http://www.blogtalkradio.com/pharmatalk/2019/07/25/dpharm-disruptive-innovations-in-clinical-trials-2019-overview-in-5-minutesThu, 25 Jul 2019 13:00:00 +0000Conference ForumIn this podcast, Valerie Bowling, Director of DPharm, walks you through what to expect at DPharm 2019 in under 5 minutes. This is the 9th annual DPharm conference featuring keynotes from: Dr Scott Gottlieb, 23rd Commissioner of the FDATakeda’s CMO, Dr...293clinical research,dpharm,innovation,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/entrepreneur-data-scientist-ben-liu-on-solving-bottlenecks-in-clinical-research--63245427http://www.blogtalkradio.com/pharmatalk/2019/07/23/entrepreneur-data-scientist-ben-liu-on-solving-bottlenecks-in-clinical-researchTue, 23 Jul 2019 23:00:00 +0000Conference ForumTrialspark, CEO, Dr Ben Liu recently sat down with Valerie Bowling, Executive Director of DPharm in a podcast discussion.  Valerie checked in with Ben on the progress of life as a data science entrepreneur. They also discussed how Ben and his team are...1132clinical research,clinical trials,data science,entrepreneur,medicine developmentfalsefullhttps://www.spreaker.com/episode/stories-from-bioinspiration-to-innovation--63245464http://www.blogtalkradio.com/pharmatalk/2019/07/22/stories-from-bioinspiration-to-innovationMon, 22 Jul 2019 13:30:00 +0000Conference ForumWhen developing technologies to solve medical problems, one often encounters significant hurdles, that at times seems insurmountable. In this discussion, recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Dr...1632brigham and women's hospital,harvard medical school,jeffrey karp,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/including-wellness-in-the-pharma-model-how-drug-delivery-will-be-a-key-enabler--63245430http://www.blogtalkradio.com/pharmatalk/2019/07/21/including-wellness-in-the-pharma-model--how-drug-delivery-will-be-a-key-enablerSun, 21 Jul 2019 13:30:00 +0000Conference ForumIn this industry keynote recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Justin Wright, PhD, Global Head of Innovation, Novartis, discusses how the transformation from traditional drugs to next-generation...1446drug delivery,justin wright,novartis,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/service-patients-in-clinical-trials--63245437http://www.blogtalkradio.com/pharmatalk/2019/07/21/service-patients-in-clinical-trialsSun, 21 Jul 2019 12:00:00 +0000Conference ForumIn this podcast from DPharm 2018, Chip Bell shows pragmatic ways to change our culture to support service-oriented thinking that benefits patients and investigators. The patient's expectations are being quickly changed today by disruptors far beyond...2740clinical trials,dpharm,patient experiencefalsefullhttps://www.spreaker.com/episode/panel-delivering-mrna-drugs-and-vaccines-progress-and-future-outlook--63245493http://www.blogtalkradio.com/pharmatalk/2019/07/20/panel-delivering-mrna-drugs-and-vaccines-progress-and-future-outlookSat, 20 Jul 2019 15:00:00 +0000Conference ForumModerated by Marian Gindy, PhD, Executive Director, Discovery Pharmaceutical Sciences, Merck, this panel discussion recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference explores how mRNA vaccines represent a...2190drug delivery,merck,mrna,partnership opportunities in d,poddfalsefullhttps://www.spreaker.com/episode/how-to-innovate-like-amazon-to-modernize-clinical-trials--63245445http://www.blogtalkradio.com/pharmatalk/2019/07/11/how-to-innovate-like-amazon-to-modernize-clinical-trialsThu, 11 Jul 2019 12:00:00 +0000Conference ForumThis session was presented at the 8th annual DPharm conference in September 2018. When Amazon announced that the creation of a new healthcare company with Berkshire Hathaway and JPMorgan Chase, the move signaled how the company is stepping into the...2398amazon,clinical trials,innovationfalsefullhttps://www.spreaker.com/episode/alzheimer-s-studies-exploring-registries-to-improve-enrollment-trial-design--63245439http://www.blogtalkradio.com/pharmatalk/2019/06/25/alzheimers-studies-exploring-registries-to-improve-enrollment-trial-designTue, 25 Jun 2019 15:30:00 +0000Conference ForumRoughly, 5.7 million people in the U.S. are living with Alzheimer’s. Globally, an estimated 47 million individuals are living with dementia. There is no cure, and treatments can only relieve certain symptoms for some people. Research studies so far...1749alzheimers,alzheimer’s studies,clinical research,clinical trials,patient registriesfalsefullhttps://www.spreaker.com/episode/4th-annual-io-combinations-360-what-to-expect-in-8-minutes--63245428http://www.blogtalkradio.com/pharmatalk/2019/05/23/4th-annual-io-combinations-360-what-to-expect-in-8-minutesThu, 23 May 2019 14:00:00 +0000Conference ForumThis 8 minute podcast summarizes what you can expect at the 4th annual IO Combinations 360° conference. This conference provides the latest data impacting immuno-oncology combinations and patient treatment with perspectives from science, clinical and...476biomarkers,cell therapy,immuno-oncology,io,io combinationsfalsefullhttps://www.spreaker.com/episode/car-t-therapy-optimization-through-engineering-t-cells-or-combinations--63245386http://www.blogtalkradio.com/pharmatalk/2019/05/02/car-t-therapy-optimization-through-engineering-t-cells-or-combinationsThu, 02 May 2019 11:00:00 +0000Conference ForumDr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies (CCI), Perelman School of Medicine, University of Pennsylvania focuses...1146car-t,immuno-oncology 360,io360,io combinations 360,university of pennsylvaniafalsefullhttps://www.spreaker.com/episode/combining-io-modalities-in-a-cost-effective-patient-beneficial-manner--63245467http://www.blogtalkradio.com/pharmatalk/2019/05/01/combining-io-modalities-in-a-cost-effective-patient-beneficial-mannerWed, 01 May 2019 11:00:00 +0000Conference ForumThe hardest thing to figure out now is what interventions and combinations make the most sense in which patients and how to combine all these emerging modalities in a way that is cost effective, benefits patients and unfolds in our lifetime. There are...2355immuno-oncology,immuno-oncology 360,io360,io combinations 360falsefullhttps://www.spreaker.com/episode/io-partnering-strategies-in-an-increasingly-complex-environment--63245482http://www.blogtalkradio.com/pharmatalk/2019/04/30/io-partnering-strategies-in-an-increasingly-complex-environmentTue, 30 Apr 2019 11:00:00 +0000Conference ForumIn this panel, moderated by Dr Axel Hoos, GSK, individuals from large pharma and biotech business development leads discuss decision-making when it comes to partnering and collaborations in today’s IO environment. What is the current nature and types...3092immuno-oncology,immuno-oncology 360,io360,partnering,r&dfalsefullhttps://www.spreaker.com/episode/next-generation-biomarker-and-companion-diagnostics-for-predicting-response--63245397http://www.blogtalkradio.com/pharmatalk/2019/04/29/next-generation-biomarker-and-companion-diagnostics-for-predicting-responseMon, 29 Apr 2019 18:00:00 +0000Conference ForumThis panel, moderated by Dr Priti Hegde, Genentech, discusses the following: How can biomarkers act as a tool for understanding the biology at a level that is sufficient for making decisions around combinations?What are the potential biomarkers that...2294biomarkers,immuno-oncology,immuno-oncology 360,io360,io combinations 360falsefullhttps://www.spreaker.com/episode/innovations-in-immuno-oncology-imaging--63245485http://www.blogtalkradio.com/pharmatalk/2019/04/25/innovations-in-immuno-oncology-imagingThu, 25 Apr 2019 18:30:00 +0000Conference ForumIn this podcast, Dr Gregory Goldmacher, Executive Director, Translational Biomarkers and Head of Clinical Imaging, Merck Research Labs along with Dr Matthew Silva, Executive Vice President, Scientific Applications, Invicro discuss innovations in IO...1996immuno-oncology,invicro,io360,io imaging,merckfalsefullhttps://www.spreaker.com/episode/2nd-annual-drug-delivery-west-5-minute-overview--63245440http://www.blogtalkradio.com/pharmatalk/2019/04/05/2nd-annual-drug-delivery-west--5-minute-overviewFri, 05 Apr 2019 15:00:00 +0000Conference ForumThe 2nd annual Drug Delivery West (DDW) Summit provides a west coast venue for biotech, pharma and drug delivery companies to address scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis...280clinical trials,drug delivery,technologyfalsefullhttps://www.spreaker.com/episode/modernizing-clinical-trials-with-iqvia-s-dr-cynthia-verst--63245392http://www.blogtalkradio.com/pharmatalk/2019/04/01/modernizing-clinical-trials-with-iqvias-dr-cynthia-verstMon, 01 Apr 2019 17:30:00 +0000Conference ForumModernizing Clinical Trials with IQVIA's Dr Cynthia Verst Host: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm:Disrupting Clinical Trials Guest: Dr Cynthia Verst, President, Design and Delivery Innovation for the Research &...1485clinical research,clinical trials,data science,human data science,patient engagementfalsefullhttps://www.spreaker.com/episode/integrating-care-and-research-with-dr-laura-esserman--63245394http://www.blogtalkradio.com/pharmatalk/2019/03/27/integrating-care-and-research-with-dr-laura-essermanWed, 27 Mar 2019 09:00:00 +0000Conference ForumIn this podcast, Valerie Bowling, Executive Director of the Conference Forum, interviews Dr Laura Esserman, breast cancer surgeon and researcher at the University of California, San Francisco. Dr Esserman shares her thoughts on how we can move towards...453clinical care,clinical research,clinical trialsfalsefullhttps://www.spreaker.com/episode/drug-delivery-global-health-challenge--63245409http://www.blogtalkradio.com/pharmatalk/2019/03/04/drug-delivery-global-health-challengeMon, 04 Mar 2019 16:00:00 +0000Conference ForumThis discussion was presented at the inaugural Drug Delivery West conference in 2018. One of the key challenges in global health is ensuring safe and effective delivery of life saving interventions to remote and non-clinical settings. The Bill &...728bill and melinda gates foundat,bill gates,drug deliveryfalsefullhttps://www.spreaker.com/episode/patient-perspectives-on-drug-delivery-needs-present-and-future--63245492http://www.blogtalkradio.com/pharmatalk/2019/02/25/patient-perspectives-on-drug-delivery-needs-present-and-futureMon, 25 Feb 2019 15:30:00 +0000Conference ForumThis panel, presented at the inaugural Drug Delivery West conference in 2018, provides patient perspectives on what they want from drug delivery technologies. These case examples provide insight that every technology can benefit from and lessons...2514drug delivery,drug development,patient advocacyfalsefullhttps://www.spreaker.com/episode/what-are-the-regulatory-and-ethical-concerns-of-integrating-care-and-research--63245408http://www.blogtalkradio.com/pharmatalk/2019/02/06/what-are-the-regulatory-and-ethical-concerns-of-integrating-care-and-researchWed, 06 Feb 2019 13:00:00 +0000Conference ForumIn this discussion, CRAACO co-chair, Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc, and Alison Bateman-House, PhD, MPH, MA, Assistant Professor Division of Medical Ethics, NYU Langone Health, consider what lines are being drawn in...2093craaco,ethics,regulatory issuesfalsefullhttps://www.spreaker.com/episode/how-can-we-work-with-medical-practices-to-offer-patients-clinical-trials--63245465http://www.blogtalkradio.com/pharmatalk/2019/02/05/how-can-we-work-with-medical-practices-to-offer-patients-clinical-trialsTue, 05 Feb 2019 16:30:00 +0000Conference ForumIn this discussion, stakeholders from medical practices, hospitals, service providers, and patient advocacy discuss how medical practices can offer clinical trials to patients. Including: Infrastructure and supportHow to establish physician...2450clinical research,craaco,patient advocatefalsefullhttps://www.spreaker.com/episode/why-are-clinical-trials-not-typically-a-care-option--63245418http://www.blogtalkradio.com/pharmatalk/2019/02/05/why-are-clinical-trials-not-typically-a-care-optionTue, 05 Feb 2019 15:30:00 +0000Conference ForumMurray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes: What are the blockers or conflicts (laws, culture, behaviors,...2699craaco,patient advocate,researchfalsefullhttps://www.spreaker.com/episode/how-to-move-clinical-research-into-communities-that-would-truly-benefit--63245421http://www.blogtalkradio.com/pharmatalk/2019/02/04/how-to-move-clinical-research-into-communities-that-would-truly-benefitMon, 04 Feb 2019 15:30:00 +0000Conference ForumJonathan Jackson, PhD, Director CARE Research Center, Massachusetts General Hospital, and Jim Kremidas, Executive Director, Association of Clinical Research Professionals (ACRP) sit down for a frank discussion on the benefits of offering clinical...2083clinical research,community,craacofalsefullhttps://www.spreaker.com/episode/lessons-learned-from-a-veteran-biotech-and-investor-md--63245468http://www.blogtalkradio.com/pharmatalk/2019/02/04/lessons-learned-from-a-veteran-biotech-and-investor-mdMon, 04 Feb 2019 15:00:00 +0000Conference ForumChief Medical Officer Summit co-chair, Jim Roach, and prominent biotech investor, Elizabeth Stoner, sit down for a fireside chat to discuss what investors are seeking when investing in a biotech company, particularly traits of a Chief Medical Officer....1803biotech,biotechnology,chief medical officer,cmo,investmentsfalsefullhttps://www.spreaker.com/episode/case-study-preparing-for-the-challenges-of-late-stage-trials--63245496http://www.blogtalkradio.com/pharmatalk/2019/02/01/case-study-preparing-for-the-challenges-of-late-stage-trialsFri, 01 Feb 2019 15:00:00 +0000Conference ForumMark Currie, President of R&D at Ironwood Pharmaceuticals, shares his amazing journey driving a product from establishing the foundation for the discovery of linaclotide by Ironwood scientists and leading every aspect of linaclotide's development...1824chief medical officer,chief medical officer summit,linaclotide,research and developmentfalsefullhttps://www.spreaker.com/episode/should-patients-have-the-right-to-try--63245489http://www.blogtalkradio.com/pharmatalk/2019/01/31/should-patients-have-the-right-to-tryThu, 31 Jan 2019 14:30:00 +0000Conference ForumIn this podcast, Dr Alison Bateman-House, Assistant Professor, Division of Medical Ethics at NYU Langone Health, discusses the debate of compassionate use and the right to try. It dives into the implications, both positive and negative, of opening up...2306chief medical officer,chief medical officer summit,medical ethics,patients,right to tryfalsefullhttps://www.spreaker.com/episode/best-practices-in-communication-and-pr-strategy--63245406http://www.blogtalkradio.com/pharmatalk/2019/01/30/best-practices-in-communication-and-pr-strategyWed, 30 Jan 2019 14:30:00 +0000Conference ForumIn this podcast, Raju Joshi, Managing Partner at Clinical Partners Group and Dr Zain Kassam, CSO at Finch Therapeutics, discuss how CMO's can more effectively communicate with CEO's, CSO's, and Clinical Operations executives in order to prove a...1559chief medical officer,chief medical officer summit,finch therapeutics,pr strategy,science and businessfalsefullhttps://www.spreaker.com/episode/translating-patient-insight-and-patient-experience-internally-into-deliverables--63245484http://www.blogtalkradio.com/pharmatalk/2019/01/24/translating-patient-insight-and-patient-experience-internally-into-deliverablesThu, 24 Jan 2019 14:30:00 +0000Conference ForumMary Stober Murray, Associate Director, Diversity and Patient Engagement for BMS, discusses applying quality systems framework (structure, processes, outcomes) to patient engagement initiatives to help create clinical development deliverables that...2187clinical development,clinical trials,patient advocacy,patient engagement,patients as partnersfalsefullhttps://www.spreaker.com/episode/progress-and-future-outlook-of-cancer-immunotherapy--63245412http://www.blogtalkradio.com/pharmatalk/2019/01/23/progress-and-future-outlook-of-cancer-immunotherapyWed, 23 Jan 2019 15:30:00 +0000Conference ForumIn this podcast, we were joined by Mr Charles Graeber, award-winning journalist and author who recently published The Breakthrough: Immunotherapy and the Race to Cure Cancer along with Dr James Gulley, Head of the Immunotherapy Section and Director of...1720charles graeber,immunotherapy,io360,james gulley,medical oncologyfalsefullhttps://www.spreaker.com/episode/panel-engaging-patients-by-giving-them-their-data--63245424http://www.blogtalkradio.com/pharmatalk/2019/01/22/panel-engaging-patients-by-giving-them-their-dataTue, 22 Jan 2019 15:00:00 +0000Conference ForumThis podcast features a panel previously recorded at the 5th annual Patients as Partners US program on Engaging Patients By Giving Them their Data. The panel, moderated by David Leventhal, Director of Clinical Innovation for Pfizer, discussed: •...1816patient advocacy,patient engagement,patients,patients as partners,returning datafalsefullhttps://www.spreaker.com/episode/mobile-technology-in-clinical-trials-clinical-trials-transformation-initiative--63245426http://www.blogtalkradio.com/pharmatalk/2019/01/15/mobile-technology-in-clinical-trials-clinical-trials-transformation-initiativeTue, 15 Jan 2019 14:30:00 +0000Conference ForumLes Jordan, Working Group Member and Cindy Geoghegan, Team Lead for CTTI, the Clinical Trials Transformation Initiative, share findings from a multi-stakeholder project undertaken by the Clinical Trials Transformation Initiative to better understand...2143clinical trials,ctti,patient advocacy,patients,patients as partnersfalsefullhttps://www.spreaker.com/episode/how-gsk-implemented-pivotal-end-to-end-engagement-initiatives-at-different-stage--63245471http://www.blogtalkradio.com/pharmatalk/2019/01/14/how-gsk-implemented-pivotal-end-to-end-engagement-initiatives-at-different-stageMon, 14 Jan 2019 21:00:00 +0000Conference ForumDr Marilyn Metcalf, Head of the Center of Innovation for GSK, at the 5th annual Patients as Partners 2018 program. Dr Metcalf shares how GSK implemented pivotal end-to-end engagement initiatives at different stages of development. Dr Metcalf walked...889clinical research,gsk,patient,patient advocacy,patients as partnersfalsefullhttps://www.spreaker.com/episode/how-to-make-patient-involvement-sustainable-throughout-medicines-development--63245474http://www.blogtalkradio.com/pharmatalk/2019/01/12/how-to-make-patient-involvement-sustainable-throughout-medicines-developmentSat, 12 Jan 2019 13:00:00 +0000Conference ForumTo prevent ticking off a box and to ensure that patient involvement is systemic and sustainable, we have to move into patient-centricity 2.0. What does this mean and how is this done so we can turn the patient voice into value, impact, and benefit?...1809patient advocacy,patient engagement,pharmaceuticalsfalsefullhttps://www.spreaker.com/episode/what-does-a-truly-patient-centered-healthcare-system-look-like-in-5-10-years--63245480http://www.blogtalkradio.com/pharmatalk/2019/01/11/what-does-a-truly-patient-centered-healthcare-system-look-like-in-5-10-yearsFri, 11 Jan 2019 18:00:00 +0000Conference ForumWhat would have to change to make a patient-centric healthcare system a reality? How can this be achieved, given the huge resistance to change built into current systems? In this session, Alastair Kent, Director of Genetic Alliance UK, addresses: New...2322drug development,healthcare,patient engagementfalsefullhttps://www.spreaker.com/episode/6th-annual-patients-as-partners-us-what-to-expect-in-8-minutes--63245407http://www.blogtalkradio.com/pharmatalk/2019/01/09/6th-annual-patients-as-partners-us-what-to-expect-in-8-minutesWed, 09 Jan 2019 14:30:00 +0000Conference ForumThis 8 minute podcast summarizes what you can expect at the 6th annual Patients as Partners US conference. This is the only event that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater...470biotech,clinical research,clinical trials,patient engagement,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/how-partnering-with-medical-research-charities-is-key-to-medicines-development--63245419http://www.blogtalkradio.com/pharmatalk/2019/01/09/how-partnering-with-medical-research-charities-is-key-to-medicines-developmentWed, 09 Jan 2019 13:00:00 +0000Conference ForumMedical research charities in the UK have been successfully integrating patient insight into their activities for over 10 years. In this session presented at the 2nd annual Patients as Partners Europe in January 2018, Claire Nolan, Research...2771drug development,medical research,patient advocacy,patient engagement,pharmaceuticalsfalsefullhttps://www.spreaker.com/episode/patients-as-partners-europe-3rd-annual-what-to-expect-in-5-minutes--63245461http://www.blogtalkradio.com/pharmatalk/2018/12/24/patients-as-partners-europe-3rd-annual-what-to-expect-in-5-minutesMon, 24 Dec 2018 06:00:00 +0000Conference ForumThis 5 minute podcast summarizes what you can expect at the 3rd annual Patients as Partners EU conference. It is the only event in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater...313biotech,clinical trials,cros,medicines development. r&d,pharmacueticalfalsefullhttps://www.spreaker.com/episode/how-tesaro-is-integrating-the-patient-in-the-clinical-development-process--63245420http://www.blogtalkradio.com/pharmatalk/2018/12/12/how-tesaro-is-integrating-the-patient-in-the-clinical-development-processWed, 12 Dec 2018 12:00:00 +0000Conference ForumIn this talk from the 5th annual Patients as Partners US conference, Beth Zaharoff, Director, Patient-Focused Clinical Trial Engagement of Tesaro will walk the audience through how they integrated patient input throughout multiple stages of the...1547clinical trials,patient advocacy,patient engagement,patient focus,patientsfalsefullhttps://www.spreaker.com/episode/keytruda-in-combo-with-chemo-in-nsclc--63245422http://www.blogtalkradio.com/pharmatalk/2018/12/11/keytruda-in-combo-with-chemo-in-nsclcTue, 11 Dec 2018 22:00:00 +0000Conference ForumOriginally recorded at the 4th annual Immuno-Oncology 360° 2018 event, Dr Corey Langer, Director, Thoracic Oncology and Professor of Medicine for the Perelman Center for Advanced Medicine at the University of Pennsylvania, discusses data on Keytruda...1488chemotherapy,corey langer,immuno-oncology,immunotherapy,io360falsefullhttps://www.spreaker.com/episode/future-value-generation-in-immuno-oncology--63245463http://www.blogtalkradio.com/pharmatalk/2018/12/05/future-value-generation-in-immuno-oncologyWed, 05 Dec 2018 12:30:00 +0000Conference ForumIn this podcast, originally recorded at the 4th annual annual Immuno-Oncology 360° 2018 event, Dr Axel Hoos, SVP, Oncology R&D, GSK, led a panel on The Future Value Generation in IO. Dr Hoos was joined by expert analyst Dr Andrew Baum, Head of...3599biomarkers,immuno-oncology,immunotherapy,investing,investmentsfalsefullhttps://www.spreaker.com/episode/reflections-of-the-cancer-moonshot-and-future-of-the-biden-cancer-initiative--63245431http://www.blogtalkradio.com/pharmatalk/2018/12/04/reflections-of-the-cancer-moonshot-and-future-of-the-biden-cancer-initiativeTue, 04 Dec 2018 22:00:00 +0000Conference ForumGreg Simon, President at the Biden Cancer Initiative and Former Executive Director of the White House Cancer Task Force will reflect on the work of the Cancer Moonshot. Which provided the leadership to harness the millions of scientists and patients,...2024combination therapy,immuno-oncology,immunotherapy,io360,treating cancerfalsefullhttps://www.spreaker.com/episode/balancing-benefit-and-toxicity-from-immunotherapeutics--63245494http://www.blogtalkradio.com/pharmatalk/2018/12/04/balancing-benefit-and-toxicity-from-immunotherapeuticsTue, 04 Dec 2018 18:30:00 +0000Conference ForumJeffrey Weber, Deputy Director at Laura and Isaac Perlmutter Cancer Center and Co-director of Melanoma Program and Head of Experimental Therapeutics at NYU Langone Medical Center, discusses the day to day management of, and the science around, IO...2862autoimmune diseases,clinical trials,immuno-oncology,immunotherapy,nyu-langonefalsefullhttps://www.spreaker.com/episode/the-biocentury-report-on-immuno-oncology-industry-trends--63245470http://www.blogtalkradio.com/pharmatalk/2018/11/28/the-biocentury-report-on-immuno-oncology-industry-trendsWed, 28 Nov 2018 19:30:00 +0000Conference ForumThe BioCentury Report on Industry Trends covers how companies and academic investigators are driving innovations within immuno-oncology, including new targets, modalities and technologies, to address some of the field's biggest challenges. Some topics...1347biocentury,immunotherapy,industry trends,innovation,trendsfalsefullhttps://www.spreaker.com/episode/5th-annual-immuno-oncology-360-12-minutes-of-what-to-expect--63245473http://www.blogtalkradio.com/pharmatalk/2018/11/19/5th-annual-immuno-oncology-360-12-minutes-of-what-to-expectMon, 19 Nov 2018 06:30:00 +0000Conference ForumIO360° brings together science, clinical and business under one roof to accelerate treatments to fight a wider range of cancers. This brief podcast gives you an overview on what you can expect at IO360°. The three-day summit features 10 plenary...776cancer research,immuno-oncology,immunotherapy,io360,the conference forumfalsefullhttps://www.spreaker.com/episode/partnership-opportunities-in-drug-delivery-2018-what-to-expect-5-min-podcast--63245423http://www.blogtalkradio.com/pharmatalk/2018/09/08/partnership-opportunities-in-drug-delivery-2018-what-to-expect-5-min-podcastSat, 08 Sep 2018 09:00:00 +0000Conference ForumThe 8th Annual Partnership Opportunities in Drug Delivery (PODD) event will take place on October 18-19, 2018. PODD is designed with 3 purposes: To present a strategic level program for pharma and biotech biz development professionals with a thorough...322drug delivery,drug delivery devices,injectable technologies and no,podd,transdermalfalsefullhttps://www.spreaker.com/episode/podcast-from-a-zimbabwean-village-kid-to-a-phd-regenerative-medicine-student--63245434http://www.blogtalkradio.com/pharmatalk/2018/08/30/podcast-from-a-zimbabwean-village-kid-to-a-phd-regenerative-medicine-studentThu, 30 Aug 2018 13:30:00 +0000Conference ForumCan you imagine coming from a family of 21 kids in a small remote village in Africa with no running water or electricity and one day a snake bite changes your entire future and you end up a PhD student in WInston-Salem, NC?  In this remarkable story,...1599biotech,goodwell nzou,pharmaceutical,regenerative medicine,wake forest institute for regefalsefullhttps://www.spreaker.com/episode/all-of-us-research-program-a-nation-wide-initiative-from-the-nih--63245483http://www.blogtalkradio.com/pharmatalk/2018/08/17/all-of-us-research-program-a-nation-wide-initiative-from-the-nih-1Fri, 17 Aug 2018 05:00:00 +0000Conference ForumPodcast guest, Elise Felicione, who is currently a Scientific Collaborator at the Scripps Translational Science Institute is playing an integral role under the direction of Dr Eric Topol on a nation-wide initiative from the NIH. The initiative is...1084all of us,elise felicione,nih,patient data,scripps translational science falsefullhttps://www.spreaker.com/episode/reimagining-clinical-trials-with-entrepreneur-dr-ben-liu-ceo-trialspark--63245486http://www.blogtalkradio.com/pharmatalk/2018/08/17/reimagining-clinical-trials-with-entrepreneur-dr-ben-liu-ceo-trialsparkFri, 17 Aug 2018 04:00:00 +0000Conference ForumDuring his graduate work, Dr Benjamine Liu observed the many bottlenecks that get in the way of clinical trials slowing the development of new treatments for patients. This challenge inspired him to launch Trialspark. Trialspark partners with doctors...1306clinical research,clinical trials,disrupting clinical trials,investigator sites,reducing burden to patientsfalsefullhttps://www.spreaker.com/episode/blockchain-opportunities-for-patient-data-donation-and-clinical-research--63245491http://www.blogtalkradio.com/pharmatalk/2018/08/16/blockchain-opportunities-for-patient-data-donation-and-clinical-researchThu, 16 Aug 2018 16:30:00 +0000Conference ForumPatients are at the center of research and their data is the foundation for clinical innovation. However, significant barriers exist that inhibit the secure and efficient sharing of patient data. In this podcast, Craig Lipset, Head of Clinical...1811blockchain,clinical trials,patient data,patient data sharing,pfizerfalsefullhttps://www.spreaker.com/episode/dpharm-podcast-what-to-expect-at-the-2018-event-in-8-minutes--63245417http://www.blogtalkradio.com/pharmatalk/2018/08/16/dpharm-podcast-what-to-expect-at-the-2018-event-in-8-minutesThu, 16 Aug 2018 04:30:00 +0000Conference ForumThis 8 minute podcast gives you an overview on what to expect from the 8th annual DPharm conference. DPharm is the annual event in the US to get the best access to innovative ideas, especially disruptive ones, to advance clinical trials with a view to...509clinical research,clinical trials,disruptive innovations,dpharm,theconferenceforum.orgfalsefullhttps://www.spreaker.com/episode/mobile-in-clinical-trials-podcast-3-1-2-minutes-on-what-to-expect--63245475http://www.blogtalkradio.com/pharmatalk/2018/08/15/mobile-in-clinical-trials-podcast-3-12-minutes-on-what-to-expectWed, 15 Aug 2018 05:00:00 +0000Conference ForumWelcome to the 5th annual Mobile in Clinical Trials podcast. In this quick fire podcast, you will get a brief overview on what to expect. The conference takes place in Boston on Sept 24th, the day before DPharm. It is researched and produced by the...217dpharm,mobile in clinical trials,reducing patient burden,the conference forum,wearables in clinical trialsfalsefullhttps://www.spreaker.com/episode/what-to-expect-at-rational-combinations-360-2018-5-min-overview--63245477http://www.blogtalkradio.com/pharmatalk/2018/07/19/what-to-expect-at-rational-combinations-360-2018--5-min-overviewThu, 19 Jul 2018 16:30:00 +0000Conference ForumRational Combinations 360° addresses business aspects, clinical advancements and scientific data in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for...326immuno-oncology,oncology,rational combinationsfalsefullhttps://www.spreaker.com/episode/how-to-innovate-in-the-drug-delivery-space--63245444http://www.blogtalkradio.com/pharmatalk/2018/06/23/how-to-innovate-in-the-drug-delivery-spaceSat, 23 Jun 2018 17:00:00 +0000Conference ForumHow to Innovate in the Drug Delivery Space What does the innovation process look likeThe barrier to the innovation process and how to overcomethemSummary of disease spaceGood design and engineering practicesHow to salvage something that goes wrong?How...1902barriers to innovation,cambridge design,disease space,drug delivery,innovationfalsefullhttps://www.spreaker.com/episode/key-trends-in-drug-delivery-expert-perspective--63245479http://www.blogtalkradio.com/pharmatalk/2018/06/23/key-trends-in-drug-delivery-expert-perspectiveSat, 23 Jun 2018 13:00:00 +0000Conference ForumOpening talk at Drug Delivery West, 2018 Key Trends in Drug Delivery: Expert Perspective Randall Mrsny, PhD Professor's Chair, Department of Pharmacy and Pharmacology, University of Bath2010cellular health,drug delivery,pharmaceutical,pharmacology,pharmacyfalsefullhttps://www.spreaker.com/episode/how-fara-and-horizon-pharma-partnered-to-improve-clinical-development--63245453http://www.blogtalkradio.com/pharmatalk/2018/06/22/how-fara-and-horizon-pharma-partnered-to-improve-clinical-developmentFri, 22 Jun 2018 15:00:00 +0000Conference ForumPatients as Partners Day 2 Session How FARA and Horizon Pharma Partnered to Improve Clinical Development and Trial Design-Case Study This session will feature how the Friedreich’s Ataxia Research Foundation collaborated with Horizon Pharma on...1994clinical trial design,drug administration,fara,fda,friedreich's ataxiafalsefullhttps://www.spreaker.com/episode/how-takeda-used-one-or-more-of-the-various-patient-engagement-frameworks--63245462http://www.blogtalkradio.com/pharmatalk/2018/06/22/how-takeda-used-one-or-more-of-the-various-patient-engagement-frameworksFri, 22 Jun 2018 14:30:00 +0000Conference ForumThis talk was given at the Patients as Partners 2018 Meeting There are many frameworks and models that exist from various organizations on aspects of patient engagement and may be challenging to navigate through when applying to your own initiatives....1446patient advocacy,patient engagement,patients as partners,r&d,takedafalsefullhttps://www.spreaker.com/episode/how-patient-research-advocates-are-driving-r-d-a-patient-case-study--63245487http://www.blogtalkradio.com/pharmatalk/2018/06/21/how-patient-research-advocates-are-driving-rd-a-patient-case-studyThu, 21 Jun 2018 16:00:00 +0000Conference ForumThis talk was given at the Patients as Partners 2018 Meeting How Patient Research Advocates are Driving R&D: A Patient Case Study In this session, patient and research advocate, Geraldine Blavat will walk the audience through 10 steps on how...1577case study,fda approval,parkinson's research,r&d,research fundingfalsefullhttps://www.spreaker.com/episode/fireside-chat-lessons-learned-from-a-drug-delivery-pioneer-and-risk-taker--63245456http://www.blogtalkradio.com/pharmatalk/2018/06/21/fireside-chat-lessons-learned-from-a-drug-delivery-pioneer-and-risk-takerThu, 21 Jun 2018 14:30:00 +0000Conference ForumJohn Patton, PhD, Chief Executive Officer and Chairman with Dance Biopharma and Ann Daugherty, PhD, Senior Manager, Drug Delivery with Genentech present the closing talk at Drug Delivery West, held May 21-22, 2018 in San Francisco.  In this talk they...2354drug delivery,medical device,medical devices,pharmaceutical,pharmaceutical devicefalsefullhttps://www.spreaker.com/episode/nanotechnology-keynote--63245488http://www.blogtalkradio.com/pharmatalk/2018/06/07/nanotechnology-keynoteThu, 07 Jun 2018 20:00:00 +0000Conference ForumNanotechnology Keynote Address given by Omid Farokhzad, MD, Professor, Harvard Medical School and Director, Center for Nanomedicine, Brigham and Women's Hospital Omid Farokhzad is an inventor of more than 145 issued / pending patents. These for the...1950bioscience,biotechnology,disruptive technology,nano-bio,nanotechnologyfalsefullhttps://www.spreaker.com/episode/utilizing-a-device-platform-technology-across-multiple-therapeutic-categories--63245443http://www.blogtalkradio.com/pharmatalk/2018/06/07/utilizing-a-device-platform-technology-across-multiple-therapeutic-categoriesThu, 07 Jun 2018 17:00:00 +0000Conference ForumPanel: Utilizing a Device Platform Technology across Multiple Therapeutic Categories Most pharma and biotech companies realize the need and benefit of having a platform device technology. The challenge then becomes figuring out how to utilize the...2141biotechnology,cancer,device technology,pharmaceutical,rare diseasesfalsefullhttps://www.spreaker.com/episode/ceo-keynote-fireside-chat--63245451http://www.blogtalkradio.com/pharmatalk/2018/06/06/ceo-keynote-fireside-chatWed, 06 Jun 2018 14:00:00 +0000Conference ForumThe Keynote was given at Partnerships Opportunities in Drug Delivery 2017 by Lars Rebein Sorensen Former President and CEO, Novo Nordisk with  Barbara Lueckel, PhD Global Business Development Director Roche Partnering Innovation, Roche  2389barbara lueckel,business development,ceofalsefullhttps://www.spreaker.com/episode/addressing-r-d-challenges-using-drug-delivery-technologies--63245490http://www.blogtalkradio.com/pharmatalk/2018/06/05/addressing-rd-challenges-using-drug-delivery-technologiesTue, 05 Jun 2018 19:30:00 +0000Conference ForumThe expert panel of scientific leaders from industry will discuss current formulation and delivery challenges for therapeutic areas (ophthalmology, immunology, oncology infectious disease, and neurodegenerative area disorders). Each panelist will...2673drug delivery,expert panel,infectious disease,oncology,treatment of diseasefalsefullhttps://www.spreaker.com/episode/panel-hitting-the-reset-button-on-direct-to-cns-delivery--63245472http://www.blogtalkradio.com/pharmatalk/2018/06/04/panel-hitting-the-reset-button-on-direct-to-cns-deliveryMon, 04 Jun 2018 18:00:00 +0000Conference ForumThe expert panel will address the scientific and business challenges and opportunities in this space. Panelists will discuss the difficult nature of providing therapies for diseases of the CNS, covering both device and chemistry-enabled technologies....2962central nervous system,cns,medical,medical therapy,therapyfalsefullhttps://www.spreaker.com/episode/current-and-emerging-drug-delivery-needs-in-oncology--63245448http://www.blogtalkradio.com/pharmatalk/2018/06/04/current-and-emerging-drug-delivery-needs-in-oncologyMon, 04 Jun 2018 15:00:00 +0000Conference ForumDrug Delivery Needs in Oncology Due to the increasing number of parenteral biologic therapies that are administered intravenously, the already high pressure on infusion capacity and healthcare resources is expected further increase. A change from...3482biologic therapy,delivery,drug delivery,intravenous,oncologyfalsefullhttps://www.spreaker.com/episode/building-blocks-of-io-clinical-trials-part-2--63245497http://www.blogtalkradio.com/pharmatalk/2018/05/11/building-blocks-of-io-clinical-trials--part-2Fri, 11 May 2018 13:30:00 +0000Conference ForumTrack 2: Clinical Operations for IO Trials This section is designed for clinical trial operation executives who want to learn what it takes to execute an IO clinical trial. This is an excellent opportunity to walk through the building blocks of IO...2952immunotherapy,io360,merckfalsefullhttps://www.spreaker.com/episode/building-blocks-of-io-clinical-trials-part-1--63245499http://www.blogtalkradio.com/pharmatalk/2018/05/10/building-blocks-of-io-clinical-trials--part-1Thu, 10 May 2018 13:30:00 +0000Conference ForumBuilding Blocks of IO Trials: This talk will consist of 7 perspectives that identify operational aspects of IO trials, including a patient perspective, site management, 3rd party component, clinical supply chain, a PI perspective, data management and...5035immunotherapy,io360,merckfalsefullhttps://www.spreaker.com/episode/endpoints-news-industry-report-on-io-collaborations-and-trends--63245481http://www.blogtalkradio.com/pharmatalk/2018/05/09/endpoints-news-industry-report-on-io-collaborations-and-trendsWed, 09 May 2018 13:30:00 +0000Conference ForumEndpoints News Industry Report on IO Collaborations and Trends In this episode of Pharma Talk Radio, John Carroll, Editor-in-Chief of Endpoints News, reviewed the build up of the immuno-oncology space over the past few years at the IO360° conference...856combination therapy,drug development,immunotherapy,io360,oncologyfalsefullhttps://www.spreaker.com/episode/ctti-report-mobile-clinical-trials-program-recommendations-on-novel-endpoints--63245435http://www.blogtalkradio.com/pharmatalk/2018/04/30/ctti-report--mobile-clinical-trials-program-recommendations-on-novel-endpointsMon, 30 Apr 2018 04:00:00 +0000Conference ForumMobile Podcast Series #2 CTTI Findings are in from their Mobile Clinical Trials Program: Recommendations on Novel Endpoints CTTI's Mobile in Clinical Trials program was launched three years ago to propose recommendations that clarify the pathway for...1339falsefullhttps://www.spreaker.com/episode/how-a-mobile-app-can-offer-unique-value-in-assessing-patient-reported-outcomes--63245460http://www.blogtalkradio.com/pharmatalk/2018/04/29/how-a-mobile-app-can-offer-unique-value-in-assessing-patient-reported-outcomesSun, 29 Apr 2018 13:00:00 +0000Conference ForumPodcast on Mobile in Clinical Trials Series #1 How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes Crescendo Biosciences's CIO, Alex Bangs, reports on how a human-centered design approach was used to create MyRA, an...1072clinical trials,medical app,mobile,myra,the conference forumfalse11fullhttps://www.spreaker.com/episode/lessons-learned-from-the-journey-of-a-cmo-leader-michael-rosenblatt-md--63245458http://www.blogtalkradio.com/pharmatalk/2018/04/18/lessons-learned-from-the-journey-of-a-cmo-leader-michael-rosenblatt-mdWed, 18 Apr 2018 12:00:00 +0000Conference ForumThe Chief Medical Officer Summit is delighted to present a podcast featuring the Keynote Fireside Chat with Michael Rosenblatt, MD, on Lessons Learned from the Journey of a CMO Leader In this session, Dr Rosenblatt, former Merck CMO, will share his...2697biotech,chief medical officer,cmo,leadership,the conference forumfalsefullhttps://www.spreaker.com/episode/developing-a-pathway-for-compassionate-use-cases--63245466http://www.blogtalkradio.com/pharmatalk/2018/04/17/developing-a-pathway-for-compassionate-use-casesTue, 17 Apr 2018 19:30:00 +0000Conference ForumThe Chief Medical Officer Summit is delighted to share a podcast featuring a presentation prepared by Drs Alison Bateman-House and Arthur Caplan of NYU's Division of Medical Ethics on the topic of:   Developing a Pathway for Compassionate Use Cases...2753chief medical officer summit,cmo,compassionate use,medical ethics,the conference forumfalsefullhttps://www.spreaker.com/episode/2018-chief-medical-officer-summit-podcast-overview-in-a-nutshell--63245459http://www.blogtalkradio.com/pharmatalk/2018/04/17/2018-chief-medical-officer-summit-podcast-overview-in-a-nutshellTue, 17 Apr 2018 14:30:00 +0000Conference ForumThis podcasts gives you an overview on what to expect for the 2018 Chief Medical Officer Summit in a nutshell. The concept of the CMO Summit came from MPM Capital’s Dr Elizabeth Stoner, who told us that there is a deep need for a Summit that is...419biotech,chief medical officer,cmo,pharmaceutical,the conference forumfalsefullhttps://www.spreaker.com/episode/clinical-research-as-a-care-option-2nd-annual-3-min-podcast-overview--63245478http://www.blogtalkradio.com/pharmatalk/2018/03/04/clinical-research-as-a-care-option-2nd-annual--3-min-podcast-overviewSun, 04 Mar 2018 07:00:00 +0000Conference ForumIn this three minute podcast, you get an overview of one of the hottest topics we are covering in a full day 2nd annual event on Clinical Research as a Care Option. (CRAACO). Making clinical trials a care option is arguably the greatest challenge we...197clinical research,clinical research as a care op,clinical trials,craaco,patientsfalsefullhttps://www.spreaker.com/episode/what-to-expect-at-clinical-trial-collaborations-2018-5-min-podcast--63245469http://www.blogtalkradio.com/pharmatalk/2018/03/04/what-to-expect-at-clinical-trial-collaborations-2018-5-min-podcastSun, 04 Mar 2018 05:30:00 +0000Conference ForumThis podcast gives you a five minute overview of the 3rd annual Clinical Trial Collaborations conference, otherwise known as CTC. CTC is a strategic level event focused on arguably the most important change in transforming drug development: How and...295clinical research,clinical trials,clinical trials collaborations,ctc,the conference forumfalsefullhttps://www.spreaker.com/episode/mobile-in-clinical-trials-europe-new-for-2018-4-min-podcast-overview--63245476http://www.blogtalkradio.com/pharmatalk/2018/03/01/mobile-in-clinical-trials-europe-new-for-2018--4-min-podcast-overviewThu, 01 Mar 2018 17:30:00 +0000Conference ForumThe Mobile in Clinical Trials conference comes to Europe for the first time on May 15th and 16th at the Millennium Gloucester Hotel in London. If you work or want to work with mobile and digital technologies to make clinical trials more efficient and...235clinical research,clinical trials,digitizing clinical trials,mobile in clinical trials,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/patients-a-seat-at-the-table-in-clinical-trials-with-pfizer-s-dr-roz-schneider--63246239http://www.blogtalkradio.com/pharmatalk/2018/03/01/patients-a-seat-at-the-table-in-clinical-trials-with-pfizers-dr-roz-schneiderThu, 01 Mar 2018 05:30:00 +0000Conference ForumDr Roslyn Schneider, Global Patient Affairs Lead at Pfizer, speaks with Valerie Bowling, Executive Director, Patients as Partners, in a podcast interview on patients at the center of clinical research. Dr Schneider, better known as Roz, helps drive...987biotech,clinical trials,dr roslyn schneider,patients as partners,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/reducing-the-burden-of-type-1-diabetes-with-patient-dana-lewis-dpharm-podcast-5--63246242http://www.blogtalkradio.com/pharmatalk/2018/02/19/reducing-the-burden-of-type-1-diabetes-with-patient-dana-lewisdpharm-podcast-5Mon, 19 Feb 2018 16:00:00 +0000Conference ForumDPharm Podcast Series #5 Reducing the Burden of Type 1 Diabetes through a Model of Democratized R&D Patient advocate star, Dana Lewis, founder of OpenAPS delivers a powerful session at DPharm on an idea to reduce the burden of type 1 diabetes...1666clinical trials,dana lewis,do-it-yourself pancreas system,openaps,type 1 diabetesfalse5fullhttps://www.spreaker.com/episode/5th-annual-patients-as-partners-what-to-expect-overview-podcast-in-7-minutes--63246191http://www.blogtalkradio.com/pharmatalk/2018/02/19/5th-annual-patients-as-partners-what-to-expect-overview-podcast-in-7-minutesMon, 19 Feb 2018 01:00:00 +0000Conference Forum 5th Annual Patients as Partners What to Expect Overview Podcast Officially approved by Patients Included, Patients as Partners is the only program in the US that truly demonstrates how to involve patients throughout the entire medicines development...425clinical research,clinical trials,michael j fox foundation,patients as partners,pfizerfalsefullhttps://www.spreaker.com/episode/wireless-remote-monitoring-dpharm-podcast-series-2--63246245http://www.blogtalkradio.com/pharmatalk/2018/02/17/wireless-remote-monitoring-dpharm-podcast-series-2Sat, 17 Feb 2018 15:00:00 +0000Conference ForumDPharm podcast series # 2  MIT Professor, Dina Katabi, PhD gave one of the best talks on in home non-intrusive patient monitoring at DPharm 2017 and provided a demo of technology that uses ambient radio signals to monitor a patient’s gait, falls,...1745clinical research,clinical trials,patients,pharmaceutical,wireless remote monitoringfalse2fullhttps://www.spreaker.com/episode/immuno-oncology-clinical-trial-operations-4-min-summary-of-what-to-expect--63246231http://www.blogtalkradio.com/pharmatalk/2018/01/28/immuno-oncology-clinical-trial-operations-4-min-summary-of-what-to-expectSun, 28 Jan 2018 16:30:00 +0000Conference ForumThe Conference Forum presents a 1 day meeting on Immuno-Oncology Clinical Trial Operations, February 8th at the Roosevelt hotel in NYC. It’s part of the IO360 conference, which runs over three days from Feb 7th through the 9th.  The OPERATIONS portion...245clinical trials,immuno-oncology,io,io clinial trial operations,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/patients-as-partners-eu-overview-in-3-minutes--63246244http://www.blogtalkradio.com/pharmatalk/2017/12/27/patients-as-partners-eu-overview-in-3-minutesWed, 27 Dec 2017 05:30:00 +0000Conference ForumThe 2nd annual Patients as Partners EU is the only conference in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. In this short podcast, Valerie...184clinical research,clinical trials,patient empowerment,patient engagement,patient recruitmentfalsefullhttps://www.spreaker.com/episode/roche-s-dr-barbara-lueckel-reviews-the-2016-drug-delivery-industry--63246205http://www.blogtalkradio.com/pharmatalk/2017/09/26/roches-dr-barbara-lueckel-reviews-the-2016-drug-delivery-industryTue, 26 Sep 2017 19:00:00 +0000Conference ForumIf you are interested in hearing the 2017 drug delivery landscape year in review in 2017, please email service@tcfllc.org Chair of the Partnership Opportunities in Drug Delivery (PODD) event, Dr Barbara Lueckel, Head of Research and Technologies...1513biotechnology,drug delivery,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/from-the-olympics-to-clinical-research--63246223http://www.blogtalkradio.com/pharmatalk/2017/09/22/from-the-olympics-to-clinical-researchFri, 22 Sep 2017 17:30:00 +0000Conference ForumPan American Games Champion, Olympian and World Championship silver medalist, Jennifer Goldsack, became a world-class athlete while working and studying at the University of Oxford. How did she do it? She recently shared her story with DPharm...1173clinical trials clinical resea,clinical trials transformation,ctti,jennifer goldsack,mobile in clinical trialsfalsefullhttps://www.spreaker.com/episode/what-to-expect-at-immuno-oncology-360-2018--63246240http://www.blogtalkradio.com/pharmatalk/2017/09/20/what-to-expect-at-immuno-oncology-360-2018Wed, 20 Sep 2017 15:00:00 +0000Conference ForumImmuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including: Discovery / Preclinical ScienceTranslational ScienceClinical DevelopmentBusiness...388cancer,cancer research,clinical trials,immuno-oncology,immunotherapyfalsefullhttps://www.spreaker.com/episode/why-pharma-r-d-has-to-start-thinking-like-a-service-industry-and-how--63246266http://www.blogtalkradio.com/pharmatalk/2017/08/24/why-pharma-rd-has-to-start-thinking-like-a-service-industry-and-howThu, 24 Aug 2017 23:30:00 +0000Conference ForumThe Conference Forum is pleased to share a podcast featuring keynote speaker and world renowned customer service expert, Dr Chip Bell who spoke at the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on the topic of service in...2867clinical research,clinical trials,patient centricity,patient engagement,patients in clinical researchfalsefullhttps://www.spreaker.com/episode/the-gap-between-clinical-care-patient-involvement-what-patients-want--63246286http://www.blogtalkradio.com/pharmatalk/2017/06/27/the-gap-between-clinical-care-patient-involvement-what-patients-wantTue, 27 Jun 2017 15:00:00 +0000Conference ForumOriginally recorded during the 4th annual Patients as Partners US event held in Philadelphia, March 2017, Bristol-Myers Squibb’s Mary Stober-Murray moderates this multi-stakeholder panel to discuss what patients truly want when it comes to clinical...3085clinical care,clinical research,patient retention,patients,patients rightsfalsefullhttps://www.spreaker.com/episode/digital-solutions-impacting-the-economic-efficacy-of-clinical-trials--63246238http://www.blogtalkradio.com/pharmatalk/2017/06/26/digital-solutions-impacting-the-economic-efficacy-of-clinical-trialsMon, 26 Jun 2017 15:00:00 +0000Conference ForumInternationally recognized digital health expert, Donald Jones, MBA, Chief Digital Officer at Scripps Translational Science Institute, shares his insights on the digital clinical trial landscape and the urgent need to pair digitization with drug...2665chief medical officer,clinical trials,digital health,technology,technology trendsfalsefullhttps://www.spreaker.com/episode/partnering-with-patient-organizations-for-advancing-cures--63246277http://www.blogtalkradio.com/pharmatalk/2017/06/23/partnering-with-patient-organizations-for-advancing-curesFri, 23 Jun 2017 18:30:00 +0000Conference ForumIn this multi-stakeholder session from the 4th annual Patients as Partners US meeting, patients, advocates, industry and nonprofit organizations come together to discuss how they partnered and the outcomes of those partnerships. • What’s the roadmap?...2471patient,patient advocacy,patient engagement,patients,patient safetyfalsefullhttps://www.spreaker.com/episode/challenges-and-opportunities-in-pursuing-a-new-therapeutic-modality--63246267http://www.blogtalkradio.com/pharmatalk/2017/06/23/challenges-and-opportunities-in-pursuing-a-new-therapeutic-modalityFri, 23 Jun 2017 15:00:00 +0000Conference ForumAdapted from the 2016 Chief Medical Officer Summit keynote address, Dr Akshay Vaishnaw, who serves as EVP of R&D and CMO at Alnylam Pharmaceuticals, tackles the challenges and opportunities in pursuing a new therapeutic modality from its...2219biotech,biotechnology,chief medical officer,cmo,r&dfalsefullhttps://www.spreaker.com/episode/partnering-with-patients-in-the-development-and-lifecycle-of-medicines--63246279http://www.blogtalkradio.com/pharmatalk/2017/06/22/partnering-with-patients-in-the-development-and-lifecycle-of-medicinesThu, 22 Jun 2017 17:30:00 +0000Conference ForumAt the 2017 Partners Europe event in London, Nicholas Brooke, Chief Executive, Patient Focused Medicines Development (PFMD) and Jan Geissler, Director, European Patients’ Academy on Therapeutic Innovation (EUPATI) call on industry to partner with...2172medicine,patient,patient advocacy,patients,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/trends-and-collaborations-in-the-io-space--63246280http://www.blogtalkradio.com/pharmatalk/2017/06/22/trends-and-collaborations-in-the-io-spaceThu, 22 Jun 2017 15:00:00 +0000Conference ForumDr Axel Hoos, GSK, leads a panel discussion on Trends and Collaborations in the Immuno-Oncology Space, featuring Dr Ramy Ibrahim, VP and Head of R&D, Parker Institute for Cancer Immunotherapy; Dr Jill O’Donnell-Tormey, CEO and Director of...2519cancer,cancer research,immuno-oncology,immunotherapyfalsefullhttps://www.spreaker.com/episode/unlocking-the-power-of-patient-engagement-within-clinical-and-commercial--63246269http://www.blogtalkradio.com/pharmatalk/2017/06/21/unlocking-the-power-of-patient-engagement-within-clinical-and-commercialWed, 21 Jun 2017 18:00:00 +0000Conference ForumAt the inaugural Patients as Partners Europe event, Duncan Arbour from inVentiv Health explores the ‘how’ and ‘when’ for involving patients within clinical and commercial to enhance the development and delivery of innovative therapies.  The patient...719medicine,patient,patient advocacy,patients,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/patients-influencing-policy-in-the-eu--63246254http://www.blogtalkradio.com/pharmatalk/2017/06/21/patients-influencing-policy-in-the-euWed, 21 Jun 2017 16:00:00 +0000Conference ForumAlastair Kent, Director of the Genetic Alliance UK, talks about how patients can and are influencing policy within the EU.  The Patients as Partners Europe program seeks to understand and incorporate the patient's voice in designing clinical trials...1845patient advocacy,patient engagement,patients,r&d,research and developmentfalsefullhttps://www.spreaker.com/episode/immuno-oncology-360-business-models-for-complex-science-by-dr-axel-hoos-of-gsk--63246229http://www.blogtalkradio.com/pharmatalk/2017/06/21/immuno-oncology-360-business-models-for-complex-science-by-dr-axel-hoos-of-gskWed, 21 Jun 2017 15:00:00 +0000Conference ForumOriginally presented during the business aspects plenary session at Immuno-Oncology 360° 2017, Dr Axel Hoos of GSK discusses business models for complex science.  Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in...1476cancer,cancer research,immuno-oncology,immunotherapyfalsefullhttps://www.spreaker.com/episode/increasingly-critical-role-of-predictive-biomarkers-in-cancer-immunotherapy--63246276http://www.blogtalkradio.com/pharmatalk/2017/06/20/increasingly-critical-role-of-predictive-biomarkers-in-cancer-immunotherapyTue, 20 Jun 2017 15:30:00 +0000Conference ForumChief Medical Officer at nanoString Technologies, Dr Alessandra Cesano, brings to light the increasingly critical role of predictive biomarkers in cancer immunotherapy, originally presented during the translational science and new technologies session...1328cancer,cancer research,immuno-oncology,immunotherapyfalsefullhttps://www.spreaker.com/episode/important-business-aspects-of-immuno-oncology-issues-and-controversies--63246285http://www.blogtalkradio.com/pharmatalk/2017/06/20/important-business-aspects-of-immuno-oncology-issues-and-controversiesTue, 20 Jun 2017 15:00:00 +0000Conference ForumOriginally recorded during a panel session at the 2017's Immuno-Oncology 360°, Mark Simon of Torreya Partners moderates the conversation around issues, controversies, and other important business aspects of IO. He's joined by IO360° lead advisor and...2657business,cancer,cancer research,immuno-oncology,immunotherapyfalsefullhttps://www.spreaker.com/episode/innovative-ways-of-patient-involvement-in-medicines-development--63246284http://www.blogtalkradio.com/pharmatalk/2017/06/20/innovative-ways-of-patient-involvement-in-medicines-developmentTue, 20 Jun 2017 15:00:00 +0000Conference ForumOriginally recorded at the inaugural Patients as Partners Europe event, held in London in February 2017. Patient, industry, and regulatory perspectives are provided by Alastair Kent of Genetic Alliance UK, Dr Anton Hoos of Amgen Europe, and Isabelle...3240medicine,patient advocacy,patient care,patient engagement,patientsfalsefullhttps://www.spreaker.com/episode/addressing-clinical-challenges-in-immuno-oncology--63246278http://www.blogtalkradio.com/pharmatalk/2017/06/20/addressing-clinical-challenges-in-immuno-oncologyTue, 20 Jun 2017 15:00:00 +0000Conference ForumOriginally recorded during the 3rd annual Immuno-Oncology 360° in February 2017, this panel discussion addresses clinical challenges within immuno-oncology. One of the IO360° lead advisors, Dr James Gulley of the National Cancer Institute, moderates...2780cancer,cancer research,immuno-oncology,immunotherapyfalsefullhttps://www.spreaker.com/episode/sequencing-of-combination-agents-in-immuno-oncology-with-dr-charles-drake--63246268http://www.blogtalkradio.com/pharmatalk/2017/06/16/sequencing-of-combination-agents-in-immuno-oncology-with-dr-charles-drakeFri, 16 Jun 2017 17:00:00 +0000Conference ForumDuring the preclinical science plenary session from 2017's Immuno-Oncology 360° conference, Dr Charles Drake's talks about "Sequencing of Combination Agents."  Dr Drake is Director, Genitourinary Oncology and Co-Director Immunotherapy Associate...1163cancer,cancer research,immuno-oncology,immunotherapy,oncologyfalsefullhttps://www.spreaker.com/episode/next-generation-of-combination-immunotherapy-with-dr-patrick-hwu-of-md-anderson--63246210http://www.blogtalkradio.com/pharmatalk/2017/06/07/next-generation-of-combination-immunotherapy-with-dr-patrick-hwu-of-md-andersonWed, 07 Jun 2017 19:30:00 +0000Conference ForumAt 2016's Rational Combinations 360° meeting, Dr Patrick Hwu of MD Anderson Cancer Center delivered a keynote address on the future outlook behind combination immunotherapy. Dr Hwu addresses innovations behind combination therapy, specifically...1930cancer,cancer research,immunotherapy,md anderson,md anderson cancer centerfalsefullhttps://www.spreaker.com/episode/patients-as-partners-europe-7-minute-overview-on-what-to-expect--63246263http://www.blogtalkradio.com/pharmatalk/2017/01/26/patients-as-partners-europe-7-minute-overview-on-what-to-expect-1Thu, 26 Jan 2017 05:00:00 +0000Conference ForumWe are delighted to bring the Patients as Partners US event to Europe on February 6-7 in London. We would like to thank our European attendees at the US conference for challenging and encouraging us to bring the conference to Europe. The goal of...382clinical trials,patient-centricity,patient engagement,patients as partners,patients in clinical researchfalsefullhttps://www.spreaker.com/episode/5-minute-overview-of-dpharm-disrupting-clinical-trials-europe-what-to-expect--63246232http://www.blogtalkradio.com/pharmatalk/2017/01/26/5-minute-overview-of-dpharm-disrupting-clinical-trials-europe-what-to-expectThu, 26 Jan 2017 05:00:00 +0000Conference ForumThe 3rd annual DPharm Europe: Disruptive Innovations to Advance Clinical Trials event is led by Co-Chairs Dr Sue Collier (GSK) and Dr Jeff Kasher (Patients Can’t Wait).  This radio blogcast gives a five minute overview of the event, which presents...337clinical trials,disruptive innovation,new models in clinical trials,prgamatic clinial trials,real world clinical trialsfalsefullhttps://www.spreaker.com/episode/immuno-oncology-360-conference-in-5-minutes-what-to-expect--63246150http://www.blogtalkradio.com/pharmatalk/2017/01/26/immuno-oncology-360-conference-in-5-minutes-what-to-expectThu, 26 Jan 2017 04:30:00 +0000Conference Forum The 3rd annual Immuno-Oncology 360° event takes place February 1-3, 2017 in NYC.  Lead advisors, Dr Axel Hoos (GSK) and Dr James Gulley (NCI) co-present a program that provides a  360-degree approach addressing the most-up-to-date information...283dr axel hoos,immuno-oncology,immuno-oncology360,immuno-oncology conference,io360falsefullhttps://www.spreaker.com/episode/dpharm-team-discuss-2016-highlights--63246272http://www.blogtalkradio.com/pharmatalk/2016/08/12/dpharm-team-discuss-2016-highlightsFri, 12 Aug 2016 15:00:00 +0000Conference ForumMembers of the DPharm team engage in an informal conversation to highlight what's happening in innovation and the latest thinking to disrupt clinical trials at the 6th annual event. Also discussed is a brief history of how this conference dedicated to...2049biotechnology,clinical trials,disruptive innovations,dpharm,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/pfizer-s-blue-sky-approach-to-help-transform-clinical-research--63246282http://www.blogtalkradio.com/pharmatalk/2016/08/10/pfizers-blue-sky-approach-to-help-transform-clinical-research-1Wed, 10 Aug 2016 17:00:00 +0000Conference ForumPfizer’s “Blue Sky” approach to transforming clinical research in Parkinson’s disease is an inspiring example of patient-centric innovation. Conference Forum's, Valerie Bowling welcomes co-host, Ed Miseta, Clinical Leader.com in a discussion with...1915blue sky approach,clinial trials,parkinson's disease,pfizer,sensorsfalsefullhttps://www.spreaker.com/episode/communicating-the-good-bad-ugly-for-cmos-and-r-d-leaders-in-biotech--63246156http://www.blogtalkradio.com/pharmatalk/2016/05/16/communicating-the-good-bad-ugly-for-cmos-and-rd-leaders-in-biotechMon, 16 May 2016 18:00:00 +0000Conference ForumThis discussion provides helpful approaches for Chief Medical Officers (CMOs) and other R&D leadership in biotech on how to communicate effectively in times of good, bad or unexpected news. Also discussed in this program are factors to evaluate...2548biotechnology,chief medical officer,pharmaceutical,physicians in biotech,r&dfalsefullhttps://www.spreaker.com/episode/clinical-trial-opportunities-in-puerto-rico--63246214http://www.blogtalkradio.com/pharmatalk/2016/05/13/clinical-trial-opportunities-in-puerto-ricoFri, 13 May 2016 13:00:00 +0000Conference ForumWhat is the quality, capacity and efficiency of running clinical trials in Puerto Rico? In this discussion we speak with Dr Myrto Lee, Director, PwC'sStrategy&, UK and Dr Kosmas Kretsos, Executive Director of the Puerto Rico Consortium for...2505clinical trials,investigative sites,sitesfalsefullhttps://www.spreaker.com/episode/alternative-model-to-transform-a-funding-gap-in-rare-disease-clinical-research--63246288http://www.blogtalkradio.com/pharmatalk/2016/04/07/alternative-model-to-transform-a-funding-gap-in-rare-disease-clinical-researchThu, 07 Apr 2016 13:30:00 +0000Conference ForumFrustrated that a promising therapy for a rare cancer was sitting in a freezer due to the lack of a relatively modest amount of funding, author Alexander Masters helped lead a campaign to crowd-fund a clinical trial: the result, iCancer.org.uk. The...2148cancer trials,clinical trials,disrupting clinical trials,icancer.org.uk,oncolytic virus fundfalsefullhttps://www.spreaker.com/episode/a-new-economic-solution-to-drive-cures-to-patients--63246289http://www.blogtalkradio.com/pharmatalk/2016/04/01/a-new-economic-solution-to-drive-cures-to-patientsFri, 01 Apr 2016 13:00:00 +0000Conference ForumGeneric drugs can be repurposed to create effective treatments in unsolved diseases. However, there is no economic incentive for industry to pay for a clinical validation and regulatory approval process for most generic drug repurposing because it...2975drug development,generic drugs,new economic model in drug dev,repurposing drugs,social impact bondsfalsefullhttps://www.spreaker.com/episode/partnering-with-patients-in-the-development-lifecycle-of-medicines--63246287http://www.blogtalkradio.com/pharmatalk/2016/01/21/partnering-with-patients-in-the-development-lifecycle-of-medicinesThu, 21 Jan 2016 15:00:00 +0000Conference ForumPharmatalk's Valerie Bowling welcomes Anton (Tony)  Hoos, MD, PhD, Head of Medical, Amgen Europe and Marc Boutin, JD, Chief Executive Officer, National Health Council.  We address how industry and patients can work together to incorporate the patient...2423clinical research,clinical trials,partnering with patients,patients,patients in clinical trialsfalsefullhttps://www.spreaker.com/episode/immuno-oncology-drug-development-challenges-next-steps--63246176http://www.blogtalkradio.com/pharmatalk/2015/12/21/immuno-oncology-drug-development-challenges-next-stepsMon, 21 Dec 2015 20:00:00 +0000Conference ForumPharmaTalk Radio's Valerie Bowling welcomes Immuno-Oncology 360° Co-Chair James Gulley, MD, PhD,National Cancer Institute as he leads a discussion with fellow Co-Chair, Axel Hoos, MD, PhD, GlaxoSmithKline. Together they discuss what's currently...3460cancer research,immuno-oncology,immuno-oncology 360,immunotherapy,iofalsefullhttps://www.spreaker.com/episode/making-clinical-trials-a-care-option-for-patients-piloting-an-infrastructure--63246255http://www.blogtalkradio.com/pharmatalk/2015/12/07/making-clinical-trials-a-care-option-for-patients-piloting-an-infrastructureMon, 07 Dec 2015 15:00:00 +0000Conference ForumAt Dpharm US 2015, Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly hosted a talk show on MakingClinical Trials a Care Option for Patients to fantastic reviews. Valerie Bowling, producer welcomes Katherine as she hosts a similar...2745care options for patients,clinical research,clinical research site network,clinical trials,patient engagementfalsefullhttps://www.spreaker.com/episode/safety-elements-of-cancer-immunotherapies-immune-related-adverse-events--63246225http://www.blogtalkradio.com/pharmatalk/2015/11/10/safety-elements-of-cancer-immunotherapies-immune-related-adverse-eventsTue, 10 Nov 2015 05:00:00 +0000Conference ForumIn this episode of Pharma Talk Radio, we feature medical oncologist, Dr Anna Pavlick, Director of the Melanoma Program at the NYU Cancer Institute on Safety Elements of Cancer Immunotherapies. Dr Pavlick originally gave this presentation in June 2015...1514cancer thereapies,immuno-oncology,immuno-oncology 360,immunotherapies,io360falsefullhttps://www.spreaker.com/episode/how-the-availability-of-capital-impacts-the-role-of-the-cmo--63246291http://www.blogtalkradio.com/pharmatalk/2015/10/19/how-the-availability-of-capital-impacts-the-role-of-the-cmoMon, 19 Oct 2015 03:30:00 +0000Conference ForumAt the May 2015 Chief Medical Officer’s Summit in Boston, we featured a session on: How the Availability of Capital Impacts the Role of the CMO In this session, the panelists cover: Optimal use of the proceeds Determining a development path, new...2330biotech,biotechnology,chief medical officer,cmo,r&dfalsefullhttps://www.spreaker.com/episode/how-investors-assess-r-d-biotech-management--63246292http://www.blogtalkradio.com/pharmatalk/2015/10/19/how-investors-assess-rd-biotech-managementMon, 19 Oct 2015 02:30:00 +0000Conference ForumAt the May 2015 Chief Medical Officer's Summit in Boston, we featured a session on: How Investors Assess R&D Biotech Management Take a look at the details below: In this session, we begin with a presentation on a perspective on the method of...2966biotech,biotechnology,cmo,physicans in life sciences,venture capitalfalsefullhttps://www.spreaker.com/episode/the-journey-of-a-physician-ceo-with-david-schenkein-md-ceo-agios--63246250http://www.blogtalkradio.com/pharmatalk/2015/09/21/the-journey-of-a-physician-ceo-with-david-schenkein-md-ceo-agiosMon, 21 Sep 2015 01:30:00 +0000Conference ForumAt the Conference Forum's 2015 Chief Medical Officer's Summit in Boston, David Schenkein, MD, CEO, Agios provided a warm and personal keynote sharing his journey as a Physican CEO. In this recording of the session, gain an insight into Dr Schenkein's...2563agios,biotech,biotech leadership,ceo,david schenkeinfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-14-consumer-electronics-in-clinical-research--63246260http://www.blogtalkradio.com/pharmatalk/2015/07/21/clinical-air-episode-14-consumer-electronics-in-clinical-researchTue, 21 Jul 2015 13:00:00 +0000Conference ForumClinical Air Episode #14 is pleased to present a discussion on Consumer Electronics in Clinical Research.Craig Lipset, Head of Clinical Innovation R&D at Pfizer welcomes guests from Rebar Interactive and Eli Lilly to address and explore an update...3248clinical research,clinical trials,mobile in clinical trials,patient engagement,wearablesfalsefullhttps://www.spreaker.com/episode/immuno-oncology-exploring-the-challenges-potential--63246234http://www.blogtalkradio.com/pharmatalk/2015/06/04/immuno-oncology-exploring-the-challenges-potential-1Thu, 04 Jun 2015 20:00:00 +0000Conference ForumThe last 30 years of Immuno-Oncology research have provided strong evidence that tumors do recognize the immune system and their development can be stopped or controlled long term. Given the impressive survival data over the past five years, it is...2390cancer immunotherapy,immune system response,immunology,immuno-oncology,immunotherapyfalsefullhttps://www.spreaker.com/episode/design-thinking-for-clinical-trials--63246249http://www.blogtalkradio.com/pharmatalk/2015/04/20/design-thinking-for-clinical-trialsMon, 20 Apr 2015 19:00:00 +0000Conference ForumDesign Thinking is a human centered approach to innovation that helps uncover the sweet spot of opportunity where the needs of people, the possibilities of technology and the requirements for business success all converge. The application of the...2721clinical trials,design thinking,patient centered clinical tria,patient-centricity,patientsfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-13-transcelerate-industry-engagement--63246283http://www.blogtalkradio.com/pharmatalk/2015/01/16/clinical-air-episode-13-transcelerate-industry-engagementFri, 16 Jan 2015 17:00:00 +0000Conference ForumIn September 2012, TransCelerate Biopharma launched with the aim of simplifying and accelerating the delivery of innovative medicines to patients.  What progress has really been made and what are the realistic goals for 2015? In our 2015 kick off...2447clinical design;patient recrui,transcelerate;pharmaceutical ifalsefullhttps://www.spreaker.com/episode/risk-based-monitoring-new-thinking-on-clinical-oversight--63246185http://www.blogtalkradio.com/pharmatalk/2014/10/21/risk-based-monitoring-new-thinking-on-clinical-oversightTue, 21 Oct 2014 14:00:00 +0000Conference ForumSince the FDA and EMA published their current thinking on clinical oversight and risk-based monitoring (RBM) strategies, the topic has received a magnitude of attention, commanding column inches, webinar discussions and industry conferences. With so...2841central statistical monitoring,clinical trials,rbm,remote data monitoring,risk based monitoringfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-12-digital-startups-applications-for-clinical-research--63246228http://www.blogtalkradio.com/pharmatalk/2014/08/29/clinical-air-episode-12-digital-startups-applications-for-clinical-researchFri, 29 Aug 2014 13:00:00 +0000Conference ForumIn Clinical Air Episode #12, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Marc Sluijs, Director Life Science Business Development at Oracle Health Sciences.  Marc shares his thoughts on the digital health space and where...2565clinical research,clinical trials,digital health,digital health start ups,patient engagementfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-11-how-can-digital-complement-and-disrupt-clinical-trials--63246256http://www.blogtalkradio.com/pharmatalk/2014/08/15/clinical-air-episode-11-how-can-digital-complement-and-disrupt-clinical-trialsFri, 15 Aug 2014 17:00:00 +0000Conference ForumDonald Jones, Chief Digital Officer, Scripps Translational Science Institute talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer on what's happening with digital in drug development. Don discusses his thoughts on the evolution...2679biotech,clinical trials,patient engagement,patient recruitment,pharamceuticalfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-10-patients-as-partners-in-clinical-trials--63246248http://www.blogtalkradio.com/pharmatalk/2014/05/29/clinical-air-episode-10-patients-as-partners-in-clinical-trialsThu, 29 May 2014 18:00:00 +0000Conference ForumJoin host, Craig H. Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on what it really means to partner with patients in clinical trials. Guests include: Jeri Burtchell, Founder, Partners in Research Regina Holliday, Artist...2198biotech,clinical trials,patient engagement,patient enrollment,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-9-investing-in-the-future-of-clinical-research--63246187http://www.blogtalkradio.com/pharmatalk/2014/05/29/clinical-air-episode-9-investing-in-the-future-of-clinical-researchThu, 29 May 2014 14:00:00 +0000Conference ForumJoin host, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion onInvesting in the future of clinical research. Guests include: Todd Pietri, Co-Founder, Milestone Ventures Jeremy Sohn, Managing Director, MPM Capital  VC...2599apps,clinical trials,digital,mobile,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-8-investigators-as-partners-in-clinical-research--63246270http://www.blogtalkradio.com/pharmatalk/2014/05/27/clinical-air-episode-8-investigators-as-partners-in-clinical-researchTue, 27 May 2014 15:00:00 +0000Conference ForumIn Clinical Air episode # 8, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer hosts a show discussing investigators as partners in clinical research. Guests include: Christine Pierre, President, Society of Clinical Research Jacalyn...2523clinical sites,clinical trials,investigators,pharmaceutical,sitesfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-7-engaging-patients-by-sharing-electronic-clinical-data--63246235http://www.blogtalkradio.com/pharmatalk/2014/02/20/clinical-air-episode-7-engaging-patients-by-sharing-electronic-clinical-dataThu, 20 Feb 2014 14:30:00 +0000Conference ForumIn 2013 Pfizer launched the Pfizer Blue Button Project, a first-of-it’s-kind initiative enabling patients who have participated in clinical trials the opportunity to download their individual clinical data.  Using the Blue Button standard launched by...2054clinical data,clinical trial results,clinical trials,patient engagement,patientsfalsefullhttps://www.spreaker.com/episode/clinical-air-6-clinical-trial-visits-of-the-future--63246258http://www.blogtalkradio.com/pharmatalk/2014/01/09/clinical-air-6-clinical-trial-visits-of-the-futureThu, 09 Jan 2014 21:00:00 +0000Conference ForumHow a patient experiences a clinical trial is changing. Access, ease, efficiencey, safety and better quality data collection are the target goals. This episode features some of the emerging technologies together with a discussion on the opportunities...2558clinical innovation,clinical technologies,clinical trials,patient engagement,patient recruitmentfalsefullhttps://www.spreaker.com/episode/barriers-and-limitations-in-engaging-patients-in-clinical-trials--63246271http://www.blogtalkradio.com/pharmatalk/2014/01/06/barriers-and-limitations-in-engaging-patients-in-clinical-trialsMon, 06 Jan 2014 15:00:00 +0000Conference ForumJoin guests Kerri Weingard, ANP, COO, Verified Clinical Trials and Susan Salgado, PhD, Founder, Hospitality Quotient as they identify the barriers and limitations in engaging patients in clinical trials. What we can do about it through communication...2239clinical protocols,clinical trials,patient centricity,patient engagement,patient recruitmentfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-5-applications-for-mobile-sensors-in-clinical-research--63246290http://www.blogtalkradio.com/pharmatalk/2013/12/10/clinical-air-episode-5-applications-for-mobilesensors-in-clinical-researchTue, 10 Dec 2013 15:00:00 +0000Conference ForumThis episode provides a recap on what's happening with mobile/sensors in clinical trials especially as they affect patients. Host: Craig Lipset, Head of Clinical Innovation, R&D, Pfizer, Inc.  Guests: Tim Davis, CEO & Co-Founder, Exco...2871clinical trial innovation,mhealth,mobile applications in clinica,mobile technology in clinical ,sensors in clinical researchfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-4-clinical-innovation-continuum--63246237http://www.blogtalkradio.com/pharmatalk/2013/10/28/clinical-air-episode-4-clinical-innovation-continuumMon, 28 Oct 2013 17:30:00 +0000Conference ForumEli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm...1801clinical trial collaborations,clinical trials,clinical trial technologies,clinical trial trends,computer-assisted designsfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-3-dpharm-beyond--63246259http://www.blogtalkradio.com/pharmatalk/2013/10/08/clinical-air-episode-3-dpharm-beyondTue, 08 Oct 2013 16:30:00 +0000Conference ForumA panel of executives from leading pharma and the venture capital community at the DPharm Disruptive Innovations conference recently awarded the 2013 Disruptive Innovator of the Year title to Medidata Solutions and Spaulding Clinical Research. They...1835clinical trials,disruptive innovation,medidata solutions,patient engagement,spaulding clinical researchfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-2-to-serve-patients-in-clinical-trials--63246281http://www.blogtalkradio.com/pharmatalk/2013/09/10/clinical-air-episode-2Tue, 10 Sep 2013 20:00:00 +0000Conference ForumJoin us in a discussion on serving patients in clinical trials. Making clinical trials more accessible for patients Emerging technologies / iPads and informed consent Disruption Headlines in the news Host: Craig Lipset, MBA Head of Clinical...2987clinical trials,disruptive innovation,innovation,patients,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/managing-the-role-of-chief-medical-officer-in-a-biotech--63246275http://www.blogtalkradio.com/pharmatalk/2013/09/06/managing-the-role-of-chief-medical-officer-in-a-biotechFri, 06 Sep 2013 16:00:00 +0000Conference ForumThe CMO of a biotech is like no other job in the world. The CMO is not only responsible for delivering on clinical trials, but also is a key player in the company's fundraising efforts.   From the Chief Medical Officer Summit, please join co-chairs...3493biotech,chief medical officer,clinical trials,cmo,raising capitalfalsefullhttps://www.spreaker.com/episode/navigating-the-complexities-of-global-clinical-trials--63246274http://www.blogtalkradio.com/pharmatalk/2013/08/28/navigating-the-complexities-of-global-clinical-trialsWed, 28 Aug 2013 14:00:00 +0000Conference ForumDrs. Christopher Gallen, CEO at SK BioPharmaceuticals and Mitchell Katz, Executive Director, Medical Research Operations at Purdue Pharma, in a candid conversation on navigating the complexities of Global Clinical Trials and addressing topics...3183biotech,clinical trials,cros,global clinical trials,pharmaceuticalfalsefullhttps://www.spreaker.com/episode/clinical-air-episode-1-clinical-trial-calling--63246243http://www.blogtalkradio.com/pharmatalk/2013/08/12/clinical-air-episode-1-clinical-trial-callingMon, 12 Aug 2013 20:30:00 +0000Conference ForumJoin host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer with guests Joe Kim, Clinical Operations Director, Shire and Dr. Hugo Stevenson, physician and serial entrepreneur, as they discuss innovation transforming the clinical trial space...2664biotech,clinical trials,google glass,mobile technology,pharmaceuticalfalsefull